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Abstract 
Solids retention time (SRT) is one of the most important factors in designing and operating 
activated sludge systems for biological wastewater treatment. Longer SRTs have been shown to 
alter the structure and function of microbial communities, thereby leading to improved treatment 
efficacy with respect to bulk and trace organics, nutrient removal, and membrane fouling. 
However, research has also shown that longer SRTs lead to increased prevalence of antibiotic 
resistant bacteria, perhaps due to increased exposure to antibiotics present in influent wastewater. 
The purpose of this study was to characterize changes in microbial community structure in a 
laboratory-scale activated sludge system as a function of SRT (2-20 days) and influent 
concentrations (1x-100x ambient concentrations) of five antibiotics: ampicillin, 
sulfamethoxazole, tetracycline, trimethoprim, and vancomycin. Also, this research aimed to 
characterize the role of SRT and elevated antibiotic concentrations on AR proliferation in 
biological treatment processes. Changes in microbial community structure were evaluated based 
on traditional plating methods and 16s rDNA sequencing, and microbial community function 
was evaluated based on changes in effluent water quality, including bulk organic matter 
characterization and antibiotic concentrations. Spread plate technique was used to determine the 
number of Gram positive Staphylococcus/Streptococcus strains. The extent of AR was also 
determined based on minimum inhibitory concentrations (MICs) of resistant isolates. The results 
indicated that SRT—but not antibiotic loading—had a significant impact on microbial 
community structure (e.g., reduction in relative prevalence of Acinetobacter and Arcobacter) and 
effluent water quality. Therefore, spikes in influent antibiotics (at sub-therapeutic concentrations) 
are not expected to adversely impact biological wastewater treatment. The results revealed that 
longer SRTs and higher antibiotic concentrations select for antibiotic resistant bacteria (ARBs). 
iv 
The data obtained from this study suggests that longer SRTs may select for trimethoprim-
resistant bacteria and/or result in false positives for trimethoprim resistance due to higher 
concentrations of free thymine or thymidine. 
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1 
1.0 INTRODUCTION 
The discovery of antibiotics is considered a turning point in human health history because 
antibiotics have been responsible for saving millions of people each year. The term “antibiotic” 
is defined as any class of organic molecule that kills or inhibits microbes by specific interactions 
with bacterial targets (Davis and Davis, 2010). Unfortunately, the intensive use of antibiotics for 
therapeutic and non-therapeutic purposes has significantly decreased the effectiveness of 
antibiotics over the past 60 years. Although there are no regulated statistics available on the 
quantity of antibiotics used in the United States, it is estimated that over 20 million pounds of 
antibiotics are used in agriculture and veterinary medicine, which is about 80 percent of the total 
antibiotics sold in the U.S. each year. 
In addition to general concerns related to antibiotic occurrence and exposure, recent studies 
suggest a link between wastewater treatment and the occurrence of antibiotic resistant bacteria 
(ARB) and antibiotic resistance genes (ARGs) (Auerbach et al., 2007; Zhang et al., 2015). In 
fact, wastewater treatment plants (WWTPs), which are critical for protecting human and 
environmental health from pollution in wastewater, are now considered significant reservoirs of 
antibiotic resistance (AR) (Novo and Manaia, 2010). The presence of antibiotics in wastewater 
matrices can form a selective pressure that increases the concentration of ARBs by inhibiting 
antibiotic-susceptible bacteria and increasing the probability of mutation and horizontal gene 
transfer (Schwartz et al., 2003; Martinez, 2008; Wang et al., 2011). As such, ARB and ARGs are 
now considered wastewater-derived contaminants of emerging concern (CECs) that pose a threat 
to public health (Pruden et al., 2006). However, the role of WWTPs in the dissemination and 
proliferation of ARB and ARGs is still unclear, and there is still a lack of comprehensive studies 
assessing the effects of operational conditions in biological processes on the prevalence of 
2 
antibiotic resistance in treated wastewater. For example, solids retention time (SRT), or the 
average amount of time bacteria are recycled within an activated sludge system, has been shown 
to impact microbial community structure (e.g., with respect to nitrification) so SRT may also 
have an impact on the prevalence of antibiotic resistance and the ability of the microbial 
community to biodegrade CECs commonly found in wastewater, including antibiotics.   
A general goal of this research is to provide a better understanding of the effects of several 
operational and water quality variables on the occurrence, proliferation, and mitigation of 
antibiotics and antibiotic resistance in wastewater. This research was divided into three tasks, 
each of which focused on specific research questions:  
1.1 Environmental reservoirs of thymidine as a mechanism of trimethoprim resistance: 
Background: Trimethoprim disrupts the conversion of dihydrofolate to tetrahydrofolate—a 
process involved in the synthesis of nucleotides. Although trimethoprim blocks the 
tetrahydrofolate pathway, bacteria might still be able to obtain thymidine or thymine from 
growth media or from their environment, thereby artificially elevating the observed level of AR. 
Bacterial cells lyse when they enter the death phase, which releases their cellular contents (e.g., 
thymine and thymidine) into their surrounding environment. In theory, more cell debris may be 
indicative of higher concentrations of free thymine and thymidine in a biological reactor. 
Because there is a higher bacterial death rate at longer SRTs, such systems may be characterized 
by greater trimethoprim resistance due to water quality differences (i.e., higher free thymine 
and/or thymidine) rather than—or in addition to—changes in the microbial community. With 
some culture-based techniques, like membrane filtration, bacteria are separated from their 
aqueous environment, but with other techniques, such as the spread plate method, an aliquot of 
3 
the aqueous sample is transferred to the growth media. Therefore, the number of trimethoprim 
resistant bacteria might be influenced by the method used. In this task, culture-based methods 
will be used to quantify the level of trimethoprim resistance as a function of media used (i.e., 
media with low levels of thymine/thymidine vs. media with higher levels of thymine/thymidine) 
and as a function of the quantity of cellular debris. 
Research question: How does thymidine in environmental samples interfere with the detection 
of trimethoprim resistant bacteria and how does SRT impact environmental reservoirs of 
thymidine-like compounds? 
Hypothesis: Because thymine/thymidine can be found in some nutrient media or the intracellular 
components of lysed bacteria from biological treatment systems, bacteria can access these 
environmental reservoirs, thereby bypassing traditional mechanisms of thymine/thymidine 
production, and grow in the presence of clinical concentrations of trimethoprim. Longer SRTs 
also yield greater quantities of cellular debris, thereby yielding greater numbers of bacteria with 
apparent trimethoprim resistance.  
Approach: The SBRs will be operated with similar conditions to those described above. The 
microbiological components of the study will be divided into four sets of experiments: (1) 
manual augmentation of thymidine with reagent-grade chemical, (2) manual augmentation of 
thymidine via cell lysing, (3) varying of SRT in the SBRs to evaluate the effects of cellular 
debris, and (4) varying of SRT in the SBRs to evaluate single- and multi-drug resistance.  
Outcome: Results from this research will show that some trimethoprim sensitive bacteria can be 
reported as resistant bacteria, which may erroneously overestimate the role of biological 
treatment systems in proliferating AR. 
4 
1.2 Microbial community structure and function: 
Background: Longer SRTs may alter microbial community structure and function, which can 
lead to reductions in TOrC concentrations, improved nutrient removal, and greater 
transformation of bulk organic matter. Despite efforts to understand the microbial communities 
in WWTPs, specifically in biological treatment systems, there are still many uncertainties 
regarding microbial community structure and function. Contradictory outcomes may arise when 
studies focus on different influent wastewater qualities, different treatment technologies and/or 
operational conditions, and even different methodologies for assessment of microbial community 
structure. Therefore, additional studies and analyses are needed to assess the role of wastewater 
treatment processes and their operational conditions (e.g., SRT) on microbial community 
structure. Furthermore, with current rates of antibiotic production and consumption, it is quite 
possible to expect higher concentrations of antibiotics in raw wastewaters. Moreover, accidental 
releases of untreated industrial wastewater (e.g., pharmaceutical manufacturing) may increase 
the risk of biological treatment failure if bacteria are exposed to unusually high concentrations of 
antibiotics. This may adversely impact microbial community structure and function, reduce the 
efficacy of wastewater treatment by inhibiting critical subpopulations, and possibly lead to the 
failure of biological treatment. Therefore, a more comprehensive understanding of the effects of 
operational conditions, specifically SRT, and varying influent antibiotic concentrations on 
wastewater treatment is needed.   
Research question 1: What is the effect of varying solids retention time (SRT) on (i) microbial 
community structure and (ii) trace organic compound (TOrC) concentrations? 
Hypothesis 1: Biological treatment systems with longer SRTs may select for slowly growing 
bacteria capable of degrading a wider variety of TOrCs and achieving lower effluent TOrC 
5 
concentrations. Longer SRTs will promote a shift in microbial community structure, as 
determined by 16s rDNA sequencing.  
Research question 2: What is the effect of varying influent antibiotic concentrations on (i) 
microbial community structure and (ii) TOrC concentrations? 
Hypothesis 2: Higher antibiotic concentrations in biological reactors may inhibit the growth and 
metabolic activity of some microorganisms, thereby promoting a shift in microbial community 
structure and hindering TOrC degradation. 
Approach: In Task 1, laboratory-scale sequencing batch reactors (SBRs) were designed to 
mimic an activated sludge process operating with SRTs of 2 days, 7 days (in duplicate), and 20 
days to understand the role of varying SRT on microbial community structure. In Task 2, the 
SBRs will be operated at a constant SRT of 7 days, but the reactor influent will be spiked with 
target antibiotics at concentrations of 1x (ambient primary effluent concentrations), 10x (in 
duplicate), and 100x. Ambient concentrations of the target antibiotics (ampicillin, 
sulfamethoxazole, tetracycline, trimethoprim, and vancomycin) will be determined during Task 
1. Despite the elevated spiking levels, the concentrations are still likely to be sub-inhibitory when 
compared against clinical standards. Samples will be collected from the SBRs for 16s rDNA 
sequencing. After extraction and purification, the DNA will be shipped to Research and Testing 
Laboratory (Lubbock, TX) for amplification with universal primers for Bacteria and analysis 
with a MiSeq sequencer (Illumina, San Diego, CA). After preliminary data processing, statistical 
analyses will be performed on the top 10 most abundant genera by principal component analysis 
(PCA). 
Outcome: Microbial community structure in biological wastewater treatment processes has been 
previously analyzed, but the analyses have generally been performed on large systems with 
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limited experimental control. The results from this study will clarify the roles of SRT and 
influent antibiotic concentrations on microbial community structure and function with respect to 
TOrC degradation. Also, SBR performance and treatment efficiency at ambient and elevated 
concentrations of antibiotics will help predict the risk of treatment process failure during 
transient antibiotic loading conditions. 
1.3 Relative abundance and extent of AR: 
Background: Despite the efforts to elucidate the role of WWTPs in relation to antibiotic 
resistance, there is still no clear evidence that WWTPs, specifically the biological treatment 
processes, are contributing to the proliferation of antibiotic resistance. Some studies suggest that 
WWTPs achieve a significant reduction in the number of ARB (Guo et al., 2015; Huang et al., 
2012), while other research indicates that WWTPs serve as major contributors of ARB and 
ARGs (Kim et al., 2010). It is important to remember that comparing the results from different 
WWTPs with different influent wastewater quality, treatment trains and technologies, and 
operational conditions may not yield meaningful relationships between antibiotic resistance and 
biological treatment. In fact, the contradictions reported in the existing literature might be 
attributable to such differences. Therefore, in order to truly understand the role of biological 
treatment systems in relation to AR, more controlled experiments are needed to reduce the 
number of uncertainties. By using laboratory-scale SBRs fed with primary effluent from a single 
WWTP, it is possible to isolate the effect of SRT and elevated antibiotic concentrations on the 
target AR metrics. 
Research question 1: What is the effect of varying SRT on relative abundance and extent of 
antibiotic resistance in biological treatment systems?  
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Hypothesis 1: Prolonged exposure of bacteria (i.e., longer SRTs) to sub-inhibitory 
concentrations of antibiotics, heavy metals, and other antimicrobial agents (e.g., triclosan) will 
lead to (i) higher rates of antibiotic resistance, as measured by relative abundance of ARBs and 
(ii) greater extent of antibiotic resistance, as measured by minimum inhibitory concentrations 
(MICs) of antibiotic resistant isolates. 
Research question 2: What is the effect of varying influent antibiotic concentrations on relative 
abundance and extent of antibiotic resistance in biological treatment systems? 
Hypothesis 2: Prolonged exposure of bacteria to elevated, yet still sub-clinical, concentrations of 
antibiotics in primary wastewater effluent will lead to (i) higher rates of antibiotic resistance, as 
measured by relative abundance of ARBs and (ii) greater extent of antibiotic resistance, as 
measured by MICs of antibiotic resistant isolates. 
Approach: The SBRs will be operated with similar conditions to those described above. In order 
to detect culturable ARB, the spread plate technique will be used. Colony counts on Mueller-
Hinton (MH) agar containing Staph/Strep Supplement will serve as the ‘total’ culturable count, 
and the colony counts on the same media supplemented with the target antibiotics at standard 
clinical concentrations will serve as the AR counts. The AR percentage will be reported to 
account for variations in total bacteria as a function of SRT. A total of eight random AR isolates 
will also be harvested for each antibiotic, and pure cultures of each isolate will be assayed with 
the MIC method. 
Outcome: The results from this study will provide a better understanding of the role of SRT and 
influent antibiotic concentrations on relative AR abundance and extent of AR in biologically 
treated wastewater effluents.  
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 This dissertation has a general literature review on antibiotic resistance followed by three 
chapters, which are presented as standalone papers. Each paper answers one of the main research 
questions and contains 5 sections including: (1) abstract, (2) critical literature review, (3) 
research methods, (4) results and discussions, and (5) conclusions. 
2.0 STATE OF KNOWLEDGE 
2.1 Antibiotic Resistance as an Emerging Threat 
In 2011, the World Health Organization (WHO) identified antibiotic resistance (AR) as “one of 
the three greatest threats to human health” (WHO, 2011). Recent scientific studies have also 
established a link between recycled water and environmental occurrence of AR (Fahrenfeld et 
al., 2013).  
The discovery of antibiotics is considered a turning point in human health history. The first class 
of sulfonamide antibiotics was introduced in the mid-20th century. Due to the initial efficacy of 
the sulfonamides, these antibiotics became more prevalent, which presumably led to the rise of 
sulfonamide resistance (Costa et al., 2006). After the discovery of sulfonamides, other classes of 
antibiotics, such as penicillin and streptomycin, were also discovered and administered, which 
led to further antibiotic resistance. Similar cycles of drug development, widespread use, and 
increased resistance have since been observed. 
In recent decades, many pathogenic bacteria have evolved into multi-drug resistant (MDR) 
bacteria. Concern is growing about MDR bacteria because of their resistance to a wide range of 
antibiotics. In fact, previous studies confirmed that patients who visited hospitals more 
frequently were more susceptible to MDR pathogens. (McAdam et al., 2010). Unfortunately, the 
rate of development and production of new antibiotics has significantly declined over the past 30 
9 
years. Therefore, the emergence of single- and multi-drug resistance coupled with the decreasing 
number of effective antibiotics necessitates a coordinated global strategy to slow the spread of 
AR. Figure 2-1 shows the antibiotic resistance evolution over the last 80 years and suggests that 
society may be returning to the pre-antibiotic era. 
 
Figure 2-1. Timeline of Antibiotic Resistance 
*VRSA = vancomycin-resistant Staphylococcus aureus, ESBL = extended spectrum beta-lactamases, VRE = 
vancomycin-resistance Enterococcus, MRSA = methicillin-resistant Staphylococcus aureus. 
Wastewater treatment plants play an important role in protecting human and environmental 
health from pollution in wastewater, but they are also considered significant reservoirs for AR. 
Previous studies investigated the role of wastewater treatment plants in the proliferation or 
mitigation of antibiotic resistant bacteria (ARBs) and antibiotic resistance genes (ARGs) (Zhang 
et al., 2015; Guo et al., 2015.; Su et al., 2014). These studies highlighted the selection pressure 
exerted on bacteria in wastewater matrices (Schwartz et al., 2003). Specifically, the presence of 
antibiotics can form a selective pressure that increases the concentration of ARBs by inhibiting 
antibiotic-susceptible bacteria. This medium also increases the chance of mutation and horizontal 
gene transfer (HGT) (Wang et al., 2011; Martinez, 2008). 
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Data reported in previous publications are sometimes inconsistent and contradictory. For 
example, Aminov et al. (2001) and Auerbach et al. (2007) showed that due to the continuous 
exposure of bacteria to sub-inhibitory concentrations of antibiotics, wastewater treatment plants 
provide an environment that is potentially suitable for proliferation of ARGs and ARBs. 
However, Suller et al. (2000) showed that continuous exposure of a triclosan-sensitive 
Staphylococcus aureus strain to sub-inhibitory concentrations of triclosan did not promote any 
changes in triclosan susceptibility or to other targeted antibiotics.  
Despite the efforts to elucidate the role of wastewater treatment plans (WWTPs) in relation to 
antibiotic resistance, there is still no clear evidence that WWTPs, especially the biological 
treatment processes, are contributing to the proliferation of antibiotic resistance. Some studies 
suggest that WWTPs achieve a significant reduction in the number of ARBs (Guo et al., 2015; 
Huang et al., 2012), while other research indicates that WWTPs serve as major contributors of 
ARBs and ARGs (Kim et al., 2010). These uncertainties may arise from research evaluating 
different treatment technologies, operational conditions, influent wastewater quality or 
wastewater constituents, and different methodologies for the detection of ARBs and ARGs. 
Therefore, additional studies and analyses are needed to assess the role of wastewater treatment 
processes on proliferation and mitigation of antibiotic resistance.  
Human and animal gastrointestinal systems are likely significant contributors to antibiotic 
resistance in the environment. As demonstrated in the recent literature, one of the potential 
pathways for the release of human-derived AR into the environment is through the discharge of 
treated wastewater effluent (Kim et al., 2010). Wastewater-impacted surface waters have been 
shown to contain many tetracycline residues (Kim et al., 2010) at concentration as high as 4 µg/L 
(Kolpin et al., 2002). Raw sewage entering the plant contains a wide variety of inorganic and 
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organic contaminants, including heavy metals, antibiotics, and detergents that have been linked 
to AR development. The raw sewage also contains a baseline level of AR in the form of ARBs 
and ARGs (Zhang et al., 2009). Once these compounds and AR building blocks reach the 
secondary biological treatment process, they enter an ideal environment for bacterial activity, 
growth, horizontal gene transfer (Kim et al., 2010), and co- or cross-resistance to antibiotics 
(Silver and Phung, 1996; Alonso et al., 2001; Baker-Austin et al., 2006). However, as mentioned 
earlier, it is not yet clear whether the secondary biological treatment process actually contributes 
to the proliferation of AR or whether it actually provides some level of mitigation due to AR 
bacteria being outcompeted. 
Kim et al. (2010) performed a mass balance to clarify the role of the activated sludge process in 
proliferating or attenuating tetracycline resistant bacteria (TRBs) and tetracycline resistance 
genes (TRGs) in different WWTPs. They found that WWTPs neither amplified nor attenuated 
the TRBs and TRGs. The results also indicated that among 20 different TRGs tested, tet(O) and 
tet(W) genes were the most abundant genes throughout the treatment train. Zhang et al. (2015) 
investigated the fate of antibiotic-resistant phenotypes of cultivable heterotrophic bacteria and 
ARGs in three WWTPs in China. The research team monitored thirteen ARGs in activated 
sludge from anaerobic, anoxic, and aerobic zones. These ARGs were from tetracycline, 
sulfonamide, streptomycin, and -lactam resistance classes.  The result from this study indicated 
that WWTPs displayed considerable reduction in the total cultivable heterotrophic bacteria 
containing resistance elements. They also showed that ARGs are more frequent in influent than 
effluent suggesting that the wastewater treatment facilities contribute to a decrease in the 
prevalence of antibiotic resistance. However, the results confirmed that during activated sludge 
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process, ARGs abundance increased, thereby suggesting that ARGs accumulate in sludge rather 
than remaining in the aqueous phase. 
Wang et al. (2015) monitored the fate of 10 subtypes of ARGs for sulfonamide, tetracycline, -
lactam class, and macrolide resistance and the class 1 integrase gene (intI1) across each stage of 
5 full-scale pharmaceutical WWTPs in China. The results showed that the WWTPs can reduce 
the number of ARGs by 0.5-2.5 orders of magnitude in the aqueous phase, but a significant 
amount of ARGs are discharged in dewatered sludge. The total load of ARGs in dewatered 
sludge was 7-fold to 308-fold higher than raw influent and 16-fold to 638-fold higher than final 
effluent. The results also showed the proliferation of ARGs in the biological treatment processes. 
Shi et al. (2013) evaluated the effect of chlorination on microbial antibiotic resistance in drinking 
water treatment plants. 16S rRNA gene cloning indicated that Proteobacteria are the main ARB 
in drinking water. The results also showed that after chlorination, resistance to chloramphenicol, 
trimethoprim, and cephalothin was higher among surviving bacteria, possibly indicating a link 
between resistance to disinfection and resistance to antibiotics.  
Pruden et al. (2012) investigated the occurrence of ARGs in different environments, including 
river sediments, dairy lagoons, irrigation ditches, and wastewater and drinking water treatment 
plants. The polymerase chain reaction (PCR) technique was used to detect several tetracycline 
and sulfonamide ARGs. Quantitative PCR (qPCR) assays were performed to further quantify 
two tetracycline ARGs tet(W) and tet(O) and two sulfonamide ARGs sul(I) and sul(II). The 
results confirmed that ARG concentrations in environments impacted by human/agricultural 
activity are higher than pristine environments. 
Kristiansson et al. (2011) investigated the microbial communities in river sediments receiving 
wastewater from pharmaceutical companies. A culture-independent shotgun metagenomic 
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technique was applied to determine the microbial communities. In order to characterize the 
resistome, the research team searched the metagenomes for signatures of known antibiotic 
resistance genes. The results showed that significant differences were found among resistance 
genes associated with different classes of antibiotics, including sulfonamides, fluoroquinolones, 
and aminoglycosides in downstream locations compared to upstream locations. The same pattern 
was observed for integrons, transposons, and plasmids. The relative abundance of class 1 
integrases, transposase (associated with insertion sequence common regions (ISCRs)), and two 
plasmids (RSF1010 and pMTSm3) were considerably higher in downstream locations compared 
to upstream locations, suggesting the higher mobility of resistance genes in downstream. These 
genes could eventually be transferred from environmental microbes to human pathogens. 
In 2009, a strain of Klebsiella pneumonia with a broad range of antibiotic resistance was 
identified from a Swedish patient previously hospitalized in India (Yong et al., 2009). The 
antibiotic resistance determinant was recognized as a novel metallo--lactamase (MBL) and 
designated the New Delhi metallo--lactamase (NDM-1), which is an enzyme that confers 
resistance to a broad range of antibiotics. Bacteria with this type of multidrug resistance pose a 
great risk to global health (Luo et al., 2014). Luo et al. (2014) investigated the proliferation of 
multidrug resistant New Delhi metallo--lactamase genes in different processes in WWTPs in 
China. The results indicated that NDM-1 gene prevailed throughout several treatment units, 
including the discharged effluent, and that NDM-1 genes were found in higher concentrations in 
dewatered sludge.  
Chen et al. (2013) conducted research to evaluate the removal rate of ARGs in WWTPs in China. 
Three WWTPs with different advanced treatment systems (biological aerated filter, constructed 
wetland, and UV disinfection) were selected to quantify the concentration of ARGs. In this 
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study, the concentrations of 16S rRNA genes, tet(M), tet(O), tet(Q), sul(I), sul(II) and intI1 were 
measured in wastewater and biosolids. The results revealed that ARGs concentration decreased 
by 1.3-2.1 orders of magnitude in the constructed wetland and by 1.0-1.2 orders of magnitude in 
the biological aerated filter. However, only small changes were observed for the targeted ARGs 
between influent and effluent of the UV disinfection system. The same observation was made by 
McKinney and Pruden (2012) regarding the limited potential of UV disinfection to damage 
ARGs in wastewater effluents. 
Although many of the recent AR studies focus on molecular methods, some studies are assessing 
AR occurrence and fate through culture-based methods. Zhang et al. (2015) studied AR among 
heterotrophic bacteria using traditional spread plating and streaking techniques. The bacterial 
isolates were tested for susceptibility to 12 different antibiotics based on the standard 
concentrations identified by the CLSI. One of the major findings from the study was that 
wastewater treatment plants typically reduced the extent of multi-drug resistance in the treated 
effluent. In other words, bacteria present in the effluent were resistant to fewer antibiotics than 
bacteria present earlier in the treatment train. Through sequencing, they also discovered that 
Gram negative bacteria dominated the wastewater influent, while Gram positive bacteria 
dominated the effluent. 
Amador et al. (2015) evaluated the role of hospitals and wastewater treatment plants as 
contributors of AR in Portugal. The ampicillin-resistant Enterobacteriaceae were enumerated 
and isolated and were tested for antimicrobial susceptibility using the disk diffusion method. The 
study measured the resistance to the -lactam group of antibiotics, including cefoxitin and the 
combination of amoxicillin and calvulanic acid, and the non--lactam group, including 
tetracycline and the combination of trimethoprim and sulfamethoxazole. The results showed that 
15 
wastewater treatment plant effluent contained a higher rate of multidrug resistance compared 
with the untreated influent. A similar study was performed by Nagulapally et al. (2009) to 
examine the occurrence of ciprofloxacin, trimethoprim/sulfamethoxazole, and vancomycin 
resistant bacteria in a wastewater treatment plant. The results revealed that a significant number 
of fecal coliforms, E. coli, and enterococci exhibited resistance to the target antibiotics in 
municipal treatment plants.  
2.2 Drivers of Antibiotic Resistance 
The rapid appearance and widespread proliferation of multidrug resistant phenotypes was a 
relatively unexpected phenomenon. It was originally believed that mutation had a key role for 
spreading antibiotic resistance, but the emergence of bacteria with multidrug resistance led to the 
discovery of transferable genetic materials like conjugative R-plasmids and transposons (Row-
Magnus and Mazel, 2002). Integrase is a type of site-specific recombinase that promotes 
recombination between two defined sequences in DNA. One typical example is integration of 
phage DNA into a bacterial chromosome. An integron is an integrase with a specific site for 
integration of gene cassettes, which might include ARGs. Integrons are thought to be one of the 
important actors in the dissemination of resistance genes among diverse Gram-negative isolates 
(Hall and Stokes, 1993; Bennett, 1999). Great attention is given to the Gram-negative bacteria of 
the Enterobacteriaceae since they are responsible for common food-borne diseases. However, 
Gram-positive bacteria are also a major reservoir of class 1 antibiotic resistance integrons (Nandi 
et al., 2004). 
Plasmids are known as extrachromosomal genetic material carrying multiple genes, including 
ARGs. Plasmids are circular molecules of double-stranded or linear DNA and may vary in size 
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from a few thousand to hundreds of thousands of base pairs. Bacterial cells carry plasmids 
because they provide gene products that benefit the bacteria in special circumstances. However, 
bacteria may lose their plasmids when they are no longer in need of those benefits (i.e., when 
encountering reduced or eliminated selective pressure). Bacteria can ‘justify the costs’ of 
harboring resistance genes when the risks of exposure to antibiotics or heavy metals are 
increased (Baquero and Coque, 2014). A study by Gullberg et al. (2014) showed that continuous 
exposure of bacteria to sublethal concentrations of antibiotics and heavy metals is sufficient to 
justify the maintenance cost of harboring resistance elements. Plasmids are of interest due to 
their ability to code for multidrug resistance and also their ability to spread genes via bacterial 
conjugation, which is one form of horizontal gene transfer (HGT). HGT can be accomplished by 
three main mechanisms: conjugation, transduction, and transformation.  
I Conjugation 
Bacterial conjugation occurs when genetic material is transferred between two cells by direct 
cell-to-cell contact. In this system, the donor cell provides the transferable genetic elements, such 
as a plasmid or transposon, via pilus attachment (Error! Reference source not found.). A 
transposon is a DNA sequence that can use transposase (a specialized recombinase) to freely 
move along the DNA from one place to another. The mechanism of conjugation has been 
highlighted in systems with high concentrations of both bacteria and antibiotics (Shoemaker et 
al., 2001; Davies and Davies, 2010; Dodd et al., 2012), such as human or animal gastrointestinal 
tracts, but some studies have also demonstrated the potential for conjugative gene transfer to 
occur in wastewater and the environment (Alcaide and Garay, 1984; Dodd et al., 2012). 
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Figure 2-2. Conjugation mechanism 
Reprinted from Antibiotic Resistance: A Guide for Effective Prescribing in Women's Health, Vol 53, Valerie A. 
Roe, Copyright 2008, with permission from Elsevier 
II Transduction  
In transduction, bacterial genetic elements, such as a piece of DNA, is transferred from one 
bacterium to another by a bacteriophage, which is a virus that infects bacteria. In transduction, 
direct contact between two cells is not required because the transfer occurs by a vector (i.e., the 
phage). Assuming the transferred DNA codes for antibiotic resistance, the ARG can potentially 
be transferred to the new host (Dodd et al., 2012). This mechanism has recently been observed in 
wastewater (Muniesa et al., 2004; Parsley et al., 2010; Colomer-Lluch et al., 2011; Dodd et al., 
2012). Error! Reference source not found. illustrates the bacterial transduction mechanism. 
Although the bacteriophages are thought to have a role in proliferation of antibiotic resistant 
bacteria, recent studies were focused on applying lytic phages to kill antibiotic resistant bacteria 
(Sulakvelidze, 2005). Lytic bacteriophages are effective in killing bacteria via mechanisms that 
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are different from those of antibiotics (Sulakvelidze, 2005). Thus, phage therapy may be a 
promising option for treating pathogenic antibiotic resistant bacteria (Sulakvelidze, 2005).  
 
Figure 2-3. Transduction mechanism 
Reprinted from Escherichia coli as a model active colloid: A practical introduction, Vol 137, Schwarz-Linek et al, 
Copyright 2016, with permission from Elsevier 
Bacteria which are infected by phages can either participate in a lysogenic cycle or a lytic cycle.  
In a lysogenic cycle, the cell continues to live and reproduce, but in a lytic cycle, the host cell is 
lysed after infection. 
III Transformation 
During transformation, bacteria will uptake foreign, free-floating genetic elements from the 
surrounding environment. The genetic elements could be naked DNA or a plasmid. For 
transformation to occur, a bacterium must be in a state of competence which can be promoted by 
changing environmental conditions. It appears that most bacteria are not able to take up DNA in 
an efficient way, but some chemicals may make them more permeable. On the other hand, there 
are bacteria that are able to take up DNA from their environment without any chemical 
treatment, which are called naturally transformable. Even naturally transformable bacteria cannot 
always take up DNA, and they must be at certain stage in their life cycle. Competence is referred 
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to the state that bacteria have in their life cycle in which they are able to take up naked DNA 
from their environment (Molecular Genetics of Bacteria, 2013). This mechanism of gene transfer 
has been specifically linked to streptococci and meningococci (Davies and Davies, 2010; Dodd 
et al., 2012), but it is not exclusive to these genera (Dodd et al., 2012). Figure 2-4 illustrates 
bacterial transformation. 
 
Figure 2-4. Transformation mechanism 
Reprinted from A simple bacterial transformation method using magnesium- and calcium-aminoclays, Vol 95, Choi 
et al. Copyright 2013, with permission from Elsevier 
2.3 Influence of Metals, Quaternary Ammonium Compounds, and Antimicrobial 
Agents  
The presence of quaternary ammonium compounds (QACs), heavy metals, and antimicrobial 
agents is another driving force for the development of antibiotic resistance. For metabolism, 
maintenance, and growth, bacteria require trace concentrations of some metals like zinc, nickel, 
chromium, and copper. Theses metals are necessary for bacterial metabolic activity and enzyme 
production, but they can also be toxic at higher concentrations (Seiler and Berendonk., 2012). 
Becerra-Castro et al. (2015) showed that copper or zinc at concentrations >60 mg/L may select 
20 
for antibiotic resistant phenotypes. Other heavy metals including silver, mercury, and lead are 
toxic to bacteria even at low concentrations (Seiler and Berendonk, 2012). In fact, the application 
of heavy metals, particularly silver, in industry and agriculture is common due to their 
bactericidal potential. 
A study by Salyers and Amabile-Cuevas (1997) suggested that decreases in antibiotic usage do 
not necessarily limit the spread and maintenance of AR because agents other than antibiotics can 
promote cross-resistance (Baker-Austin et al., 2006). For example, bacteria have evolved 
mechanisms of metal tolerance, including (1) complexation or sequestration of metals, (2) 
intercellular ion reduction via proteins (e.g., reduction of Hg2+ to Hg0 by MerA protein), and (3) 
efflux systems (Seiler and Berendonk, 2012). These mechanisms are relevant to antibiotic 
resistance because the bacterial response to antibiotics and heavy metals is similar (Koditschek 
and Guyre, 1974). The resistance can be described as “cross-resistance,” in which the same 
mechanism (e.g., efflux pumps) is responsible for protection against metals and antibiotics, or 
“co-resistance,” in which resistance to metals and antibiotics is genetically coded in close 
proximity on a plasmid (Seiler and Berendonk, 2012). Both Gram negative and Gram positive 
bacteria are susceptible to metal resistance, but for some heavy metals like cadmium, Gram 
positive bacteria are more sensitive (Babich and Stotzky, 1977). Gram negative bacteria also 
have an outer cell membrane which may limit the penetration of metals. 
2.4 Antibiotic Compounds and Resistance Mechanisms 
Antibiotics have established themselves as some of the most powerful tools against pathogenic 
diseases in humans and animals. As a result, many research projects have been conducted to 
discover new antibiotics and to understand their structure and mechanisms of action. A subset of 
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clinically significant antibiotics is presented in this section. These antibiotics will serve as the 
target compounds for the research described later. 
The sulfonamide antibiotic class includes sulfamethoxazole (SMX), which is often administered 
in conjunction with the dihydrofolate reductase inhibitor trimethoprim (Bushby and Hitchings, 
1968). The combination of these two antibiotics is effective against a variety of Gram positive 
and Gram negative bacteria. Sulfamethoxazole is an antimicrobial substance with the formula of 
C10H11N3O3S. SMX is a member of the sulfonamide antibiotic class, which was the first 
antibiotic to be used for clinical practice on a large scale (Zhang et al., 2009). Sulfonamide 
antibiotics disrupt folate synthesis by inhibiting dihydropteroate synthetase (DHPS), which is 
responsible for transformation of para-aminobenzoic acid to dihydrofolate. Dihydrofolate has a 
pivotal role in DNA precursor synthesis in that DNA synthesis cannot be performed in the 
absence of dihydrofolate. 
Trimethoprim (TMP) also targets folic acid synthesis and was first used in 1962 to treat human 
infections (Huovinen et al., 2001). TMP disrupts the conversion of dihydrofolate to 
tetrahydrofolate—a process involved in the synthesis of nucleotides. TMP kills the cell by 
depleting it of dihydrofolate reductase, which catalyzes the transformation of dihydrofolate to 
tetrahydrofolate.  
The β-lactam antibiotic class includes ampicillin (AMP). β-lactam antibiotics interfere with the 
cross-linking of peptidoglycan in bacterial cell walls, which prevents cell division and ultimately 
results in bacterial cell lysis (Struthers et al., 2003). Ampicillin is effective against Gram positive 
and some Gram negative bacteria. Enterobacterial ampC is a chromosomal antibiotic resistance 
gene (ARG) for the synthesis of β-lactamase, which hydrolyzes ampicillin at the β-lactam ring. 
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The ampC ARG has also been described as an indicator of fecal contamination in wastewater, 
surface water, and drinking water (Schwartz et al., 2003; Volkmann et al., 2004).  
Tetracycline is another class of antibiotics used against a broad range of Gram-negative and 
Gram-positive bacteria (Auerbach et al., 2007; Struthers et al., 2003). Tetracycline interrupts 
protein synthesis in the bacterial cell. Tetracycline resistant bacteria are able to eject the 
antibiotic from its cytoplasm through efflux pump mechanisms. Resistant bacteria are also able 
to eliminate tetracycline from their ribosome via ribosomal protection proteins (RPPs) (Roberts, 
2005). The tetW ARG, which has been detected in wastewater treatment plants, is responsible for 
RPP. Usually, conjugative plasmids or transposons carry tetR genes, which make them easier to 
be transferred via horizontal gene transfer mechanisms (Auerbach et al., 2007). With the 
introduction of tetracycline, at least 38 different tetracycline resistance genes (tet) have been 
detected in a variety of bacterial genera (Auerbach et al., 2007; Dancer et al., 1997; Roberts, 
2005). Among all tet genes, 22 genes have been identified in water environments.  
Vancomycin (VA) is an antibiotic of last resort for the treatment of bacterial infections when 
other antibiotics therapies have been failed. Vancomycin is a glycopeptide antibiotic prescribed 
for serious Gram-positive bacterial infections. VA is not able to pass across the cell membrane of 
Gram-negative bacteria due to the large glycopeptide molecule. Therefore, most Gram negative 
bacteria (e.g., E. coli) are intrinsically resistant to VA. Vancomycin-resistant Enterococcus 
(VRE) is a severe bacterial infection associated with outbreaks of hospital-acquired infections 
around the world (Schwartz et al, 2003). Six different types of vancomycin ARGs have been 
discovered, but the vanA ARG is the most abundant in surface water and wastewater (Messi et 
al., 2006; Volkmann et al., 2004). The VA ARGs typically result in morphological changes to 
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the bacterial cell wall that hinder VA attachment. Table 2-1 summarizes these antibiotics and 
their related genes. 
Table 2-1. Target antibiotics and respective antibiotic resistance genes 
Antibiotic Class Target Antibiotic Antibiotic                 Mode of Action 
Target AR 
Gene 
Antibiotic 
Resistance Mode 
of Action 
β-lactam Ampicillin 
Interferes with the 
cross-linking of 
peptidoglycan in 
bacterial cell 
walls; bactericidal 
ampC 
(Gram 
negative 
bacteria) 
Hydrolysis of 
antibiotic at β-
lactam ring 
Sulfonamide Sulfamethoxazole 
Inhibits folate 
synthesis; 
bacteriostatic 
sulI 
sulII 
Modification to 
membrane 
permeability, 
efflux pumps, and 
target enzymes 
Dihydrofolate 
Reductase 
Inhibitor 
Trimethoprim 
Inhibits 
conversion of 
dihydrofolate to 
tetrahydrofolate; 
bacteriostatic 
dfrA 
Modification to 
membrane 
permeability, 
efflux pumps, and 
target enzymes 
Tetracycline Tetracycline 
Protein synthesis 
inhibition; 
bacteriostatic 
tetW 
Efflux pumps or 
elimination from 
ribosome 
Glycopeptide Vancomycin 
Interferes with the 
cross-linking of 
peptidoglycan in 
bacterial cell 
walls; bactericidal 
vanA 
(Gram positive 
bacteria) 
Extrinsic: 
morphological 
changes that 
inhibit attachment; 
Intrinsic: 
impermeable 
membrane of 
Gram negative 
bacteria 
 
2.4.1 Thymidine Interference with the Detection of Trimethoprim Resistant Bacteria 
A study by Amyes and Smith (1972) revealed that the presence of thymidine or thymine reduces 
the antibacterial efficacy of trimethoprim. As mentioned earlier, trimethoprim interferes with the 
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ability of bacteria to generate thymidine/thymine for DNA replication. However, if bacteria are 
able to utilize secondary reservoirs of thymine/thymidine, trimethoprim is rendered ineffective. 
This was observed in Amyes and Smith (1972), which used different types of media with 
different ambient concentrations of thymidine/thymine for testing trimethoprim sensitivity. For 
this reason, some manufacturers are producing nutrient media with limited or reduced 
thymine/thymidine content to reduce potential interference when testing trimethoprim sensitivity. 
However, free thymine/thymidine in environmental samples may still cause overestimation of 
AR prevalence unless bacteria are separated from their matrix before assay (e.g., with membrane 
filtration). 
Metcalf and Eddy (2014) presented an equation to obtain the volatile suspended solids (VSS) 
production rate in terms of substrate removed, influent nonbiodegradable VSS, and kinetic 
coefficient as follows: 
  ,    =
  (    )
  (  )   
+ (  )(  )  (    )     (  )    +    , 	 (Eq. 2-1)	
  ,    = net waste activated sludge produced each day, kg VSS/d 
   = influent substrate concentration, mg/L 
  = effluent substrate concentration, mg/L 
  = influent flowrate, m3/d 
   = fraction of cell mass remaining as cell debris, g/g 
  = synthesis yield coefficient for heterotrophic bacteria, g VSS/g COD 
  ,  = nbVSS concentration in influent, g/m3 
   = specific endogenous decay coefficient, g VSS/g VSS.d 
or 
  ,    =   +   +  	 (Eq. 2-2)	
25 
The first part of Eq. 2-1 (Part A in Eq. 2-2) represents the amount of heterotrophic biomass 
production. Biomass production by heterotrophic bacteria is a function of flow rate, bacterial 
growth yield, amount of substrate consumed in the process, endogenous decay coefficient, and 
SRT. The second part represents the amount of cell debris produced in the process. In this part, 
SRT is a very important parameter since there is a direct correlation between SRT and the 
amount of cell debris. According to the Eq. 2-1, a longer SRT results in higher cell debris present 
in the biological reactor (Figure 2-5). 
 
Figure 2-5. Relationship between cell debris and SRT 
Bacterial cells begin to lyse when they enter the death phase, which releases their cellular 
contents (e.g., thymine and thymidine) into their surrounding environment. In theory, more cell 
debris may result in higher concentrations of free thymine and thymidine in a biological reactor. 
Therefore, systems with longer SRTs may be characterized by greater trimethoprim resistance 
due to water quality rather than changes in the microbial community. 
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2.5 Methods for Quantifying Antibiotic Resistance  
Antibiotic resistance can be quantified by two main approaches: culture methods and molecular 
methods. These two techniques are used in this study to evaluate the level of antibiotic resistance 
in wastewater. It is important to note that the combined use of culture and molecular methods is 
novel in that studies generally rely on one approach or the other, which might not provide a 
complete understanding of the AR issue.   
2.5.1 Culture Techniques 
Culture methods such as spread plates or membrane filtration are typically used to enumerate and 
isolate specific groups of bacteria. The use of selective culture media is very common when a 
specific group of bacteria are of interest. With respect to AR, disc diffusion and micro-dilution 
methods are commonly used to differentiate between resistant and susceptible strains. Spread 
plates with selective culture media supplemented with antibiotics can be used to determine the 
ratio between the number of AR bacteria and the ‘total’ number of cultivable bacteria in a 
sample. For example, the Staph/Strep selective supplement, which contains a mixture of 
nalidixic acid and colistin sulfate, can be used to select for Gram positive cocci, including 
Staphylococcus aureus, streptococci, and enterococci, while inhibiting the growth of 
Pseudomonas, Klebsiella, Proteus, Enterobacter, Clostridium, and Escherichia. Nalidixic acid is 
a bacteriostatic antibiotic, and colistin is a bactericidal antibiotic with a similar mode of action to 
that of the QACs (i.e., solubilizing bacterial membranes to release intracellular components). Just 
as with other antibiotics, resistance to nalidixic acid and colistin is possible. However, colistin, in 
particular, is considered a ‘last resort’ antibiotic for multidrug-resistant Gram negative bacteria 
(Blair et al., 2015), and resistance to this particular antibiotic is uncommon in wastewater (Zhang 
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et al., 2009). Nalidixic acid is also used to a much lesser extent than other antibiotics (Watkinson 
et al., 2009), and one study indicated that the median concentration of nalidixic acid in 
Australian wastewaters was below the detection limit (Watkinson et al., 2009), which suggests 
that there is less selective pressure to develop and maintain resistance to this antibiotic. The 
colonies that grow in the presence of the Staph/Strep selective supplement without the target 
antibiotics can be assumed to represent the total cultivable Staph/Strep in the sample, while the 
colonies that grow in the presence of the Staph/Strep selective supplement in addition to the 
target antibiotic(s) can be assumed to represent the antibiotic resistant, cultivable, Staph/Strep. 
In order to determine the extent to which bacteria are resistant to antibiotics, the minimum 
inhibitory concentration (MIC) assay can be used. Briefly, antibiotic concentrations are serially 
diluted, and the minimum concentration at which the growth of pure culture isolates is inhibited 
is described as the MIC. The Clinical and Laboratory Standards Institute (CLSI) publishes the 
currently accepted MICs for a variety of antibiotics, although these numbers typically increase 
over time to account for greater levels of antibiotic resistance.  
2.5.2 Molecular Techniques 
A study by Amann et al. (1995) showed that only a small portion of aquatic bacterial 
communities can be cultured by standard methods. Therefore, any type of culture-based method 
may only provide information on a small portion of bacterial communities. Instead, molecular 
methods can be used to detect microorganisms for which culture-based methods are ineffective 
or those that grow too slowly relative to the larger microbial community (Oliver, 2005, 2010; 
Trevors, 2010). Molecular methods, such as real-time polymerase chain reaction (qPCR), 
provide a highly sensitive and specific alternative without the need for cultivation. After sample 
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collection and DNA extraction and purification, qPCR employs target-specific primers and 
fluorescent probes to quantify the original number of copies of the target sequence in the sample. 
The process involves repeated denaturing of the DNA, annealing of the primers and probes, and 
enzymatic extension of the primers and initiation of the fluorescent probes. Once the 
fluorescence reaches an established threshold, the cycle number is noted and compared to a 
corresponding standard curve. Despite the utility of qPCR, the method’s basic reliance on the 
presence of DNA means that it cannot always distinguish between extracellular vs. intracellular 
DNA, damaged vs. intact DNA, or non-viable vs. viable microorganisms. 
Genetic characterization of antibiotic resistant mutants is of interest since it provides further 
information about responsible mutations. For years, genetic mapping was the only way to locate 
a mutation in the genome and the gene responsible for that mutation. Now the genome of the 
bacterium can be sequenced easily, and many genes can be identified by annotation. In order to 
locate the mutations in the genome sequence, marker rescue or complementation techniques can 
be used to clone the region containing mutations. The clones can then be sequenced and located 
in the annotated sequence of the genome. When the mutation is located and identified, the 
appropriate primers can be designed. In order to design the forward and reverse primers in PCR 
and qPCR, it is important to pay attention to the length of primers, the annealing and melting 
temperature, and the GC content, since these factors can affect the efficiency of amplification 
(Molecular Genetics of Bacteria, 2013). 
Target-specific methods such as qPCR are now being supplemented with non-specific 
metagenomics approaches, such as pyrosequencing, which allows one to simultaneously identify 
a large number of microorganisms or non-specific gene sequences present in a sample. 
Pyrosequencing involves the stepwise addition of nucleotides to a complementary strand of 
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DNA. Nucleotide availability is controlled by the system (i.e., only one of four possible 
nucleotides is available at any given time), and each time a nucleotide is added to the strand of 
DNA, pyrophosphate is released and converted to adenosine triphosphate (ATP), which then 
combines with luciferin to emit light. Increasing light intensity indicates that the same nucleotide 
has been added repeatedly. Once the signal stabilizes, the remaining nucleotides and ATP are 
destroyed, and the system moves on to the next of the four possible nucleotides. The resulting 
sequences are then assembled into genomes. Kristiansson et al. (2011) employed multiplexed 
massively parallel pyrosequencing to characterize the microbial communities upstream and 
downstream of sites impacted by pharmaceutical wastewater discharge and a control site 
impacted by municipal wastewater discharge. The sites were also tested for antibiotic 
accumulation in river sediment. The pharmaceutical sites showed relatively consistent detection 
of fluoroquinolones in the sediments, but the upstream samples were orders of magnitude lower 
in concentration. The upstream and downstream Swedish sites registered below the method 
detection limits for all antibiotics. With respect to the pyrosequencing data, the researchers were 
able to simultaneously identify a range of microorganisms and detect an assortment of antibiotic 
resistance genes, integrons, plasmids, and transposons. The authors found that several antibiotic 
resistance genes, including those encoding resistance to sulfamethoxazole (sulII) and 
streptomycin (strA and strB), were detected at significantly higher concentrations (22-62 times 
higher) downstream of the pharmaceutical wastewater discharge points. The ARGs were 
supplemented with an abundance of integrons, transposons, and plasmids, which are critical in 
facilitating horizontal gene transfer. On the other hand, quinolone resistance genes were detected 
at lower concentrations downstream of the pharmaceutical wastewater discharge sites. 
Presumably due to the lower concentrations of antibiotics in the Swedish wastewater effluent, the 
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ARGs were much less abundant at those locations. Despite the utility of pyrosequencing for 
characterizing a wide variety of genetic elements related to AR, it is a relatively costly approach 
and is not well suited for the objectives of the current study. 
2.6 Antibiotic Resistance in Wastewater Treatment Plants 
Wastewater is a source of constituents of concern, including pathogenic bacteria, nutrients, 
heavy metals, and trace organic contaminants (TOrCs), including antibiotics. Therefore, 
wastewater treatment plants have the potential to continuously expose bacteria to sub-inhibitory 
concentrations of a wide range of antimicrobial compounds (Aminov et al., 2001; Auerbach et 
al., 2007). 
A typical WWTP usually has three major treatment steps: (1) preliminary/primary, (2) secondary 
treatment, and (3) tertiary/advanced treatment. During primary treatment, large solids and grit 
are physically removed by screening and sedimentation. In secondary treatment, a major portion 
of the biodegradable organic matter, or biochemical oxygen demand (BOD), is removed via 
cellular respiration by native biomass. In addition to BOD removal via aeration, the biological 
process can be engineered to achieve nitrification (aerobic), denitrification (anoxic), and 
phosphorus removal (sequential anerobic and aerobic). The secondary process also involves 
physical removal of the biomass by sedimentation in secondary clarifiers or by membranes in 
membrane bioreactors. In many WWTPs, secondary effluent is then subjected to tertiary 
treatment involving filtration and disinfection.  
In particular, biological treatment processes in WWTPs provide an ideal environment for the 
proliferation of AR. Bacteria in these systems are exposed to sub-inhibitory concentrations of a 
suite of antibiotics and other AR inducing elements and compounds (Aminov et al., 2001; 
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Auerbach et al., 2007). Depending on the operational conditions, bacteria remain in the 
bioreactors for varying amounts of time depending on the treatment target (i.e., BOD removal or 
BOD/nutrient removal). Solids retention time (SRT) is one of the key operational parameters in a 
suspended growth bioreactor and refers to the average amount of time the bacteria stay in the 
system before being ‘wasted.’ With longer SRTs, bacteria may have a greater chance of 
obtaining antibiotic resistance elements through horizontal gene transfer mechanisms. Those 
elements can then be propagated via vertical gene transfer, or bacterial replication. Despite the 
potential for AR transfer, it is not yet clear whether the biological treatment process actually 
contributes to the proliferation of AR or whether it actually provides some level of mitigation 
due to AR bacteria being outcompeted.   
2.6.1 Secondary Biological Treatment 
Biological treatment processes are designed to transform dissolved and particulate biodegradable 
components of wastewater. Before the 1980s, the main goal of the biological treatment process 
was to remove BOD and total suspended solids (TSS). Since then, with more stringent discharge 
limits, several modifications and configurations have evolved to remove nutrients, specifically 
nitrogen and phosphorous, from wastewater biologically (Metcalf and Eddy, 2014). Typical 
secondary biological treatment processes now incorporate multiple tanks operated in anaerobic, 
anoxic, and/or aerobic conditions to meet specific treatment goals.  
Multiple technologies are available for biological treatment but are typically applied in one of 
three forms: (1) trickling filters, which rely on attached biomass growth (i.e., biofilms) and are 
relatively uncommon in newer facilities; (2) activated sludge systems, which rely on suspended 
biomass growth and solids separation by sedimentation; and (3) membrane bioreactors, which 
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combine suspended biomass growth with solids separation by membranes. In activate sludge 
process, microorganisms, especially the heterotrophic bacteria, use dissolved oxygen to grow and 
consume BOD. A series of chemical compounds must be present to serve as the carbon source, 
electron donor, and electron acceptor, as summarized in Table 2-2. 
Table 2-2- Classification of bacteria by electron donor, electron acceptor and source of carbon 
Type of Bacteria Carbon Source Electron Donor Electron Acceptor 
Aerobic heterotrophic Organic compounds 
Organic 
compounds O2 
Aerobic autotrophic CO2 
NH4+, NO2-, Fe(II), 
H2S, S, S2O32- 
O2 
Facultative heterotrophic Organic compounds 
Organic 
compounds NO2
-, NO3- 
Anaerobic heterotrophic Organic compounds 
Organic 
compounds 
CO2, SO42-, 
Fe(III), Organic 
compounds 
Anaerobic autotrophic CO2 NH4+ NO2- 
 
 For BOD removal, the biological treatment system must provide sufficient contact time between 
the wastewater and heterotrophic microorganisms, sufficient oxygen, and sufficient nutrients. In 
all aerobic oxidation processes, the conversion of organic compounds is carried out by mixed 
bacterial cultures in general accordance with the stoichiometry shown below (Metcalf and Eddy, 
2014). In Eq. 2.3, organic matter in wastewater is presented as COHNS. 
Oxidation and synthesis: 
	      +	   +             	
          
 ⎯⎯⎯⎯⎯ 	    +	    +         +       	   	         
	 (Eq. 2-3)	
Endogenous respiration: 
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        +    
          
 ⎯⎯⎯⎯⎯ 	5    +      +     +        (Eq. 2-4)  
The bacterial growth pattern in a batch reactor is characterized by four different phases. The first 
phase, which is known as the lag phase, represents the time required for the organisms to 
acclimate to their new environment. In the second phase—known as the exponential growth 
phase—bacterial cells multiply at their maximum rate due to the availability of substrate and 
nutrients. In the stationary phase, the biomass concentration remains relatively constant with 
time. In the death phase the biomass concentration decreases due to cell death, primarily because 
the substrate has been depleted. 
Under steady state conditions, for which the influent flowrate and substrate concentration are 
relatively constant, the mixed liquor suspended solids (MLSS) and the mixed liquor volatile 
suspended solids (MLVSS) concentrations are also relatively constant in a reactor. The following 
equations show the rate of substrate utilization and biomass growth based on Monod kinetics and 
the Michaelis-Menten equation (Bailey and Ollis, 1986):  
    = −
   
    
	 (Eq. 2-5)		
   =  
   
    
−    	 (Eq. 2-6)		
    = rate of substrate utilization, g/m3.d 
   = net biomass production rate, gVSS/m3.d 
  = maximum specific substrate utilization rate, g substrate/g microorganisms.d 
  = biomass (microorganisms) concentration, g/m3 
  = growth-limiting substrate concentration in solution, g/m3 
   = half-velocity constant, g/m3 
  = synthesis yield coefficient, g VSS/g bsCOD 
   = endogenous decay coefficient, g VSS/g VSS.d 
The biomass mass balance can be written as: 
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               =         −          +    	     ℎ	 (Eq. 2-7)	
or 
  
   =     − [(  −   )  ] − (    ) +    	 (Eq. 2-8) 
In steady-state condition (dX/dt = 0), and the Eq. 2-8 can be simplified to: 
(    )       
   =  
   
  −  	 (Eq. 2-9)	
The inverse of the left-hand side of the Eq. 2-9 is defined as solids retention time. Therefore: 
    =	   (    )   	    	 (Eq. 2-10)	
SRT = solids retention time, D 
V = reactor volume, m3 
Q = influent flowrate, m3/d 
X = concentration of biomass in aeration tank, g VSS/m3 
Qw = waste sludge flowrate, m3/d 
Xe = concentration of biomass in effluent, g VSS/m3 
XR = concentration of biomass in the RAS line from the clarifier, gVSS/m3 
The substrate utilization rate (rsu) can be rewritten as the amount of substrate removed in the 
reactor divided by reactor volume, so: 
    =
 (    )
  	 (Eq. 2-11)	
Finally, by combining Eq. 2-9 and Eq. 2-10: 
 
    =
  (    )
   −  	 (Eq. 2-12)	
Some of the key operational parameters in the activated sludge process include the MLSS 
(typical values range from 1000 mg/L to 8000 mg/L), the hydraulic retention time (HRT), and 
the SRT. In simplest terms, SRT is the average amount of time the biomass remains in the 
reactor before being wasted. The selection of an appropriate SRT is related to the target growth 
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rate of microorganisms in the aeration tank. A longer SRT allows slowly growing 
microorganisms to enrich, which promotes the development of bacterial species capable of 
specific treatment objectives (e.g., nitrification).  
In a typical wastewater treatment scenario, the substrate concentration is typically described by 
the BOD parameter but can also be described by other bulk organic surrogate parameters, 
including total or dissolved organic carbon (TOC or DOC) or fluorescence.  
Figure 2-6 illustrates the relationship between total fluorescence and SRT. 
 
Figure 2-6. Relationship between total fluorescence and SRT (different full-scale facilities).  
The red circle highlights the organic matter fraction specific to protein and soluble microbial products  
2.6.2 Antibiotic Resistance in Biofilm 
 Antibiotic resistance has also been observed in attached growth systems, such as in biofilms. A 
biofilm is a group of bacteria that attaches to a surface by producing a mixture of polymers 
consisting of polysaccharide and proteins. Antibiotic resistance in biofilms often involves 
different mechanisms than those observed in suspended growth systems (e.g., efflux pumps, 
modifying enzymes, and mutations) (Stewart and Costerton, 2001). Instead, the dominant 
mechanisms of resistance in biofilms are thought to be 1) poor antibiotic penetration, 2) nutrient 
limitation, and 3) formation of highly protected phenotypes (Stewart and Costerton, 2001). 
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Biofilm bacteria generate extracellular polymeric substances (EPS) that prevent the diffusion of 
certain antibiotics into the biofilm (Chadha, 2014). Antibiotics that are more hydrophilic and 
positively charged, like aminoglycosides, are hindered to a greater degree than other antibiotics 
(Chadha, 2014). 
The bacteria in biofilm live close to each other, which facilitates the exchange of plasmids and 
free DNA in the case of environmental stresses (Chadha, 2014). The cells in the biofilm are 
known to use chemical communication tools known as quorum sensing. Quorum sensing enables 
bacteria to coordinate their metabolism and help them to adapt to ongoing changes in the 
environment (e.g., exposure to antibiotics) (Chadha, 2014).  Bacteria are able to use quorum 
sensing to activate specific genes in response to chemical signals that they receive from other 
bacteria (Shih and Huang, 2002). Many of these chemical signals are homoserine lactones 
(HSLs). Due to the high cell densities in the biofilm, HSL-mediated gene expression may play an 
important role in biofilm formation and antibiotic resistance (Shih and Huang, 2002). 
Shih and Huang (2002) used P. aeruginosa variants, wild-type PAO1, single mutants JP1 
(lasI::Tn10, Tcr) and PDO100 (rhlI::Tn501, Hgr), and double mutant JP2 (lasI::Tn10, Tcr ; 
rhlI::Tn501, Hgr) for batch culture and continuous biofilm cultivation. Except the wild-type, 
the other strains are actually quorum sensing-deficient mutants. The biofilms were exposed to 
kanamycin for 2 hours at 1X, 5X and 10X the MIC of kanamycin for PAO1 (MIC is 10 mg/L). 
After treatment with kanamycin, viable cell and total cell densities were determined by plating 
on R2A agar and fluorescence microscope, respectively. Figure 2-7 shows surviving cell 
fractions between the wild-type and the mutants. As shown in Figure 2-7, PAO1 biofilms were 
not significantly affected by kanamycin, even at concentrations 10 times higher than the MIC 
(i.e., 100 mg/L), whereas quorum sensing-deficient mutants JP1 and JP2 were susceptible to all 
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kanamycin concentrations (i.e., 10, 50, and 100 mg/L). PDO100 mutants were susceptible to 100 
mg/L. The results suggest that quorum sensing bacteria are more resistant to antibiotics. 
 
Figure 2-7 Surviving cell fractions of P. aeruginosa 
P. aeruginosa PAO1, PDO100, JP1, and JP2 after treatment with kanamycin (Shih and Huang, 2002) 
Infectious diseases caused by biofilms are difficult to treat because the bacteria are profoundly 
resistant to antibiotics. As noted earlier, one of the mechanisms by which bacteria in biofilms 
show resistance to antibiotics is slow or incomplete penetration of antibiotics into the biofilm. 
Interestingly, when the bacteria detach from the biofilm, they become sensitive to antibiotics 
again. Therefore, as long as the bacteria in the biofilm do not contribute to permanent AR 
proliferation in suspended bacteria, they may not pose a significant public health risk. However, 
more research is needed to clarify the role of biofilms in AR proliferation. This is beyond the 
scope of the current study, which focuses on AR in suspended growth applications. 
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2.7 TOrC Removal by Biological Treatment 
Once the readily biodegradable compounds are depleted in engineered biological treatment 
applications, the microbial community experiences some degree of starvation, and only those 
bacteria with the ability to degrade recalcitrant compounds can survive. This selective pressure 
associated with longer SRTs may select for bacteria with the ability to degrade a wide variety of 
organic compounds, including some TOrCs. Recent studies have demonstrated the relationship 
between SRT and TOrC removal. Suarez et al. (2010) suggested that TOrC removal was linked 
to nitrification, while other studies reported that it was specifically related to SRT (Melcer and 
Klecka, 2011; Clara et al., 2005). Multiple studies identified “critical” SRTs for significant TOrC 
removal. Clara et al. (2005) identified a broadly applicable “critical” SRT of 10 days, while 
Oppenheimer et al. (2007) and Salveson et al. (2012) identified compound-specific “minimum” 
or “threshold” SRTs, respectively, as summarized in  
Table 2-3. 
Table 2-3. Threshold SRT for 80% TOrC degradation (Salveson et al., 2012) 
TOrC Threshold SRT 
Acetaminophen 2 
Caffeine 2 
Ibuprofen 5 
Naproxen 5 
Bisphenol A 10 
Triclosan 10 
DEET 15 
Gemfibrozil 15 
Atenolol 15 
BHA 15 
Diphenhydramine 20 
Benzophenone 20 
Trimethoprim 30 
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Gerrity et al. (2013) examined the effects of solids retention time on standard wastewater 
parameters and the degradation of TOrCs in independent, full-scale activated sludge basins with 
SRTs ranging from 5.5-15 days. The results showed that biological process optimization 
strategies (e.g., longer SRTs) can be implemented to reduce reliance on advanced treatment 
technologies, such as advanced oxidation and reverse osmosis. Batt et al. (2007) was also able to 
evaluate the effects of SRT at a single facility, and that study also concluded that longer SRTs 
achieving nitrification conditions achieved greater removal of four antibiotics. 
As mentioned earlier, substrate biodegradation can be modeled by the Michaelis-Menten 
equation, but the removal of TOrCs at the ng/L or lower g/L level is slightly different because 
the removal of such compounds does not contribute significantly to biomass growth. Instead, 
these substances may be transformed by cometabolism. In cometabolism, microorganisms are 
able to simultaneously degrade a primary substrate as the growth substrate and a secondary 
substrate as the non-growth substrate (Nzila, 2013). The secondary substrates are recalcitrant to 
normal biodegradation since they are not considered a source of energy by bacteria, but they can 
be removed biologically as a result of this fortuitous event (Nzila, 2013). As an example, Chen 
and Aitken (1999) showed that benzo[a]pyrene can be converted to CO2 while phenanthrene or 
salicylate is used as the primary substrate. 
2.7.1 Occurrence of Indicator Trace Organic Compounds and Antibiotics 
Many medications and personal care products are not completely metabolized or absorbed by the 
human body. Therefore, these compounds are excreted from the human body and are present in 
raw wastewater as a diverse mixture of TOrCs. Watkinson et al. (2009) examined the presence of 
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28 antibiotics in different hospital effluents, wastewater effluents, rivers, and finished drinking 
waters in Queensland, Australia. The β-lactams (e.g., amoxicillin, cephalexin, and penicillin) 
were by far the most commonly used antibiotics for human purposes, with macrolides (e.g., 
erythromycin) and sulfonamides (e.g., sulfasalazine and sulfamethoxazole) also used in 
significant quantities. The results showed that the median antibiotic concentrations in the 
municipal wastewater influent ranged from non-detect for 14 of the antibiotics to as high as 1.4 
μg/L for amoxicillin. The median concentrations of the target antibiotics in the current study 
(sulfamethoxazole, trimethoprim, and tetracycline) in wastewater influent were 250 ng/L, 430 
ng/L, and non-detect, and their maximum concentrations were 3.0 μg/L, 4.3 μg/L, and 100 ng/L, 
respectively. In general, the results showed that WWTPs are able to achieve greater than 80% 
removal of all targeted antibiotics present in the aqueous phase (Watkinson et al., 2009). 
Gerrity et al. (2011) demonstrated the temporal variability in TOrC concentrations in primary 
effluent and finished effluent from a wastewater treatment plant in Las Vegas. Some compounds 
(e.g., atenolol) exhibited significant changes in concentration in the primary effluent over time, 
while others were relatively stable throughout the sampling period. The concentrations of 
sulfamethoxazole in the primary effluent were found to vary from approximately 750 ng/L to just 
over 1,500 ng/L, whereas the concentrations of trimethoprim were found to be stable around 600 
ng/L on both sampling days. The MIC for sulfamethoxazole is 76 g/ml, which is significantly 
higher than the MIC for trimethoprim at 4 g/ml (CLSI, 2012). Therefore, higher concentration 
of sulfamethoxazole are expected in the primary effluent, as Gerrity et al. (2012) reported, 
because people are likely to be administered higher doses in accordance with the higher MIC. It 
should be noted that the biodegradability of the compounds, solubility, and stability of the 
compound in water also affect the concentration of antibiotics in wastewater. Gerrity et al. 
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(2011) showed that many of the target compounds were removed to a high degree, except for the 
more recalcitrant compounds (e.g., sulfamethoxazole and TCEP). It is important to remember 
that high TOrC concentrations (e.g., antibiotics) may contribute to the proliferation of antibiotic 
resistance by imposing selective pressure on microorganisms in biological treatment systems.  
Kim et al. (2005) explored the effect of SRT on the fate of tetracycline in the activated sludge 
process by using two SBRs. The SBRs were operated with ambient concentration and elevated 
concentration of tetracycline (0.25 mg/L). The research team employed 96-well plates employing 
a tetracycline-based enzyme-linked immunosorbent assay (ELISA) to monitor the tetracycline 
concentrations in the SBRs. The results showed that the removal efficiency of tetracycline at an 
SRT of 3 days was significantly lower than that of the 7-day SRT, thereby indicating that longer 
SRTs are able to achieve superior removal rates. 
2.7.2 Modeling the Removal of Trace Organic Compounds in Biological Treatment 
Systems 
Raw wastewater contains a wide variety of compounds, including natural and synthetic organic 
compounds. The biological treatment process is designed to remove biodegradable organic 
compounds in wastewater, but not the all of organic compounds are readily biodegradable (i.e., 
those that are refractory). There are also organic compounds that are not only resistant to 
biodegradation, but may also pose a threat to the environment due to their toxicity.  
Recalcitrant compounds can be removed from wastewater by three main mechanisms: 
biodegradation, sorption or solids partitioning, and volatilization (Metcalf and Eddy, 2014). In 
aerobic biodegradation, with proper environmental and operational conditions, some of the 
refractory compounds can serve as growth substrates (Metcalf and Eddy, 2014). Heterotrophic 
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bacteria can consume some petroleum compounds, like benzene and toluene, non-halogenated 
solvents like alcohols and ketones, and some halogenated solvents such as methylene chloride. 
Some chlorinated compounds can be degraded in a process called cometabolic degradation. In 
this process, some bacteria will produce specific enzymes that mediate a reaction with oxygen 
and hydrogen, which finally change the structure of the compounds that make them easier to be 
degraded by other aerobic bacteria. Partitioning onto the biomass is another mechanism by which 
the compounds can be removed from wastewater. In order to describe solids partitioning, 
modified Freundlich isotherms can be used (n=1) for relatively low contaminant concentrations: 
  =    	 (Eq. 2-13)	
  = g organic adsorbed/g adsorbent 
   = partition coefficient, L/g 
  = concentration of organic compound in liquid, g/L 
The amount of organic compounds removed by adsorption can be estimated by the following 
equation: 
    =          	 (Eq. 2-14)	
    = rate of organic compound removed via adsorption daily, g/d 
       = rate of solids wasted daily, g/d 
The rate of solids wasted from a biological reactor is dependent on SRT, so; 
       =
   
    	 (Eq. 2-15)	
   =total MLVSS concentration in aeration tank, g VSS/m3 
  =Volume of reactor, m3 
By substituting Eq. 2-15 into Eq. 2-16, the equation for the mass loss rate would be: 
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    =
      
    	 (Eq. 2-16)	
Mass loss by volatilization can be modeled by the mass transfer expression introduced by 
(Bielefeldt and Stensel, 1999): 
    =     ,    =   ( )  ,     1 −     
(    ,     )
  ( )
   (Eq. 2-17)	
   =	gas flowrate through reactor, m3/d 
  ,    = VOC content in the gas leaving the reactor, g/m3 
  = Henry’s constant of the VOC at the reactor temperature, Lwater/Lair 
  ,    = liquid concentration of the VOC, g/m3 
   ,    = VOC mass transfer coefficient, d-1 
  = ratio of mass transfer in reactor mixed liquor to that in clean water 
  = reactor volume, m3 
Therefore, the steady-state mass balance for modeling the mass loss due to biodegradation, 
sorption, and volatilization would be: 
0 =           	– 	             	–           	– 	                     	– 	        		 (Eq. 2-18)	
    =     +     +     +   	 (Eq. 2-19)	
    =mass of compound in influent, g/d 
    =biodegradation rate, g/d 
    =solids adsoption rate, g/d 
    =volatilization rate, g/d 
   = mass of compound in effluent, g/d 
    =  
 
  
   
(    )
(  )( ) +
      
    +        +   	 (Eq. 2-20)	
 X  = biomass concentration cable of degrading the specific organic compound 
Eq. 2-20 can also be used for the biological removal of trace organic compounds, but since the 
TOrC concentrations are very low compared to the growth substrate, a pseudo-first order 
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biodegradation model can be used instead. Also, the volatilization term can be neglected for most 
TOrCs. Therefore, the simplified biodegradation model is as follows: 
    =     , ( ) 	 (Eq. 2-21)	
 r   = specific compound removal rate by biodegradation, ng/d 
K  = first order degradation rate coefficient, m3/g.d 
X ,  = concentration of bacteria capable of degrading specific compound, g/m3 
E = reactor specific compound concentration, ng/m3 
V = reactor volume 
Therefore, the steady-state mass balance is:  
    =     , ( )  +   	 (Eq. 2-22)	
Antibiotics are typically found in domestic wastewater in the ng/L to g/L range. These 
concentrations are considerably lower than minimum inhibitory concentrations (MICs). It seems 
that antibiotics at these concentrations have little or no effect on the operation of any biological 
reactor. So regardless of the presence of antibiotics, the biological reactors are able to achieve 
their goals in removing organic and inorganic pollutants. It should be noted that antibiotics at 
higher concentrations may inhibit the growth of some bacterial species and alter the microbial 
community, which would eventually reduce treatment efficiency. 
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3.0 AN EVALUATION OF BACTERIAL RESISTANCE TO TRIMETHOPRIM AND THE 
ROLE OF WASTEWATER AS A RESERVOIR OF ENVIRONMENTAL THYMINE 
AND THYMIDINE 
3.1 Abstract 
The antibiotic trimethoprim acts by disrupting dihydrofolate reductase during nucleotide 
synthesis. Bacteria can grow in the presence of trimethoprim by expressing trimethoprim 
resistance genes or by acquiring thymine or thymidine from environmental reservoirs to facilitate 
nucleotide synthesis. The purpose of this study was to evaluate the impact of thymine or 
thymidine in activated sludge from a biological wastewater treatment process on the 
quantification of trimethoprim-resistant bacteria (TRB). The biological treatment process was 
also modified to assess the impacts of varying solids retention time (SRT) on trimethoprim 
concentrations, culturable trimethoprim-resistant bacteria, and multi-drug resistant bacteria. This 
is significant because longer SRTs are often employed to improve the quality of treated 
wastewater effluent. In the presence of trimethoprim at standard clinical concentrations, greater 
numbers of culturable bacteria were observed with (1) samples manually augmented with 
reagent-grade thymidine, (2) samples manually augmented with sonicated biomass (i.e., cell 
lysate), (3) samples manually augmented with activated sludge filtrate, and (4) activated sludge 
samples collected from reactors with longer SRTs. These observations suggest that longer SRTs 
may select for trimethoprim-resistant bacteria and/or result in false positives for trimethoprim 
resistance due to higher concentrations of free thymine or thymidine. 
46 
3.2 Introduction 
Wastewater treatment plants (WWTPs) play an important role in protecting human and 
environmental health from wastewater-derived pollution, but they are also considered significant 
reservoirs of antibiotic resistance (AR) (Novo and Manaia, 2010). Previous studies have 
highlighted the selective pressure exerted on bacteria in wastewater matrices and the impact of 
wastewater treatment on antibiotic resistant bacteria (ARBs) and antibiotic resistance genes 
(ARGs) (Schwartz et al., 2003; Su et al., 2014; Guo et al., 2015; Zhang et al., 2015). 
Specifically, the engineered biological treatment systems in WWTPs are intended to maximize 
bacterial activity and growth. Coupled with continuous exposure to antibiotics, these systems 
have the potential to increase the concentration of ARBs by promoting horizontal gene transfer 
(Wang et al., 2011; Martinez, 2008) and/or inhibiting antibiotic susceptible bacteria (Lopatkin et 
al., 2016).  
There is still no consensus as to whether WWTPs truly contribute to the proliferation of AR. 
Some studies suggest that WWTPs achieve a significant reduction in the number of ARBs (Guo 
et al., 2015; Huang et al., 2012), while other research indicates that WWTPs serve as major 
contributors of ARBs and ARGs (Kim et al., 2010). Luo et al. (2014) conducted a mass balance 
of the New Delhi metallo-β-lactamase (NDM-1) ARG in two wastewater treatment plants in 
China. The number of gene copies increased through the biological treatment process in both 
facilities, but the net loading in the finished effluent increased in only one of the two facilities. 
Such contradictory outcomes may arise when studies focus on different influent wastewater 
qualities, different treatment technologies and/or operational conditions, or different 
methodologies for the detection of ARBs and ARGs. 
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Biological treatment is common to nearly all municipal wastewater facilities, but the treatment 
objectives in each facility (e.g., biochemical oxygen demand (BOD) removal, 
nitrification/denitrification, phosphorus removal) may differ depending on a variety of factors. 
One of the critical operational parameters for biological wastewater treatment, specifically the 
activated sludge process, is solids retention time (SRT). In simplest terms, the SRT is the average 
amount of time the biomass is recycled within the system. SRT is also related to the growth rate 
of microorganisms: a longer SRT selects for more slowly growing microorganisms, which 
ultimately results in a more diverse microbial population. This is particularly important when 
nitrification is desired because slow-growing nitrifiers can be washed out of the system with 
SRTs shorter than ~5 days (Tai et al., 2006). 
Longer SRTs have also been correlated with lower total organic carbon (TOC) (Leu et., 2012) 
and trace organic compound (TOrC) concentrations (Clara et al., 2005; Oppenheimer et al., 
2007; Suarez et al., 2010; Melcer and Klecka, 2011; Salveson et al., 2012; Gerrity et al., 2013). 
TOrCs include various classes of over-the-counter and prescription pharmaceuticals, personal 
care products, pesticides, herbicides, flame retardants, etc., which are present in water and 
wastewater at trace levels (i.e., μg/L and ng/L). Gerrity et al. (2013) determined that lower 
effluent concentrations of the antibiotics sulfamethoxazole (SMX) and trimethoprim (TMP) 
could be achieved with longer SRTs in a full-scale activated sludge process. However, there are 
limited studies that directly evaluate the relationship between SRT and the prevalence of ARBs 
and/or ARGs. Therefore, additional studies are needed to assess the role of such operational 
conditions on AR occurrence. 
SMX, which is a member of the sulfonamide antibiotic class, disrupts folate synthesis by 
inhibiting dihydropteroate synthetase (DHPS) (Bushby and Hitchings, 1968). TMP, which is 
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often administered in tandem with SMX, also targets folic acid synthesis by disrupting the 
conversion of dihydrofolate to tetrahydrofolate. Without tetrahydrofolate, thymidylate synthetase 
is unable to transfer a methyl group to deoxyuridine monophosphate (dUMP) to make 
deoxythymidine monophosphate (dTMP) (Molecular Genetics of Bacteria, 2013). In short, SMX 
and TMP achieve bacteriostatic disruption of nucleotide synthesis for both Gram positive and 
Gram negative bacteria. These pathways are summarized in Figure 3-1. 
Bacteria may be able to bypass these pathways by obtaining thymidine or thymine from their 
environment. Amyes and Smith (1974) discovered that secondary reservoirs of thymidine or 
thymine, which are present at varying concentrations in different types of growth media, reduce 
the antibacterial efficacy of TMP. For this reason, TMP sensitivity tests require nutrient media 
with limited thymine/thymidine content [e.g., Mueller Hinton (MH) agar]. However, free 
thymine/thymidine in environmental samples may still result in overestimation of AR prevalence 
unless bacteria are separated from their matrix before assay (e.g., with membrane filtration). For 
example, longer SRTs achieve greater microbial diversity and treatment efficacy but also lead to 
higher rates of cell death and decay (Metcalf and Eddy, 2014). This can potentially result in a 
significant environmental reservoir of thymine/thymidine as the intracellular components are 
released from the cells. 
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Figure 3-1. Pathways describing the disruption of DNA synthesis 
Pathways describing the disruption of DNA synthesis with sulfamethoxazole (SMX) and/or trimethoprim (TMP). External sources of thymine/thymidine 
allow bacteria to bypass the conversion of dUMP to dTMP, thereby negating the effects of SMX and TMP 
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This research explores the impact of thymine/thymidine in environmental samples consisting of 
activated sludge from a biological wastewater treatment process. The wastewater samples were 
generated from laboratory-scale sequencing batch reactors (SBRs) fed with full-scale primary 
effluent and operated at varying SRTs. Experiments were performed to (1) confirm the effects of 
secondary thymidine reservoirs, (2) evaluate the effects of sonicated biomass (i.e., cell lysate), 
(3) evaluate the effects of cellular debris as a function of SRT, and (4) evaluate the effects of 
SRT on single- and multi-drug resistance and the removal of TOrCs, including TMP and SMX. 
3.3 Materials and methods 
3.3.1 Description of laboratory-scale sequencing batch reactors 
The laboratory-scale activated sludge process was achieved with four parallel SBRs (Figure 3-2) 
fed with primary effluent from a full-scale WWTP in Las Vegas, Nevada. The acrylic SBRs had 
a total volume of 8 L and a working volume of 4 L after accounting for the volume of settled 
solids. Automation of the SBRs was achieved with a series of multi-station outlet timers, a 
peristaltic pump, electric actuated ball values, and solenoid valves. A MasterFlex peristaltic 
pump (Model 77200-62, Cole Parmer, Vernon Hills, IL) was used to transfer primary effluent 
from a wet well through a polytetrafluoroethylene/stainless steel strainer (Hach, Loveland, CO) 
and a 50-µm cartridge filter (Watts WPC50-975) prior to filling the reactors. The cartridge filters 
were replaced every two days to mitigate fouling and anaerobic conditions. A four-station 
irrigation timer (Orbit, Bountiful, UT) was used to control the volume fed to each reactor. 
Electric actuated solenoid valves (Parker Hannifin Corporation, Cleveland, OH) and an industrial 
grade air compressor (Porter-Cable PCFP02003; 3.5 gallons; 135 psi) were used to aerate the 
SBRs to achieve a relatively constant dissolved oxygen concentration of 3 to 4 mg/L. The 
51 
compressed air was passed through a pressure gauge and air flow meter before being fed into the 
SBRs via stone diffusers. Aeration was sufficient to achieve adequate mixing of the mixed liquor 
without the need for mechanical mixing. The target SRTs were achieved by wasting 
predetermined volumes of mixed liquor toward the end of each aeration phase, and this was 
accomplished with four electric actuated ball valves (W.E. Anderson, Michigan City, IN).  
 
 
Figure 3-2. Sequencing batch reactors (varying SRT) 
Top: Photos of the (A) exterior of the experimental shed, (B) interior of the shed, and (C) parallel 
sequencing batch reactors (SBRs). The reactors were set up at a full-scale wastewater treatment plant in 
Las Vegas, NV. The reactors were fed with primary effluent from the full-scale facility. Bottom: 
Schematic of the SBRs, target solids retention times (SRTs), and target waste activated sludge flow rates 
(Qw) 
The SBRs were initially seeded with return activated sludge (RAS) from the full-scale WWTP, 
which operates at an SRT of ~7 days. The SBRs were operated with a cycle time of 8 hours for 3 
cycles per day over a period of 60 days. Each cycle consisted of the following five stages: (1) 
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filling with primary effluent for 29 minutes as the irrigation timer cycled through each reactor, 
(2) immediate aeration for 6.5 hours, (3) solids settling for 1 hour, (4) discharge of settled 
effluent for 30 minutes, and (4) idle for 1 minute. Again, solids wasting was performed toward 
the end of each aeration phase to minimize clogging of the ball valves. SRTs of 2 days, 7 days 
(in duplicate), and 20 days were targeted for this research (Figure 3-3). The corresponding waste 
activated sludge (WAS) flow rates (Qw) were determined according to Eq. 3-1. 
 
 
 
Figure 3-3. Sequencing batch reactors (varying antibiotic concentrations) 
Top: Photos of the (A) exterior of the experimental shed, (B) interior of the shed, and (C) parallel sequencing batch 
reactors (SBRs). The reactors were set up at a full-scale wastewater treatment plant in Las Vegas, NV. The reactors 
were fed with primary effluent from the full-scale facility. Bottom: Schematic of the SBRs, target solids retention 
times (SRTs), and target waste activated sludge flow rates (Qw) 
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Qw	 =	 1f   
VR
θc
	–	   ∗     =	
VR
f 	 * 	θC
	(when	Ce	≈	 0)		 (Eq. 3-1)	
Qw = WAS flow rate, L/cycle 
f = frequency, cycles/day 
VR = volume of the SBR, L = 8 L 
θC = SRT, days 
Qe = effluent flow rate, L/day 
Ce = total suspended solids in settled effluent, mg/L 
C = mixed liquor suspended solids, mg/L.  
3.3.2 Preparation of trimethoprim stock solution  
Trimethoprim (Sigma Aldrich, St. Louis, MO) was used for this study. The antibiotic stock 
solution was prepared based on the Clinical and Laboratory Standards Institute (CLSI, 2012). 
Appropriate solvent was used for trimethoprim, which was 90% volume of sterile nanopure 
water with 10% volume of 0.05 M hydrochloric acid. The antibiotic stock solution was then 
passed through a acrodisc syringe filter to be sterilized. The stock solution was stored in 
refrigerator at at 4±2°C and was used within 48 hours. 
3.4 Analytical methods 
3.4.1 General water quality parameters 
A series of general water quality parameters was monitored for the duration of the study to 
ensure the SBRs were properly mimicking a full-scale activated sludge system. These tests 
included pH, mixed liquor suspended solids (MLSS) concentration, mixed liquor volatile 
suspended solids (MLVSS) concentration, soluble chemical oxygen demand (sCOD), nitrogen 
speciation (i.e., ammonia, nitrate, and nitrite), and dissolved oxygen (DO). Standard methods 
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were employed when applicable; a summary of the analyses and associated methods is provided 
in Table 3-1.  
3.4.2 Trace organic compounds 
To demonstrate the relationship between SRT and TOrC removal, samples were analyzed for 
ambient levels of the target antibiotics (TMP and SMX) and the beta-blocker atenolol, which 
served as an indicator compound. Primary and secondary effluent (i.e., settled effluent) samples 
from the four SBRs were collected in 1-L, silanized, amber glass bottles preserved with sodium 
azide (1 g/ L) and ascorbic acid (50 mg/L). Samples were immediately placed on ice and held at 
4°C for up to 14 days until further processing, which consisted of filtration with 0.7-μm glass 
fiber filters and on-line solid phase extraction (SPE). The samples were then analyzed for the 
target compounds by liquid chromatography tandem mass spectrometry (LC-MS/MS) with 
isotope dilution according to previously published methods (Vanderford and Snyder, 2006). The 
method reporting limits (i.e., 3-5x the method detection limits) were determined to be 5 ng/L. 
Table 3-1. Summary of methods for water quality parameters 
Measurement Sampling and 
Measurement 
Method 
Analysis Method Sample 
Container/ 
Quantity of 
Sample 
Preservation/ 
Storage 
Hold Time 
pH Orion Model 720A pH meter 
Standard Method 
4500-H B 
20 mL glass 
vials/10 mL None 
Immediate 
analysis 
MLSS  
0.45-µm glass fiber 
filters, 25-mL baking 
crucibles, 105ºC oven, 
analytical balance 
Standard Methods 
2540 D  
50 mL centrifuge 
tube/10 mL 
Refrigeration/ 
Store @ 42C 7 d 
MLVSS 
0.45-µm glass fiber 
filters, 25-mL baking 
crucibles, 550ºC oven, 
analytical balance 
Standard Methods 
2540 D,E 
50 mL centrifuge 
tube/10 mL 
Refrigeration/ 
Store @ 42C 7 d 
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Measurement Sampling and 
Measurement 
Method 
Analysis Method Sample 
Container/ 
Quantity of 
Sample 
Preservation/ 
Storage 
Hold Time 
NH3 
Hach DR/5000 
spectrophotometer, 
Salicylate Method 
Hach Method 
10031 
150 mL amber glass 
bottle/100 μL 
HCl addition to 
pH<2 / Store @ 
42C 
28 d 
NO3 
Hach DR/5000 
spectrophotometer, 
Cadmium Reduction 
Method 
Hach Method 8039 150 mL amber glass 
bottle/10 mL 
Filter / Store @ 
42C 48 h 
NO2 
Hach DR/5000 
spectrophotometer, 
Diazotization Method 
Hach Method 8507 150 mL amber glass 
bottle/10 mL 
Filter / Store @ 
42C 48 h 
DO O2 electrode probe 
Standard Method 
4500-O G 
40 mL glass 
vials/20 mL None 
Immediate 
analysis 
Soluble COD 
(sCOD) 
Hach DR/5000 
spectrophotometer, 
Reactor Digestion 
Method 
U.S. EPA method 
410.4, Hach 
Method 8000 
20 mL glass vials/2 
mL 
H2SO4 addition to 
pH<2 / Store @ 
42C 
28 d 
Spread Plates 
Spread plate on MH 
agar (w/ and w/o 
antibiotics) 
Described in main 
text 
50 mL conical 
tube/100 μL per 
plate 
None 8 h 
Trimethoprim 
LC-MS/MS, API 4000 
triple-quadrupole mass 
spectrometer 
Vanderford and 
Snyder (2006) 
500 mL pre-cleaned 
amber bottle 
1 g/L NaN3 and 50 
mg/L Ascorbic 
Acid / Store @ 
42C 
28 days 
Reference: Vanderford, B.J., Snyder, S.A., 2006. Analysis of pharmaceuticals in water by isotope dilution liquid 
chromatography/tandem mass spectrometry. Environmental Science and Technology 40 (23): 7312-20. 
The TOrC sampling was performed at the conclusion of the testing period (i.e., after 60 days of 
operation). Two independent sets of samples were collected to assess variability in compound 
occurrence and removal between cycles. Primary effluent was collected in duplicate on both 
days. For the first sample set, secondary effluent from the SBR operating with a 2-day SRT was 
collected in duplicate. For the second sample event, secondary effluent from the SBR operating 
with a 20-day SRT was collected in duplicate. For the 7-day SRT, two independent reactors were 
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operated under similar conditions, and only one set of samples was collected from each reactor 
on both days. 
3.5 Microbiological methods 
The microbiology components of the study were divided into four sets of experiments, as 
summarized in Table 3-2: (1) manual augmentation of thymidine with reagent-grade chemical, 
(2) manual augmentation of thymidine via cell lysing, (3) varying of SRT in the SBRs to 
evaluate the effects of cellular debris, and (4) varying of SRT in the SBRs to evaluate single- and 
multi-drug resistance. In each of these experiments, spread plates were prepared with 100 µL of 
sample on MH agar (Thermo scientific, Waltham, MA) supplemented with 4 μg/mL of 
trimethoprim (Sigma Aldrich, St. Louis, MO). This trimethoprim concentration represents the 
published standard minimum inhibitory concentration (MIC) according to the Clinical and 
Laboratory Standards Institute (CLSI, 2014). Final samples were serially diluted in 0.01% 
phosphate buffered saline (PBS) to target plate counts of 25 to 250 colony forming units (CFU). 
Plates were incubated at 35±0.5°C for 36±2 hours. The results were reported as the mean of 
triplicate plates ±1 standard deviation in CFU/100 µL. Modifications specific to each set of 
experiments are described in the sections below. 
 
 
 
 
 
57 
Table 3-2. Summary of experimental conditions 
Experiment Description Media Supplements1 SRT of 
plated MLSS 
1 Manual augmentation of 
thymidine with reagent-grade 
chemical 
0, 20, 60, or 100 μg/mL 
of thymidine 
7 days 
2 Manual augmentation of 
thymidine2 via cell lysing 
0%, 0.01%, 0.1%, or 1% 
sonicated MLSS (SRT = 
7 days) 
7 days 
3 Varying of SRT in the SBRs 
to evaluate effects of cellular 
debris 
0%, 0.01%, 0.1%, or 1% 
MLSS filtrate (SRT = 7 
days) 
2, 7, 20 days 
4 Varying of SRT in the SBRs 
to evaluate the effects of 
multi-drug resistance among 
Gram positive bacteria 
76 μg/mL of 
sulfamethoxazole and 
Staph/Strep supplement 
2, 7, 20 days 
1Base media = Mueller Hinton agar with 4 μg/mL of trimethoprim 
2Thymidine, among other intracellular components, assumed to be present in the cell lysate 
3.5.1 Manual augmentation of thymidine with reagent-grade chemical 
Three sets of grab samples of mixed liquor suspended solids (MLSS) (i.e., activated sludge) were 
collected in sterile conical tubes from one of the SBRs operating with a 7-day SRT. The samples 
were immediately transported on ice to the laboratory for same-day processing and analysis. 
Samples were serially diluted and plated as described above, except that the MH agar was also 
supplemented with 0, 20, 60, or 100 μg/mL of reagent-grade thymidine (Sigma Aldrich). Two 
sets of negative controls were used: (1) MH agar with TMP (no MLSS or thymidine) and (2) MH 
agar with thymidine (no MLSS or TMP). Both were negative for bacterial growth. Another set of 
controls consisting of MLSS and varying concentrations of thymidine (no TMP) confirmed that 
manual augmentation of thymidine had no significant impact on bacterial growth in the absence 
of TMP (p>0.05; Figure 3-4).  
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Figure 3-4. The effect of thymidine on total bacterial growth  
The effect of thymidine on total bacterial growth on MH agar in the absence of TMP. Manual augmentation of 
thymidine had no significant effect on plate counts (p>0.05). Columns represent the mean values of triplicate plates, 
and error bars represent ±1 standard deviation 
3.5.2 Manual augmentation of thymidine via cell lysing  
Three sets of grab samples of MLSS were collected in sterile conical tubes from one of the SBRs 
operating with a 7-day SRT. The samples were immediately transported on ice to the laboratory 
for same-day processing and analysis. 10 mL of each sample were passed through a 0.45-μm 
filter (Whatman) to collect the suspended solids and eliminate aqueous thymine and thymidine. 
The filters were then placed in sterile conical tubes containing 50 mL of 0.9% sodium chloride 
solution and shaken at 400 rpm for 2 hours at 20°C to resuspend the solids. Then, 12 mL of each 
suspension were transferred to a 15-mL conical tube for sonication. Sonication was performed 
with a Branson 450 Sonifier (VWR, Radnor, PA) at a constant frequency of 20 kHz and power 
input of 160 W (13 kW/L) for 4 min, which resulted in a specific energy of ~900 kWh/m3. 
Sonication was performed in an ice batch to avoid increases in temperature. Sonicated samples 
were then passed through 0.1-μm Acrodisc syringe filters (PALL, Ann Arbor, MI) to remove 
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large cellular debris and intact bacterial cells, and the resulting filtrate served as the final solution 
of dissolved intracellular components (e.g., free thymine/thymidine). MLSS samples—also from 
the 7-day SRT—were serially diluted and plated as described above, except that each plate was 
supplemented with 0, 1.2, 12, or 120 μL of post-sonication filtrate. These volumes correspond 
with concentrations of 0%, 0.01%, 0.1%, and 1% by volume (based on 12 mL of MH agar). Two 
sets of negative controls were used to ensure no bacterial contamination was present: (1) MH 
agar supplemented with TMP (no MLSS or post-sonication filtrate) and (2) MH agar 
supplemented with 0.01%, 0.1%, and 1% post-sonication filtrate (no MLSS or TMP). Both were 
negative for bacterial growth. 
3.5.3 Varying of SRT to evaluate the effects of cellular debris 
The SBRs were operated with SRTs of 2 days, 7 days, and 20 days for a period of ~30 days prior 
to these experiments. Three sets of grab samples of MLSS were collected in sterile conical tubes 
from each of the SBRs. The samples were immediately transported on ice to the laboratory for 
same-day processing and analysis. MLSS samples from each SBR were serially diluted and 
plated as described above, except that the MH agar was supplemented with 0%, 0.01%, 0.1%, or 
1% MLSS filtrate (by volume) from the SBR operated with a 7-day SRT. To prepare the stock 
filtrates, the MLSS was passed through 0.1-μm Acrodisc syringe filters (PALL, Ann Arbor, MI). 
The filtrate, which presumably contained intracellular components from lysed cells, was then 
used to supplement the media based on the aforementioned concentrations. Therefore, these 
experiments simultaneously evaluated the effects of SRT and varying concentrations of 
intracellular components on the prevalence of TMP resistant bacteria. Two sets of negative 
controls were used to ensure no bacterial contamination was present: (1) MH agar supplemented 
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with TMP and (2) MH agar supplemented with 0.01%, 0.1%, or 1% MLSS filtrate. Both were 
negative for bacterial growth. 
3.5.4 Varying of SRT to evaluate multi-drug resistance 
The SBRs were operated with SRTs of 2 days, 7 days (in duplicate), and 20 days. 50-mL grab 
samples of primary effluent (i.e., feed to the SBRs) and MLSS were collected in sterile conical 
tubes. Three separate sample events were performed over a period of 60 days: 3 days after 
seeding/startup (9 total cycles), 30 days after startup (90 total cycles), and 60 days after startup 
(180 total cycles). Each set of samples was immediately transported on ice to the laboratory for 
same-day processing and analysis. Samples were serially diluted and plated as described above, 
except that the plates were also supplemented with 76 μg/mL of SMX (CLSI, 2014) to target 
multidrug-resistant bacteria and Staph/Strep supplement (Pro-Lab Diagnostics, Ontario, Canada) 
consisting of 1 mg/L of colistin sulfate and 1.5 mg/L of nalidixic acid to select for Gram positive 
Staphylococcus and Streptococcus. The addition of SMX was warranted because TMP is often 
administered in conjunction with SMX in clinical applications due to their complementary 
inhibition of DNA synthesis (Figure 3-1). The addition of Staph/Strep supplement was warranted 
because vancomycin was also added in independent samples (data not shown), to which Gram 
negative bacteria are intrinsically resistant. Therefore, this particular set of experiments focused 
on Gram positive bacteria as the target microorganisms. 
3.6 Statistical analysis 
 Single factor analysis of variance (ANOVA) with post-hoc Tukey’s test was performed 
with XLSTAT (Addinsoft, NY) at a significance level of 0.05.  
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3.7 Results and discussion 
3.7.1 General water quality 
The general water quality of the SBRs was monitored on an approximately weekly basis to 
validate the performance of the activated sludge process. The average pH of the primary effluent 
was 6.4±0.2, and the pH of the secondary effluent was relatively constant, regardless of SRT, 
with an average of 6.9±0.2. During the aeration phase, the average DO concentration was 
relatively constant in the four SBRs with an average of 4.7±0.5 mg/L and no reading lower than 
3.7 mg/L. 
The principal treatment objectives of the activated sludge process are the removal of organic 
matter and nitrogen (sometimes phosphorus as well). Reductions in BOD are typically used to 
verify the removal of organic matter, although TOC or COD can also be used as a surrogate in 
some applications (Christian et al., 2016). Figure 3-5 illustrates the average sCOD, total 
suspended solids (or MLSS), and volatile suspended solids (or MLVSS) in the primary and 
secondary effluents as a function of SRT. Consistent with full-scale activated sludge systems, 
there was a clear trend in sCOD removal in that longer SRTs resulted in lower and more 
consistent effluent sCOD concentrations. There was also a positive correlation between SRT and 
MLSS/MLVSS because of the greater recycle ratio for longer SRTs.  
To further validate the performance of the reactors, nitrogen speciation was performed to 
determine the extent of nitrification in each reactor (Figure 3-6). 
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Figure 3-5. Average concentrations of sCOD, MLSS and MLVSS in the SBRs  
Average concentrations of sCOD, MLSS and MLVSS in the SBRs as a function of SRT. The primary effluent (PE) 
represents the feed water quality prior to biological treatment in the SBRs. Columns represent the mean values for 5 
sample events over 60 days of operation of the SBRs, and error bars represent ±1 standard deviation 
 
Figure 3-6. Average concentrations of ammonia, nitrate, and nitrite in the SBRs  
Average concentrations of ammonia, nitrate, and nitrite in the SBRs as a function of SRT. The primary effluent (PE) 
represents the feed water quality prior to biological treatment in the SBRs. Columns represent the mean values for 3 
sample events over 60 days of operation of the SBRs, and error bars represent ±1 standard deviation. The final 2 
sample events were excluded because of temperature effects 
 As expected, the nitrogen in the primary effluent was almost entirely in the form of ammonia, 
and the extent of nitrification increased with longer SRTs. Activated sludge systems with SRTs 
<5 days are typically assumed to be deficient in nitrifying bacteria (Tai et al., 2006), which limits 
the conversion of ammonia to nitrite and nitrate. Assuming sufficient oxygen input, longer SRTs 
lead to the development of more mature microbial communities that are capable of converting 
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nearly all of the ammonia to nitrate, nitrite, and/or nitrogen gas, depending on the exact 
operational conditions. In the current study, the longer SRTs achieved nearly complete 
nitrification and also appeared to achieve partial denitrification based on an estimation of the 
nitrogen mass balance. 
As the experiment progressed, the ambient temperature at the study site decreased from 
approximately 32°C down to less than 10°C, thereby causing the water temperature to decrease 
and hindering the removal of organic matter and the extent of nitrification (Head and 
Oleszkiewicz, 2004). These trends were observed for sCOD, ammonia, and nitrate, as shown in 
Figure 3-7. The sCOD in the secondary effluents increased only slightly at lower temperatures, 
but nitrification was clearly impeded, as indicated by the increasing ammonia concentrations and 
decreasing nitrate concentrations in the secondary effluents. Despite the change in water quality, 
the target SRTs were still achieved throughout the study period so the experimental objectives 
were not compromised, and the change in temperature allowed for an additional evaluation of 
temperature effects on antibiotic resistance. 
 
Figure 3-7. Effect of temperature on sCOD, ammonia, and nitrate  
Effect of temperature on sCOD, ammonia, and nitrate as a function of SRT over 60 days of operation of the SBRs 
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3.7.2 Trace organic compounds 
There is some disagreement in the literature regarding the dominant removal mechanisms (i.e., 
sorption, biodegradation, volatilization) for various TOrCs. For example, Li and Zhang (2010) 
demonstrated that TMP and SMX removals were primarily attributable to adsorption, while 
Salveson et al. (2012) suggested that their removals were primarily linked to biodegradation. 
Regardless, longer SRTs will lead to higher MLSS concentrations (suggesting greater adsorption 
potential), higher MLVSS concentrations (suggesting more abundant biomass available for 
biodegradation), and a more diverse microbial community. This synergism between higher solids 
concentrations and a more abundant and diverse microbial community will lead to greater 
removals of hydrophobic and/or biodegradable compounds. However, as the bacteria are 
recycled within these systems, they will be repeatedly exposed to antibiotics in the primary 
effluent, and those effects might be magnified for hydrophobic compounds that accumulate on 
solid surfaces.  
65 
 
Figure 3-8. Concentration of trimethoprim, sulfamethoxazole, and atenolol 
Aqueous concentrations of trimethoprim, sulfamethoxazole, and atenolol in the primary and secondary effluents as a 
function of SRT. Columns represent the mean values of replicate samples (2-4 replicates), and error bars represent 
±1 standard deviation or the span of the data, depending on the number of replicates 
Figure 3-8 summarizes the occurrence and removal of TMP, SMX, and atenolol in the SBRs. 
The corresponding raw data are provided in Table A1 (Appendix A). Consistent with the 
literature (Salveson et al., 2012; Gerrity et al., 2013), the removal of the biodegradable 
compound atenolol was positively correlated with SRT, with removals of 8-13%, 44-73%, and 
90-92% for SRTs of 2, 7, and 20 days, respectively. TMP concentrations remained relatively 
constant in the primary and secondary effluents until the SRT was increased to 20 days, at which 
point the reactor consistently achieved 70% removal. This is supported by Salveson et al. (2012), 
which identified a ‘threshold SRT’ of 30 days to achieve 80% removal of TMP. Other studies 
reported TMP removals of 20-40% with SRTs ranging from 10-16 days (Göbel et al., 2007; 
Radjenovic et al., 2009), and Pérez et al. (2005) attributed TMP removal to aerobic nitrifiers that 
should be present in systems operated with longer SRTs. SMX exhibited no consistent trend as a 
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function of SRT and actually increased in concentration by as much as 53%. Radjenovic et al. 
(2009) noted that increases in SMX have been reported previously and may be related to 
reformation of the parent compound during biological wastewater treatment. Therefore, the 
extent and mechanism of removal may be compound-specific, but longer SRTs have the 
potential to achieve lower concentrations of certain TOrCs, including the antibiotic TMP. But as 
noted earlier, the recycled biomass will be repeatedly exposed to antibiotics in the primary 
effluent and those accumulated on the solids. For this study, the primary effluent concentrations 
ranged from 370-710 ng/L for TMP and 970-1,300 ng/L for SMX, but solids partitioning was not 
quantified.  
3.7.3 Estimation of thymidine concentration   
One of the primary goals of this study was to monitor the level of TMP resistant bacteria in the 
absence/presence of TMP and different concentrations (0, 20, 60, and 100 µg/mL) of reagent-
grade thymidine. Subsequent experiments assessed the impacts of intracellular components 
released from biomass either through laboratory sonication or through natural cell lysis (i.e., cell 
death and decay). As a basis for comparison, the total amount of thymine/thymidine present in 
the SBRs as a function of SRT can be estimated based on the following assumptions: DNA 
comprises 3% of the total dry weight of the bacterial population (Physiology of the bacterial cell: 
a molecular approach, 1990) and thymine comprises 25% of the total bases. The resulting 
estimates of thymine/thymidine content are summarized in Table 3-3. The thymidine contents 
listed in Table 3-3 was then used as a starting point to select a range of concentrations for manual 
augmentation of thymidine and the other two experiments.  
 
67 
Table 3-3. Summary of calculation of thymidine concentration in samples  
SRT 
(d) 
Active 
biomass 
(mg/L)  
Inert 
biomass 
(mg/L) 
Weight ratio 
(DNA/DW1) 
(%) 
Thymidine 
content2 
(%) 
Intracellular 
thymidine 
content3 
(mg/L) 
Extracellular 
thymidine 
content4 
(mg/L) 
Total 
thymidine 
content 
(mg/L) 
2 310 240 3 0.75 2.3 1.8 4.1 
7 1050 1100 3 0.75 7.9 8.3 8.3 
20 2050 3400 3 0.75 15 25 40 
1DW = Dry Weight; 2Thymidine content assumes AT ratio of 50%; 3Intracellular estimated from active 
biomass; 4Extracellular estimated from inert biomass. 
3.7.4 Manual augmentation of thymidine with reagent-grade chemical 
In the first set of microbiological experiments, the level of TMP resistance within the microbial 
community was evaluated in the absence/presence of TMP and varying concentrations (0, 20, 60, 
and 100 µg/mL) of reagent-grade thymidine. The plate counts are summarized in Figure 3-9, and 
relative TMP resistance is summarized in Figure 3-10.  
Over the three sample sets, the total bacterial count in the absence of TMP and thymidine was an 
average of (2.22±0.39)×105 CFU per 100 µL of MLSS from the 7-day SRT. As noted earlier, 
there was no significant impact of thymidine on bacterial counts in the absence of TMP (p>0.05; 
Figure S3). With the addition of 4 μg/mL of TMP, the bacterial count decreased significantly 
because of the TMP sensitivity of a large portion (~90%) of the microbial community. However, 
the apparent TMP resistance increased from 11% to 44% with increasing concentrations of 
thymidine. The corresponding average plate counts were (2.39±0.65)×104 CFU/100 µL, 
(4.18±0.74)×104 CFU/100 µL, (5.99±0.61)×104 CFU/100 µL, and (9.79±0.91)×104 CFU/100 µL 
for thymidine concentrations of 0, 20, 60, and 100 µg/mL, respectively. The data for thymidine 
concentrations of 0 and 20 µg/mL proved to be statistically similar to each other, but all other 
pairings were found to be statistically different (p<0.05; Table A2).  
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Figure 3-9. Bacterial growth in the presence of different thymidine concentrations  
Bacterial growth in the presence of different thymidine concentrations and in the presence/absence of trimethoprim. 
Columns represent the mean values of triplicate plates, and error bars represent ±1 standard deviation 
 
Figure 3-10. Apparent TMP resistance in the presence of thymidine 
Apparent TMP resistance within the microbial community in the presence of 4 μg/mL of TMP and varying 
concentrations of thymidine. TMP resistance is reported as the percentage of bacteria that grew in the presence of 
TMP relative to the total culturable count in the absence of TMP. Columns represent the mean values of triplicate 
plates, and error bars represent ±1 standard deviation 
These data suggest that a baseline level of ~10% of the culturable microbial community is either 
truly resistant to TMP or is able to access environmental reservoirs of thymine/thymidine. 
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Furthermore, manually augmenting the concentration of thymidine increases apparent TMP 
resistance within the microbial community in a linear fashion. This supports the findings of 
Amyes and Smith (1974) and highlights the importance of media selection for antibiotic 
susceptibility testing. The following sections expand on this concept by illustrating how the 
sample matrix can also cause significant interferences.      
3.7.5 Manual augmentation of thymidine via cell lysing 
When bacterial cells enter the death phase, they lyse and release their cellular contents (e.g., 
thymine and thymidine) into their surrounding environment. In theory, more cellular debris may 
result in higher concentrations of free thymine and thymidine in a biological reactor, and as 
shown in the previous section, free thymidine has the potential to increase apparent resistance to 
TMP. Therefore, samples with greater cellular debris may exhibit greater TMP resistance due to 
water quality rather than actual changes in the microbial community.  In the second set of 
microbiological experiments, the level of TMP resistance within the microbial community was 
evaluated in the presence of 0%, 0.01%, 0.1%, and 1% post-sonication filtrate. The plate counts 
are summarized in Figure 3-11, and relative TMP resistance is summarized in Figure 3-12. 
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Figure 3-11. Bacterial growth in the presence of post-sonication filtrate 
Bacterial growth in the presence of different concentrations of post-sonication filtrate. Columns represent the mean 
values of triplicate plates, and error bars represent ±1 standard deviation 
 
Figure 3-12. Apparent TMP resistance in the presence of PSF  
Apparent TMP resistance within the microbial community in the presence of 4 μg/mL of TMP and varying 
concentrations of post-sonication filtrate (PSF). TMP resistance is reported as the percentage of bacteria that grew in 
the presence of TMP relative to the total culturable count in the absence of TMP. Columns represent the mean 
values of triplicate plates, and error bars represent ±1 standard deviation 
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Over the three sample sets, the total bacterial count in the absence of TMP and post-sonication 
filtrate was an average of (2.73±0.56)×105 CFU per 100 µL of MLSS from the 7-day SRT. With 
the addition of 4 μg/mL of TMP, the bacterial count decreased by ~90% due to bacterial 
sensitivity to TMP. These baseline total and resistant counts were consistent with those observed 
during the thymidine testing phase. With the addition of the post-sonication filtrate, the apparent 
TMP resistance increased from 12% to 30%. The corresponding average plate counts were 
(3.22±0.40)×104 CFU/100 µL, (3.68±0.50)×104 CFU/100 µL, (6.16±0.49)×104 CFU/100 µL, 
and (7.83±0.60)×104 CFU/100 µL for post-sonication filtrate concentrations of 0%, 0.01%, 
0.1%, and 1%, respectively. Adjacent pairings of post-sonication filtrate (i.e., 0% and 0.01%, 
0.01% and 0.1%, and 0.1% and 1%) proved to be statistically similar to each other, but all other 
pairings were found to be statistically different (p<0.05; Table A3). 
3.7.6 Varying of SRT to evaluate the effects of cellular debris 
The previous experiments indicated that TMP sensitivity is affected by thymidine and the 
addition of bacterial intracellular components. The next set of experiments assessed whether 
cellular debris naturally present in the MLSS matrix affects TMP sensitivity and whether those 
effects are also related to SRT. Metcalf and Eddy (2014) describes the MLVSS production rate 
in activated sludge systems as a function of substrate removed, influent nonbiodegradable VSS 
(nbVSS), and a series of kinetic coefficients (Eq. 3-2): 
   ,    =
  (    )
  (  )   
+ (  )(  )  (    )     (  )    +    ,    (Eq. 3-2) 
  ,    = daily VSS production rate, g VSS/d 
   = influent substrate concentration, mg COD/L 
  = effluent substrate concentration, mg COD/L 
  = influent flowrate, m3/d 
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   = fraction of cell mass remaining as cell debris, g VSS/g VSS 
  = synthesis yield coefficient for heterotrophic bacteria, g VSS/g COD 
  ,  = nbVSS concentration in influent, g/m3 
   = specific endogenous decay coefficient, d-1 
The second term in Eq. 3-2 represents the amount of cellular debris generated in the activated 
sludge process each day, and it also indicates there is a strong relationship between SRT and 
rates of bacterial death and decay. After normalizing to flow rate, Eq. 3-2 can be used to 
determine the corresponding concentration of cellular debris as a function of SRT, as shown in 
Figure 3-13. The SRTs in the current study correspond with theoretical cellular debris 
concentrations of 1.9, 4.7, and 7.6 mg/L, which suggests there may be higher concentrations of 
free thymidine at longer SRTs.  
 
Figure 3-13. Relationship between theoretical concentration of cellular debris  
Relationship between theoretical concentration of cellular debris (see Eq. 3 in main text) and SRT. Typical values 
for microbial kinetics were assumed (see below). Eq. 3 actually determines the daily volatile suspended solids 
production rate in g/day, but Eq. 3 can be normalized to flow rate to determine the corresponding concentration of 
cellular debris in mg/L, as shown in the figure. In other words, the concentration of cellular debris is independent of 
flow rate. Assumed parameters: kd =0.1 d-1; Y = 0.4 g VSS/g COD; fd = 0.15 g/g; S0 = 190 g COD/m3; Sf = 1 g 
COD/m3. 
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The objectives of these experiments were to (1) evaluate whether the addition of MLSS filtrate 
impacts apparent TMP resistance and (2) evaluate whether apparent TMP resistance varies as a 
function of SRT. By definition, longer SRTs require less ‘wasting’ of solids and higher biomass 
concentrations. Therefore, plating of fixed sample volumes may result in higher colony counts 
simply due to the higher biomass concentrations as a function of SRT. Reporting TMP resistance 
in relative terms (i.e., as a percentage of the total culturable bacteria) corrects for this issue. 
MLSS samples from the 2-day, 7-day, and 20-day SRTs were plated in the presence of 0%, 
0.01%, 0.1%, and 1% MLSS filtrate from the 7-day SRT. The aggregated data are summarized in 
Figure 3-14, and raw data are shown in Figures 3-15 - 3-20. 
 
Figure 3-14. Apparent TMP resistance in the presence of filtered MLSS 
within the microbial community as a function of SRT in the presence of 4 μg/mL of TMP and varying 
concentrations of MLSS filtrate. TMP resistance is reported as the percentage of bacteria that grew in the presence 
of TMP relative to the total culturable count in the absence of TMP. Columns represent the mean values of triplicate 
plates over three samples events, and error bars represent ±1 standard deviation 
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Figure 3-15. Bacterial growth in the presence of different concentrations of MLSS filtrate (2-day SRT) 
Bacterial growth in the presence of different concentrations of MLSS filtrate collected from the 7-day SRT. The 
bacteria represent MLSS collected from the 2-day SRT. Columns represent the mean values of triplicate plates, and 
error bars represent ±1 standard deviation 
 
Figure 3-16. Apparent TMP resistance in the presence of MLSS filtrate (2-day SRT) 
Apparent TMP resistance within the microbial community in the presence of 4 μg/mL of TMP and varying 
concentrations of MLSS filtrate (7-day SRT). The bacteria represent MLSS collected from the 2-day SRT. TMP 
resistance is reported as the percentage of bacteria that grew in the presence of TMP relative to the total culturable 
count in the absence of TMP. Columns represent the mean values of triplicate plates, and error bars represent ±1 
standard deviation 
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Figure 3-17. Bacterial growth in the presence of different concentrations of MLSS filtrate (7-day SRT) 
Bacterial growth in the presence of different concentrations of MLSS filtrate collected from the 7-day SRT. The 
bacteria represent MLSS collected from the 7-day SRT. Columns represent the mean values of triplicate plates, and 
error bars represent ±1 standard deviation 
 
Figure 3-18. Apparent TMP resistance in the presence of MLSS filtrate (7-day SRT) 
Apparent TMP resistance within the microbial community in the presence of 4 μg/mL of TMP and varying 
concentrations of MLSS filtrate (7-day SRT). The bacteria represent MLSS collected from the 7-day SRT. TMP 
resistance is reported as the percentage of bacteria that grew in the presence of TMP relative to the total culturable 
count in the absence of TMP. Columns represent the mean values of triplicate plates, and error bars represent ±1 
standard deviation 
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Figure 3-19. Bacterial growth in the presence of different concentrations of MLSS filtrate (20-day SRT) 
Bacterial growth in the presence of different concentrations of MLSS filtrate collected from the 7-day SRT. The 
bacteria represent MLSS collected from the 20-day SRT. Columns represent the mean values of triplicate plates, and 
error bars represent ±1 standard deviation 
 
Figure 3-20. Apparent TMP resistance in the presence of MLSS filtrate (20-day SRT) 
Apparent TMP resistance within the microbial community in the presence of 4 μg/mL of TMP and varying 
concentrations of MLSS filtrate (7-day SRT). The bacteria represent MLSS collected from the 20-day SRT. TMP 
resistance is reported as the percentage of bacteria that grew in the presence of TMP relative to the total culturable 
count in the absence of TMP. Columns represent the mean values of triplicate plates, and error bars represent ±1 
standard deviation 
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Over the three sample sets, the average bacterial counts in the absence of TMP and MLSS filtrate 
were (1.17±0.08)×105 CFU/100 µL, (1.66±0.20)×105 CFU/100 µL, and (2.30±0.19)×105 
CFU/100 µL for SRTs of 2, 7, and 20 days, respectively. As expected, the bacterial counts were 
positively correlated with SRT—consistent with the higher MLSS and MLVSS concentrations. 
With the addition of 4 μg/mL of TMP, relative TMP resistance averaged (8.5±0.3)%, 
(11.6±1.1)%, and (14.3±0.9)% for SRTs of 2, 7, and 20 days, respectively. The adjacent SRTs 
proved to be statistically similar for this experiment, but the SRTs of 2 and 20 days proved to be 
statistically different (p<0.05; Table A7). 
The addition of MLSS filtrate led to consistent increases in relative TMP resistance—up to 44-
47% resistance for the 1% dosing condition. In each dosing scenario, the SRT effect was still 
apparent in that longer SRTs were correlated with greater prevalence of resistance. For the 
MLSS collected from the 2-day SRT, all but one adjacent filtrate dose pairing (i.e., 0.01% and 
0.1%) proved to be statistically different (p<0.05; Table A4). For the 7-day SRT, all dose 
pairings proved to be statistically different (p<0.05; Table A5), and for the 20-day SRT, all but 
two adjacent dose pairings (i.e., 0.01% and 0.1%; 0.1% and 1%) proved to be statistically 
different (p<0.05; Table A6). Therefore, these data suggest that there are positive correlations 
between (1) SRT and relative TMP resistance and (2) exposure to dissolved constituents and 
relative TMP resistance. One possible explanation for the SRT effect might be the higher 
concentrations of cellular debris present at longer SRTs.   
3.7.7 Varying of SRT to evaluate multidrug resistance among Gram positive bacteria 
The last set of experiments highlighted several issues: (1) multi-druge resistance, (2) the general 
impact of biological treatment (i.e., primary effluent vs. MLSS), (3) the impact of SRT, and (4) 
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the impact of temperature. In contrast with the previous experiments, these analyses focused on a 
subset of the microbial community, specifically culturable Gram positive Staphylococcus and 
Streptococcus. Over the three sample events, the average Staph/Strep count in the primary 
effluent was approximately (3.34±1.69)×104 CFU/100 µL, and the counts increased by a factor 
of 1.5-3.6 in the MLSS, with a positive correlation with SRT. For sample event 1, it is important 
to note that the microbial communities may not have completely stabilized prior to sampling. 
The SBRs were seeded with RAS from the full-scale facility, which operates at an SRT of ~7 
days. Considering that the first set of samples was collected three days post-startup, the SBRs 
operating at the 2-day and 20-day SRTs may have still been acclimating, although the SBRs with 
a 7-day SRT should have been relatively stable. Figure 3-21 illustrates the relative SMX/TMP 
resistance as a function of SBR operation time, SRT, and temperature. The first feature that can 
be noted is the apparent increase in the relative SMX/TMP resistance during biological 
treatment. In other words, the primary effluent samples exhibited the lowest levels of resistance, 
but those levels increased dramatically, particularly in the first sample event, due to the 
biological treatment process. Furthermore, consistent with the SRT experiments with TMP only, 
the data exhibited a positive correlation between SRT and relative SMX/TMP resistance, 
although the statistical significance of those differences varied over time (Table A9). The 2-day 
SRT was always significantly different from the 20-day SRT, and it was often significantly 
different from the 7-day SRTs. Both 7-day SRTs were always statistically similar to each other 
and often statistically similar to the 20-day SRT. 
The other clear feature of Figure 3-21 is the decrease in relative SMX/TMP resistance over time, 
which corresponds with the decrease in ambient temperature. In fact, the SRT differences were 
least significant for the last sample event, which exhibited the lowest levels of relative resistance 
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and the lowest temperature. This does not appear to be an artifact of microbial community 
acclimation to the target SRTs because the SBRs operating with a 7-day SRT did not require any 
acclimation period. Previous studies observed increases in ARG abundance, including the sul1 
ARG that encodes resistance to SMX, during cold storage of biosolids (Miller et al., 2013; Miller 
et al., 2014). However, those studies focused only on molecular detection of AR and did not 
evaluate the expression of those genes or employ culture methods. Therefore, additional studies 
are needed to further evaluate the influence of temperature and the potential differences between 
culture and molecular methods in characterizing AR. 
 
Figure 3-21. Ambient air temperature and apparent SMX/TMP resistance 
Ambient air temperature and apparent SMX/TMP resistance within the microbial community as a function of SRT 
over the duration of the study. Relative resistance is reported as the percentage of bacteria that grew in the presence 
of the antibiotics relative to the total culturable count in the absence of the antibiotics. Columns represent the mean 
values of triplicate plates, and error bars represent ±1 standard deviation 
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3.8 Conclusions 
Bacterial antibiotic resistance is becoming an increasingly important issue for the municipal 
wastewater industry because treated wastewater effluent is known to contain numerous 
antibiotics and antibiotic resistance elements. Treated wastewater effluents are increasingly 
being used to augment conventional water supplies for various industrial, commercial, 
agricultural, and municipal applications. Therefore, stakeholders and decision makers must now 
address concerns related to wastewater-derived antibiotic resistance amidst uncertainty related to 
its potential public and environmental health impacts. 
One operational change that can be implemented to improve the quality of wastewater effluent is 
increasing the SRT of activated sludge systems. This study demonstrated that longer SRTs are 
effective in improving water quality with respect to reductions in bulk organic matter, nitrogen, 
and some trace organics. However, this study also demonstrated that longer SRTs are associated 
with higher rates of cell death and decay and higher concentrations of cellular debris. This 
cellular debris may consist of dissolved intracellular components such as thymine or thymidine, 
which bacteria can use to negate the bacteriostatic effects of some antibiotics, including TMP 
and SMX. Increases in thymidine concentration—either from culture media or from 
environmental reservoirs—increase apparent bacterial resistance to TMP. In this study, these 
increases were achieved through manual thymidine addition, lysing of bacterial cells, and by 
supplementing with dissolved constituents present in mixed liquor.  
Finally, this study demonstrated that biological treatment promotes single- and multi-drug 
resistance among non-specific heterotrophic bacteria and also among Staphylococcus and 
Streptococcus. The effect is also exacerbated by longer SRTs. However, it is not clear whether 
the SRT effect is due to selective pressure or higher concentrations of cellular debris. On the 
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other hand, decreasing temperature appears to reduce the prevalence of antibiotic resistance 
based on culture methods. Future studies should explain the role of temperature in promoting or 
attenuating AR, and studies must also consider potential differences between molecular and 
culture-based methods in quantifying AR.  
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4.0 IMPACT OF SOLIDS RETENTION TIME AND ANTIBIOTIC LOADING IN 
ACTIVATED SLUDGE SYSTEMS ON MICROBIAL COMMUNITY STRUCTURE AND 
BULK AND TRACE ORGANIC MATTER 
4.1 Abstract 
Solids retention time (SRT) is one of the most important factors in designing and operating 
activated sludge systems for biological wastewater treatment. Longer SRTs have been shown to 
alter the structure and function of microbial communities, thereby leading to improved treatment 
efficacy with respect to bulk and trace organics, nutrient removal, and membrane fouling. 
However, research has also shown that longer SRTs lead to increased prevalence of antibiotic 
resistant bacteria, perhaps due to increased exposure to antibiotics present in influent wastewater. 
The purpose of this study was to characterize changes in microbial community structure in a 
laboratory-scale activated sludge system as a function of SRT (2-20 days) and influent 
concentrations (1x-100x ambient concentrations) of five antibiotics: ampicillin, 
sulfamethoxazole, tetracycline, trimethoprim, and vancomycin. Changes in microbial community 
structure were evaluated based on traditional plating methods and 16s rDNA sequencing, and 
microbial community function was evaluated based on changes in effluent water quality, 
including bulk organic matter characterization and antibiotic concentrations. The results 
indicated that SRT—but not antibiotic loading—had a significant impact on microbial 
community structure (e.g., reduction in relative prevalence of Acinetobacter and Arcobacter) and 
effluent water quality. Therefore, spikes in influent antibiotics (at sub-therapeutic concentrations) 
are not expected to adversely impact biological wastewater treatment.  
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4.2 Introduction 
Due to the importance of potable reuse throughout the world, municipalities are increasingly 
turning to advanced wastewater treatment trains to achieve stringent water quality criteria 
(Gerrity et al., 2013). However, the more conventional aspects of wastewater treatment, 
particularly biological processes, are sometimes overlooked, despite the fact that they play 
critical roles in effluent water quality and operational performance (Leu et al., 2012). For 
example, rapid membrane fouling at an advanced treatment facility in California was attributed 
to the use of non-nitrified secondary wastewater effluent (Trussell et al., 2000). Instead of 
modifying the biological treatment process, the facility was upgraded with pre-ozonation to 
achieve bulk organic matter transformation to reduce membrane fouling rates (Stanford et al., 
2011) but the pre-ozone process also resulted in significant increases in direct N-
nitrosodimethylamine (NDMA) formation (Gerrity et al., 2015). Similar reductions in fouling 
with net reductions in NDMA could likely be achieved with optimized biological treatment (Leu 
et al., 2012; Ouyang and Liu, 2009; Sharp et al., 2010; Wang et al., 2014), potentially leading to 
reduced costs and energy consumption (Gerrity et al., 2014). 
The objectives of secondary biological treatment at municipal wastewater treatment plants 
(WWTPs) vary considerably between facilities (e.g., biochemical oxygen demand, 
nitrification/denitrification, phosphorus). Solids retention time (SRT), which is defined as the 
average amount of time biomass is recycled within an activated sludge system, is critically 
important in determining whether these treatment objectives can be achieved. For example, 
systems with shorter SRTs (<5 days) are known to be deficient in nitrifiers, as these organisms 
are washed out of the system due to their relatively slow growth rates (Li and Wu, 2014). 
Systems with longer SRTs select for more slowly growing microorganisms, such as nitrifying 
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microorganisms (Roh and Chu, 2011) and estrogen degrading bacteria (Roh and Chu, 2011), 
thereby resulting in a more diverse microbial community (Roh and Chu, 2011) potentially 
capable of emerging treatment needs such as trace organic compound (TOrC) mitigation.  
TOrCs are ubiquitous in untreated and treated wastewater (Luo et al., 2014) and are frequently 
detected in surface water (Kolpin et al., 2002; Pal et al., 2010) and groundwater supplies 
(Lapworth et al., 2012) impacted by wastewater effluent. As a result, some municipalities are 
considering operational changes or treatment upgrades for TOrC mitigation (Gerrity et al., 2013). 
Numerous studies have documented the relationship between SRT and reductions in TOrC 
concentrations (Clara et al., 2005; D. Gerrity et al., 2013; Melcer and Klecka, 2011; 
Oppenheimer et al., 2007; Suarez et al., 2010; Leu et al., 2012; Salveson et al., 2012; Vuono et 
al., 2016) For example, Vuono et al. (2016) reported increases in rRNA/rDNA ratios for rare 
taxa associated with longer SRTs, possibly indicating higher rates of TOrC degradation by these 
rare taxa. In general, longer SRTs may lead to lower TOrC concentration, however due to the 
complexity of removal mechanisms, outcomes may vary between studies. Sorption on primary 
sludge might be the main mechanisms for micropollutants removal in primary treatment, while a 
range of processes like biodegradation/biotransformation, sorption, and volatilization may be 
responsible for TOrC removal during secondary treatment (Luo et al., 2014). Biological reactors 
operating with longer SRTs contain higher mixed liquor suspended solids (MLSS) concentration, 
therefore lower TOrC concentration in longer SRTs may be correlated with higher biomass 
concentration in these reactors. Previous studies have shown that diclofenac and galaxolide 
(Clara et al., 2011) and triclosan (Samaras et al., 2013) can be removed by sorption mechanism.  
In aerobic biodegradation, with proper environmental and operational conditions, some of the 
refractory compounds can serve as growth substrates (Metcalf and Eddy, 2014). Some 
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chlorinated compounds can be degraded in a process called cometabolic degradation. In this 
process, some bacteria will produce specific enzymes that mediate a reaction with oxygen and 
hydrogen, which finally change the structure of the compounds that make them easier to be 
degraded by other aerobic bacteria (Metcalf and Eddy, 2014). Also, biological treatment systems 
with longer SRTs may select for slowly growing bacteria, which promote degradation of some 
compounds (Roh and Chu., 2011). 
In addition to general concerns related to antibiotic occurrence and exposure, recent studies 
suggest a link between wastewater treatment and the occurrence of antibiotic resistant bacteria 
and antibiotic resistance genes (Auerbach et al., 2007; Zhang et al., 2015). Although longer 
SRTs often result in lower effluent TOrC concentrations, there is evidence to suggest that longer 
SRTs may proliferate antibiotic resistance (Neyestani et al., 2016). The mechanism of the 
observed increase in antibiotic resistance at longer SRTs is still unclear, but it may be related to 
longer exposure to antibiotics in a system that is conducive to microbial growth and horizontal 
gene transfer (Baquero et al., 2008) .Furthermore, concentrations of antibiotics vary considerably 
over time, either due to typical intraday variability (Gerrity et al., 2011) or unique discharges 
(e.g., hospital wastewater effluent; (Coutu et al., 2013)). The occurrence of antibiotics in hospital 
and urban wastewater have been investigated by previous studies. For some antibiotics such as 
ciprifloxacin and ofloxacin, higher concentrations (at least one order of magnitude) were 
detected in hospital wastewater compared with urban wastewater since fluoroquinolones 
frequently used antibiotics in hospitals (Rodriguez-Mozaz et al., 2015). In contrast, other group 
of antibiotics like cephalosporins, which include cefazolin and cefotaxime, were detected in 
lower concentrations in hospital wastewaters compared to those detected in domestic wastewater 
(Gros et al., 2013). Therefore, it is important to understand typical microbial community 
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structure and how the community responds to varying SRTs and antibiotic loadings. This will 
provide critical information for evaluations of treatment efficacy and antibiotic resistance, 
including the most appropriate subpopulations to target for antibiotic resistance studies.  
Culture-dependent techniques have traditionally been used to characterize microbial 
communities, but these techniques may result in bias considering that more than 99% of 
environmental microorganisms cannot be detected by culture-dependent methods (Hugenholtz, 
2002). Culture-independent microbial community characterization based on 16s rDNA 
sequencing has become increasingly accessible in recent years, leading to an abundance of 
published literature on the topic. For example, bacterial communities among different WWTPs 
with different technological configurations have been investigated previously. Gonzales-
Martinez et al. (2016) explored bacterial communities among 10 different WWTPs and between 
conventional and highly loaded A-stage activated sludge systems. Zhang et al. (2012) 
investigated the bacterial communities among different WWTPs in Asia and North America. 
Although these studies explored bacterial communities among different WWTPs with different 
treatment technologies and operational conditions, they reported a core of genera was 
consistently shared between activated sludge samples (Gonzalez-Martinez et al., 2016; Zhang et 
al., 2012; Wanger and Loy., 2002). The same pattern was also monitored among all the 
secondary influent samples (Gonzales-Martinez et al., 2016). However, microbial community 
characterization and assessments of operational variables are often performed on samples 
collected from different systems (Gonzales-Martinez et al., 2016; Zhang et al., 2012), which may 
introduce confounding factors. Few studies have evaluated changes in microbial community 
structure within the same system (Ahmed et al., 2007; Vuono et al., 2016). 
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The current research explores the impacts of varying SRT (2-20 days) on microbial community 
structure in controlled laboratory-scale sequencing batch reactors (SBRs) fed with primary 
effluent (PE) from a full-scale municipal WWTP. Influent antibiotic concentrations (1x-100x 
ambient concentrations) are also discussed in the context of microbial community structure and 
treatment efficacy, specifically bulk water quality parameters and effluent antibiotic 
concentrations. This information will aid researchers in identifying important subpopulations for 
studies of TOrC mitigation, antibiotic resistance proliferation, and other issues related to 
operational performance and public health.  
4.3 Materials and methods 
4.3.1 Automation and operation of the laboratory-scale sequencing batch reactors 
The laboratory-scale activated sludge process was achieved with four parallel SBRs fed with PE 
from a full-scale WWTP in Las Vegas, Nevada (Figure 3-2). The acrylic SBRs had a total 
volume of 8 L and a working volume of 4 L, after accounting for the volume of settled solids. 
Automation of the SBRs was achieved with a series of multi-station outlet timers, a pump, and 
electric actuated ball and solenoid valves. A MasterFlex peristaltic pump (Model 77200-62, Cole 
Parmer, Vernon Hills, IL) was used to pump PE from a wet well through a 
polytetrafluoroethylene/stainless steel strainer (Hach, Loveland, CO) and a 50-m cartridge filter 
(Watts WPC50-975) prior to filling the reactors. The cartridge filters were replaced every two 
days to mitigate fouling and anaerobic conditions. A four-station irrigation timer (Orbit, 
Bountiful, UT) was used to control the volume fed to each reactor. Electric actuated solenoid 
valves (Parker Hannifin Corporation, Cleveland, OH) and an industrial grade air compressor 
(Porter-Cable PCFP02003; 3.5 gallons; 135 psi) were used to aerate the SBRs to achieve a 
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relatively constant dissolved oxygen (DO) concentration of 3 to 4 mg/L. The compressed air was 
passed through a pressure gauge and air flow meter before being fed into the SBRs via stone 
diffusers. Aeration was sufficient to achieve adequate mixing of the mixed liquor without the 
need for mechanical mixing. The target SRTs were achieved by wasting predetermined volumes 
of mixed liquor toward the end of each aeration phase, and this was accomplished with four 
electric actuated ball valves (W.E. Anderson, Michigan City, IN).  
The SBRs were initially seeded with return activated sludge (RAS) from the full-scale facility, 
which typically operates at an SRT of ~7 days. The SBRs were operated with a total cycle time 
of 8 hours for 3 cycles per day over 2 experimental phases—60 days of operation for the SRT 
experiments and 60 days of operation for the antibiotic loading experiments. Each cycle 
consisted of the following five stages: (1) filling with PE for 29 minutes as the irrigation timer 
cycled through each reactor, (2) aeration for 6.5 hours (from the start of the filling cycle), (3) 
solids settling for 1 hour, (4) discharge of settled effluent for 30 minutes, and (4) idle for 1 
minute. Again, solids wasting was performed toward the end of each aeration phase to minimize 
clogging of the ball valves. 
In phase 1, the SBRs were operated with SRTs of 2 days, 7 days (in duplicate), and 20 days and 
fed with PE and ambient concentrations of antibiotics. The corresponding waste activated sludge 
(WAS) flow rates (Qw) (Figure 3-2) were determined according to Eq. 3-1. The primary and 
secondary effluents from phase 1A were tested for bulk water quality parameters and TOrCs, and 
the PE and MLSS were analyzed with 16S rDNA sequencing.    
At the conclusion of phase 1, the system was restarted by seeding different volumes of RAS in 
each SBR to target final MLSS concentrations of 1000 mg/L, 2000 mg/L, 3000 mg/L, and 4000 
mg/L. These MLSS concentrations are characteristic of SRTs of 3, 6, 10, and 15 days, although 
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the microbial community of the full-scale RAS is characteristic of a ~7-day SRT. Therefore, the 
intent of this experiment was to simulate the MLSS effect (i.e., varying solids concentration and 
biomass abundance) while controlling for microbial community structure. The primary and 
secondary effluents from phase 1B were tested for TOrC concentrations.  
In phase 2, the SRT was held constant at  ~7 days, but the antibiotic concentrations in the PE 
were varied between 1x (ambient), ~10x (in duplicate), and ~100x. The antibiotic spike solutions 
were stored at the study site in coolers and replaced every 3 days. The antibiotic spike solutions 
were delivered to the SBRs with 12V DC, timer-controlled peristaltic pumps during the filling 
phase. The spiking levels (Table 4-1) were determined based on TOrC data collected during the 
SRT testing in phase 1.  
Table 4-1. Summary of Spiked Antibiotic Concentrations in the SBRs 
Antibiotic Units 1x 10x 100x MIC1 100x/MIC 
Ampicillin μg/L 0.2 (spiked)2 2 20 32,000 0.06% 
Sulfamethoxazole μg/L 1 (ambient) 10 100 76,000 0.13% 
Tetracycline μg/L 0.1 (spiked)2 1 10 16,000 0.06% 
Trimethoprim μg/L 0.5 (ambient) 5 50 4,000 1.25% 
Vancomycin μg/L 0.5 (ambient) 5 50 4,000 1.25% 
1MIC = minimum inhibitory concentration (CLSI, 2014) 
2Ampicillin and tetracycline were spiked at 2×MRL because they were <MRL during phase 1 testing 
 
The table also shows the corresponding minimum inhibitory concentrations (MICs; i.e., clinical 
standards) to illustrate that the concentrations still represent sub-inhibitory levels (CLSI, 2014). 
The highest concentrations as a percentage of the MIC are for trimethoprim and vancomycin, 
which were spiked at 1.25% of the MIC. Because the concentrations of ampicillin and 
tetracycline were <method report limit (MRL) in the PE (described later), the 1x concentrations 
were actually spiked at twice the analytical MRL. The primary and secondary effluents from 
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phase 2 were tested for bulk water quality parameters and TOrCs, and the PE and MLSS were 
analyzed with 16S rDNA sequencing. 
4.3.2 Preparation of antibiotic stock solutions 
As mentioned earlier, five different antibiotics were selected for this project including: ampicillin 
sodium salt (Sigma Aldrich, St. Louis, MO), sulfamethoxazole (Sigma Aldrich, St. Louis, MO), 
tetracycline hydrochloride (Sigma Aldrich, St. Louis, MO), vancomycin hydrochloride (Sigma 
Aldrich, St. Louis, MO), and trimethoprim (Sigma Aldrich, St. Louis, MO). All antibiotic stock 
solutions were prepared based on the Clinical and Laboratory Standards Institute (CLSI, 2012). 
Appropriate Solvents were used for each antibiotic including: 0.01 M PBS for ampicillin, sterile 
nanopure hot water and minimal amount of 2.5 M NaOH for sulfamethoxazole, 90% volume of 
sterile nanopure water with 10% volume of 0.05 M hydrochloric acid for trimethoprim, and 
sterile nanopure water for tetracycline and vancomycin. The antibiotic stock solutions were then 
passed through acrodisc syringe filters to be sterilized. All stock solutions were stored in 
refrigerator at at 4±2°C and were used within 48 hours. 
4.3.3 General water quality parameters 
To ensure the SBRs were operating as intended and were properly mimicking a full-scale 
activated sludge system, a series of general water quality parameters were monitored for the 
duration of the study. These tests included temperature, pH, MLSS, mixed liquor volatile 
suspended solids (MLVSS), soluble chemical oxygen demand (sCOD), nitrogen speciation (i.e., 
ammonia, nitrate, and nitrite), and DO. Standard methods were employed when applicable; a 
summary of the analyses and associated methods is provided in Table B1 (Appendix B). 
91 
4.3.4 UV-Vis and fluorescence spectroscopy 
Bulk organic matter was also characterized according to previously published methods (Chen et 
al., 2003; Christian et al., 2016; Gerrity et al., 2012). Briefly, UV-Vis and fluorescence 
spectroscopy were performed following laboratory filtration with 0.7-μm glass fiber syringe 
filters (GD/X, Whatman, GE Healthcare Bio-Sciences, Pittsburgh, PA). The analysis was 
performed with an Aqualog spectrofluorometer (Horiba, Edison, NJ) equipped with a 150-watt, 
short-arc xenon lamp with an excitation range from 230 to 1200 nm. Excitation was limited to λ 
≥ 240 nm, and emissions were collected over 3 seconds of integration time. Data processing 
included corrections for blank response, the spectral sensitivity of the lamp, the inner filter 
effect, and Rayleigh masking, all of which were performed within the instrument software, and 
excitation emission matrices (EEMs) were also prepared with Matlab (Natick, MA). The 
fluorescence data were normalized to an average Raman peak area, which was based on 
excitation at 350 nm and emission from 380 to 410 nm in deionized water. Fluorescence regional 
integration was performed according to Chen et al. (2003) to calculate the regional and total 
fluorescence intensities. Integration was based on three regions representing (1) microbial 
byproducts, proteins, and biopolymers; (2) fulvic-like substances; and (3) humic-like substances.  
4.3.5 Trace organic compounds 
Primary and secondary effluent samples from the four SBRs were collected in 1-L silanized 
amber glass bottles preserved with sodium azide (1 g/ L) and ascorbic acid (50 mg/L). Samples 
were immediately placed on ice and transported to the laboratory where they were refrigerated at 
4°C for up to 14 days. Sample processing consisted of filtration with 0.7-μm glass fiber filters 
and on-line solid phase extraction (SPE). The samples were then analyzed for the five target 
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antibiotics (ampicillin, sulfamethoxazole, tetracycline, trimethoprim, and vancomycin) and nine 
indicator TOrCs [acetaminophen, caffeine, ibuprofen, atenolol, gemfibrozil, triclosan, primidone, 
sucralose, and tris(2-chloroethyl) phosphate (TCEP)] by liquid chromatography tandem mass 
spectrometry (LC-MS/MS) with isotope dilution according to previously published methods 
(Trenholm et al., 2006; Vanderford and Snyder, 2006; Salveson et al., 2012). Method reporting 
limits (MRLs) were set at 3-5x the corresponding method detection limits. 
4.3.6 Molecular-based microbial community characterization of SBRs 
Four sets of samples were collected from the laboratory-scale SBRs for 16s rDNA sequencing—
two sets of samples during phase 1 SRT testing and two sets of samples during phase 2 antibiotic 
concentration testing. The samples included PE and MLSS from each SBR and were collected on 
consecutive days toward the end of each 60-day testing phase. The DNA was extracted and 
purified using the PowerBiofilm DNA isolation kit (MO BIO, Carlsbad, CA), following 
manufacturer’s protocol. The extracted DNA was shipped to Research and Testing Laboratory 
(Lubbock, TX) for further analysis. Briefly, amplicons were sequenced on the Illumina MiSeq 
platform using MiSeq Reagent Kits V3 2×300 (Illumina, San Diego, CA). Initial amplification 
was performed with universal primers for Bacteria (28F and 388R). Quality assurance/quality 
control (QA/QC) procedures included denoising and chimera checks to eliminate potentially 
erroneous data. The remaining sequences were processed through the USEARCH global 
alignment program for diversity analysis and taxonomic classification. Statistical analyses were 
performed for the top 10 most abundant genera in the samples by principal component analysis 
(PCA) with XLSTAT (Addinsoft, NY).  
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4.4 Results and discussion 
4.4.1 General water quality parameters 
General water quality parameters were monitored on an approximately biweekly basis to validate 
the performance of the SBRs. The average pH of the PE was 6.4 in phase 1 and 6.8 in phase 2, 
and the average pH of the SBR effluents was approximately 6.9 in phase 1 and 7.1 in phase 2. 
During the aeration cycle, the average DO concentrations ranged from 4.5-5.2 mg/L in phase 1 
and 3.7-3.8 in phase 2. As described later, one parameter that proved to be highly significant 
during long-term testing was temperature, which decreased from 30°C to 10°C in phase 1 
(September to November) but increased from 22°C to 37°C during phase 2 (March to May). 
During phase 1, the average MLSS concentrations were 654±33, 2142±104, 2374±219, and 
5172±182, and the average MLVSS concentrations were 575±5, 1747±50, 1937±174, and 
4000±120 for SRTs of 2, 7A, 7B, and 20, respectively. During phase 2, the SBRs were operated 
at a constant SRT of 7 days so the MLSS and MLVSS concentrations were relatively constant at 
2274±43 and 1840±53, respectively. 
Figures 4-1A and 4-1B illustrate the average sCOD and ammonia concentrations in the primary 
and secondary effluents during phase 1 as a function of SRT. Figures 4-1C and 4-1D illustrate 
the same parameters as a function of influent antibiotic concentration during phase 2. The 
corresponding data for nitrate and nitrite are shown in Figure 4-2. As expected, sCOD removal 
and the extent of nitrification were positively correlated with SRT, and there was no significant 
difference in sCOD or nitrification when the SBRs were spiked with higher concentrations of 
antibiotics. As noted earlier, the temperature decreased to 10°C toward the end of phase 1. This 
resulted in a ~15% reduction in sCOD removal for the longer SRTs (i.e., decrease from 85-90% 
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removal to 69-74% removal), and it severely inhibited nitrification for all SRTs (i.e., decrease 
from 33-99% conversion to 0-40% conversion), as summarized in Table 4-2 and illustrated in 
Figure 4-3. Previous research has documented reductions in nitrification rates at lower 
temperatures (Head and Oleszkiewicz, 2004). 
 
Figure 4-1. Average concentrations of (A) sCOD and (B) ammonia 
Average concentrations of (A) sCOD and (B) ammonia in the primary (PE) and secondary effluents as a function of 
SRT during phase 1 testing. Columns represent the mean values of 5 and 3 sample events, respectively. Fewer 
sample events are included for ammonia due to temperature effects (described in main text). Average concentrations 
of (C) sCOD and (D) ammonia in the PE and secondary effluents as a function of influent antibiotic concentration 
during phase 2 testing (mean values of 3 sample events). Error bars represent ±1 standard deviation 
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Figure 4-2. Average concentrations of (A) nitrate and (B) nitrite 
Average concentrations of (A) nitrate and (B) nitrite in the primary (PE) and secondary effluents as a function of 
SRT during phase 1 testing (mean values of 3 sample events). Average concentrations of (C) nitrate and (D) nitrite 
in the PE and secondary effluents as a function of influent antibiotic concentration during phase 2 testing (mean 
values of 3 sample events). Nitrite concentrations were consistently <0.02 mg-N/L during phase 2 testing. Error bars 
represent ±1 standard deviation 
 
 
 
96 
Table 4-2. Extent of nitrification and apparent denitrification  
Phase Sample Nitrification4 Denitrification5 
1A1 
PE -- -- 
SRT = 2 d 33% 11% 
SRT = 7 d (A) 96% 42% 
SRT = 7 d (B) 99% 37% 
SRT = 20 d 96% 43% 
1B2 
PE -- -- 
SRT = 2 d 0% 0% 
SRT = 7 d (A) 15% 12% 
SRT = 7 d (B) 40% 31% 
SRT = 20 d 37% 34% 
23 
PE -- -- 
AB = 1X 98% 14% 
AB = 10X (A) 97% 14% 
AB = 10X (B) 98% 13% 
AB = 100X 98% 16% 
Extent of nitrification and apparent denitrification during (top) first three sample events of phase 1 (moderate 
temperature), (middle) final sample event of phase 1 (cold temperature), and (bottom) three sample events from 
phase 2 (moderate temperature) 
1Averages from first three sample events for phase 1A (average temperature = 25°C) 
2Data from final sample event for phase 1B (temperature = 10°C) 
3Averages from three sample events for phase 2 (average temperature = 28°C) 
4% removal = ([Ammonia]PE – [Ammonia]SBR) / [Ammonia]PE × 100 
5% removal = ([TIN]PE – [TIN]SBR) / [TIN]PE × 100  
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Figure 4-3. Temporal variability in the sCOD, ammonia, nitrate, and nitrire 
(A) Temporal variability in the sCOD concentrations relative to ambient temperature in the primary effluent and 
SBR effluents as a function of SRT. (B) Temporal variability in effluent ammonia, nitrate, and nitrite concentrations 
relative to ambient temperature from the SBR operating with a 20-day SRT. These data are provided as examples of 
the effects of decreasing temperature during phase 1 testing 
4.4.2 UV-Vis and fluorescence spectroscopy  
As noted earlier, more extensive transformation and/or removal of bulk organic matter may yield 
significant benefits for advanced treatment with respect to membrane fouling (Stanford et al., 
2011), ozone efficacy due to reductions in dissolved organic carbon concentrations (Lee et al., 
2013), and the efficacy of ultraviolet (UV) disinfection, photolysis, or advanced oxidation due to 
increases in UV transmittance (Lee et al., 2016). The current study evaluated changes in 
fluorescence, as measured by EEMs, peak fluorescence, and regional fluorescence, and also 
changes in UV absorbance to describe how biological treatment might impact downstream 
treatment efficacy. 
The EEMs in Figure 4-4 illustrate that bulk organic matter transformation and/or removal was 
positively correlated with SRT, while the EEMs in Figure 4-5 indicate that there were no 
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apparent differences in fluorescence resulting from varying influent antibiotic concentrations. 
The peak fluorescence data in Figure 4-6 demonstrate that effluents from systems with shorter 
SRTs may be characterized by more variable fluorescence signatures, consistent with the greater 
variability in sCOD values presented earlier. In fact, the 2-day SRT sometimes exhibited 
increases in fluorescence associated with humic-like peak C, while fulvic-like peak A exhibited 
more consistent reductions ranging from 15% to 36% for SRTs of 2 and 20 days, respectively. 
Protein-like peak T exhibited the most consistent reductions and was less dependent on SRT, 
with reductions ranging from 74% to 85%, respectively. Although these compounds are typically 
considered as organic foulant for microfiltration, ultrafiltration, and reverse osmoses, however 
the role of each component on membrane fouling is based on other factors such as pH (Ang and 
Elimelech, 2007), water quality constituents (e.g., calcium) (Ang and Elimelech, 2007), and type 
of membrane (e.g., hydrophilic or hydrophobic) (Lee et al., 2006). Literatures suggest that 
effluent organic matter (EfOM) contribute to organic fouling of ultrafiltration, microfiltration, 
and RO systems (Jarusutthirak et al., 2002; Jarusutthirak and Amy, 2001; Zhao et al., 2010) and 
any reduction in EfOM could possibly lead to alleviating membrane fouling issues. In fact, 
longer SRTs are associated with lower membrane fouling (Farias et al., 2014; Van den Broeck et 
al., 2012) probably due to reduction in EfOM. Additional fluorescence data are summarized in 
Table 4-3 – 4-6 and in Figure 4-7. 
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Figure 4-4. Representative EEMs as a function of SRT 
Representative EEMs to illustrate changes in fluorescence as a function of SRT. The EEM in the top left defines the 
peaks and regions typically discussed in the literature, and the remaining EEMs illustrate the fluorescence of the 
primary and secondary effluents from the SBRs during the first sample event (similar results observed for 
subsequent sample events) 
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Figure 4-5. Representative EEMs as a function of influent antibiotic concentration 
Representative EEMs to illustrate changes in fluorescence as a function of influent antibiotic concentration. There 
were no apparent differences in the EEMs for the SBRs spiked with different concentrations of antibiotics 
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Figure 4-6. Average reductions in peak fluorescence 
Average reductions in peak fluorescence during (A) phase 1 SRT testing and (B) phase 2 antibiotic 
testing. Error bars represent ±1 standard deviation 
Table 4-3. Average peak fluorescence values during phase 1 SRT testing (5 sample events) 
Sample Peak T (AFU) Peak A (AFU) Peak C (AFU) 
Primary Effluent 9.01 ± 2.23 2.98 ± 0.46 2.08 ± 0.30 
SRT = 2 Days 2.16 ± 0.41 2.48 ± 0.19 2.07 ± 0.26 
SRT = 7 Days (A) 1.59 ± 0.20 2.10 ± 0.05 1.82 ± 0.27 
SRT = 7 Days (B) 1.69 ± 0.30 2.16 ± 0.09 1.78 ± 0.08 
SRT = 20 Days 1.30 ± 0.12 1.89 ± 0.05 1.60 ± 0.14 
Table 4-4. Average peak fluorescence values during phase 2 antibiotic testing (3 sample events) 
Sample Peak T (AFU) Peak A (AFU) Peak C (AFU) 
Primary Effluent 6.77 ± 0.84 2.99 ± 0.19 2.15 ± 0.07 
AB = 1X 1.31 ± 0.04 2.02 ± 0.20 1.78 ± 0.26 
AB = 10X (A) 1.36 ± 0.03 2.09 ± 0.24 1.87 ± 0.31 
AB = 10X (B) 1.32 ± 0.09 1.95 ± 0.20 1.81 ± 0.29 
AB = 100X 1.32 ± 0.03 1.87 ± 0.15 1.80 ± 0.21 
Table 4-5. Average regional fluorescence values during phase 1 SRT testing (5 sample events) 
Sample Region 1 (AFU) Region 2 (AFU) Region 3 (AFU) Total Fluorescence (AFU) 
Primary Effluent 99,337 ± 20,992 47,972 ± 7,224 14,787 ± 2,372 162,096 ± 27,130 
SRT = 2 Days 27,514 ± 3,493 30,069 ± 2,021 13,988 ± 1,376 71,571 ± 5,810 
SRT = 7 Days (A) 22,272 ± 1,996 26,079 ± 1,096 12,322 ± 1,471 60,673 ± 3,847 
SRT = 7 Days (B) 22,902 ± 2,947 26,660 ± 980 12,275 ± 543 61,837 ± 3,958 
SRT = 20 Days 19,079 ± 1,410 23,679 ± 900 11,074 ± 799 53,921 ± 1,707 
Table 4-6. Average regional fluorescence values during phase 2 antibiotic testing (3 events) 
Sample Region 1 (AFU) Region 2 (AFU) Region 3 (AFU) Total Fluorescence (AFU) 
Primary Effluent 78,725 ± 8,231 46,863 ± 3,753 15,510 ± 462 141,097 ± 11,482 
AB = 1X 19,536 ± 993 25,266 ± 2,721 12,299 ± 1,598 57,101 ± 5,259 
AB = 10X (A) 20,285 ± 1,032 26,348 ± 2,684 12,864 ± 1,701 59,496 ± 5,315 
AB = 10X (B) 19,679 ± 1,315 24,800 ± 2,392 12,206 ± 1,551 56,685 ± 5,181 
AB = 100X 19,468 ± 863 23,945 ± 1,921 11,629 ± 1,231 55,042 ± 3,927 
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Figure 4-7. Average reductions in regional fluorescence during (A) phase 1 and (B) phase 2 
Based on the UV absorbance data in Table 4-7, there is a clear benefit to operating with longer 
SRTs for systems employing low pressure UV processes for disinfection, photolysis, or 
contaminant oxidation. Based on the same reactor assumptions in Lee et al. (2016) including an 
electrical efficiency of 30% and a path length of 10 cm, the average UV254 absorbance of 0.171 
cm-1 for the 2-day SRT results in energy consumption values of 0.030 kWh/m3 and 0.372 
kWh/m3 for UV doses of 80 mJ/cm2 and 1000 mJ/cm2. These UV doses were selected to 
represent typical conditions in disinfection and photolysis or advanced oxidation applications, 
respectively. In contrast, the average UV254 absorbance of 0.135 cm-1 for the 20-day SRT results 
in lower energy consumption values of 0.024 kWh/m3 and 0.301 kWh/m3, respectively. 
Therefore, potential cost savings associated with the UV process (and other forms of tertiary 
treatment) may help offset the additional costs associated with longer SRTs (Canales et al., 1994; 
Li and Wu, 2014). Finally, the reductions in UV280 absorbance, which is sometimes used as a 
measure of the protein content of a water sample, were also positively correlated with SRT, 
consistent with the reductions in fluorescence associated with protein-like peak T. 
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Table 4-7. Reductions in regional fluorescence and UV absorbance  
Sample UV254 
Absorbance 
(cm-1) 
UVT254 Low Dose 
UV Energy 
Consumption
1,3 (kWh/m3) 
High Dose 
UV Energy 
Consumption
2,3 (kWh/m3) 
UV280 
Absorbance 
(cm-1) 
PE 0.510 ± 0.109 31% 0.087 1.09 0.418 ± 0.110 
SRT = 2 d 0.171 ± 0.009 67% 0.030 0.37 0.129 ± 0.008 
SRT = 7 d (A) 0.149 ± 0.008 71% 0.026 0.33 0.112 ± 0.005 
SRT = 7 d (B) 0.153 ± 0.010 70% 0.027 0.34 0.115 ± 0.009 
SRT = 20 d 0.135 ± 0.008 73% 0.024 0.30 0.099 ± 0.006 
PE 0.427 ± 0.033 37% 0.073 0.91 0.328 ± 0.032 
AB = 1X 0.146 ± 0.003 71% 0.026 0.32 0.107 ± 0.003 
AB = 10X (A) 0.148 ± 0.006 71% 0.026 0.33 0.110 ± 0.006 
AB = 10X (B) 0.144 ± 0.005 72% 0.025 0.32 0.106 ± 0.003 
AB = 100X 0.143 ± 0.005 72% 0.025 0.32 0.106 ± 0.003 
Reductions in regional fluorescence and UV absorbance as a function of SRT (5 sample events) and influent 
antibiotic concentration (3 sample events). Error bars represent ±1 standard deviation 
1Assumes UV dose = 80 mJ/cm2 for disinfection applications (NWRI/WRF, 2012) 
2Assumes UV dose = 1000 mJ/cm2 for advanced oxidation applications 
3Based on Lee et al. (2016): Energy Consumption (kWh/m3) =  ` ×    ×     ×
 .   ×      × 
            ×    
UVT = UV transmittance; H` = target UV dose (mJ/cm2); L = pathlength (cm);      = electrical efficiency of lamp 
4.4.3 Trace organic compounds  
I. Phase 1 SRT testing  
Monitoring of antibiotics and indicator TOrCs during phase 1 focused on two different 
objectives: (1) verifying previously documented relationship between SRT and TOrC removal 
and (2) identifying target concentrations for phase 2 antibiotic testing. Primary effluent and SBR 
effluent samples were collected on consecutive days at the end of phase 1. Therefore, treatment 
performance was characteristic of cold temperature conditions in which the extent of nitrification 
ranged from 0% to 37% and the extent of denitrification ranged from 0% to 34% for SRTs of 2 
and 20 days, respectively (Table 4-2). The resulting TOrC concentrations are summarized in 
Table 4-8.  
In phase 1, the antibiotics ampicillin and tetracycline were the only compounds with 
concentrations lower than their respective MRLs in all samples, although it is important to note 
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that their respective MRLs were also higher than some of the other target compounds. Other 
studies also reported undetected or very low concentrations of penicillin and tetracycline families 
of antibiotics (Graham et al., 2011; Hirsch et al., 1999; Rodriguez-Mozaz et al., 2015). Very low 
concentration of ampicillin was expected since ß-lactam rings are readily susceptible to 
hydrolysis (Hirsch et al., 1999). Tetracyclines also tend to form stable complexes with calcium 
or similar ions and can bind to suspended matter and sediment (Hirsch et al., 1999). In contrast, 
the concentration of the antibiotic sulfamethoxazole was approximately 1 μg/L in the PE and 
actually increased in concentration in some of the SBR effluents, as has been previously 
described by Radjenovic et al. (2009). Trimethoprim and vancomycin were present in the PE at 
concentrations of approximately 0.5 μg/L, but trimethoprim eventually exhibited an overall 
decrease in concentration for the 20-day SRT while vancomycin exhibited an increase in 
concentration similar to sulfamethoxazole. The trimethoprim data support Salveson et al. (2012), 
which reported that SRTs of approximately 30 days were required for 80% removal of 
trimethoprim. Vancomycin, which is described as a ‘last resort’ antibiotic, is less commonly 
described in the literature. A recent study by Qiu et al. (2016) reported vancomycin removal of 
up to 99% and attributed that removal to biodegradation. However, that study focused on the 
biological processes at two vancomycin-producing facilities with influent concentrations of 
approximately 50 mg/L. Therefore, the microbial community may have been better acclimated to 
vancomycin degradation. Also, the effluent vancomycin concentrations were still on the order of 
240-500 μg/L, which is three orders of magnitude higher than the SBR effluents in the current 
study. 
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Table 4-8. Summary of TOrC concentrations during phase 1 (variation of SRT) 
Group Antibiotic Unit 
Day 1 Day 2 
PE PE1 SRT 2 SRT 21 SRT 7A SRT 7B SRT 20 PE PE1 SRT 2 SRT 7A SRT 7B SRT 20 SRT 201 
Antibiotics 
Ampicillin ng/L <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 
Sulfamethoxazole ng/L 990 970 1100 1000 1400 1500 1300 1100 1300 1100 1200 1400 1200 1200 
Tetracycline ng/L <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 
Trimethoprim ng/L 380 370 370 330 420 420 120 530 710 500 470 410 180 180 
Vancomycin ng/L 420 470 670 890 980 760 770 450 460 740 1000 770 820 770 
High 
Removal 
Acetaminophen ng/L 95000 94000 <10000 <10000 <10000 <10000 <10000 93000 100000 <10000 <10000 <10000 <10000 <10000 
Caffeine ng/L 67000 68000 50000 51000 <50 <50 <50 66000 73000 43000 <50 61 <50 <50 
Ibuprofen ng/L 19000 19000 15000 16000 220 110 17 23000 24000 16000 89 250 <10 <10 
Moderate 
Removal 
Atenolol ng/L 880 830 790 710 480 320 71 1100 1100 960 440 300 110 110 
Gemfibrozil ng/L 1800 1700 1500 1500 1700 1300 72 1400 1700 1600 1500 1100 140 140 
Triclosan ng/L 140 140 400 360 160 71 59 210 220 470 190 72 58 67 
Low 
Removal 
Primidone ng/L 180 180 200 190 210 200 210 210 200 210 210 220 220 200 
Sucralose ng/L 42000 41000 54000 47000 49000 49000 47000 45000 45000 51000 48000 40000 40000 42000 
TCEP ng/L 260 250 260 260 260 260 260 300 300 310 280 280 330 330 
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The nine indicator TOrCs were divided into three groups based on their relative removals. The 
compounds with high removal (acetaminophen, caffeine, and ibuprofen) were all present at 
relatively high concentrations (20-100 μg/L) in the PE. The 2-day SRT achieved moderate 
reductions in these compounds, but the concentrations were still in the μg/L level. The 7-day 
SRTs achieved up to 99% removal of these compounds, and with the exception of ibuprofen on 
day 1, the 20-day SRT achieved the MRLs for all three compounds. For the second group of 
compounds, the concentrations in the PE were significantly lower, and two of the compounds 
exhibited steady decreases in concentration with longer SRTs, although the compounds were still 
detectable even for the 20-day SRT. The third compound—triclosan—actually consistently 
increased in concentration for the 2-day SRT but generally exhibited a net decrease in 
concentrations for SRTs of 7 and 20 days. Triclosan is a highly sorbing and biodegradable 
compound (Salveson et al., 2012). Therefore, it is assumed that triclosan desorbed from the 
solids in the SBR with a 2-day SRT, and the immature microbial community was unable to 
biodegrade the compound. On the other hand, the higher solids concentrations and desorption 
potential for the 7-day and 20-day SRTs was likely offset by higher biodegradation rates, thereby 
resulting in net decreases in concentration. Finally, the third group, which contained compounds 
with low sorption potential and low biodegradability, exhibited no consistent change in 
concentration regardless of SRT. 
II. Phase 1 MLSS testing  
To evaluate the effects of solids concentration while controlling for the microbial community, a 
follow-up experiment was performed with different volumes of seeded RAS. The volumes were 
selected to simulate the MLSS concentrations associated with SRTs ranging from 3 to 15 days 
(Table 4-9). It is important to note that the SBRs were seeded with RAS from a full-scale system 
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with a ~7-day SRT, which suggests that the initial microbial community was more mature than 
that of a system with a truly short SRT (e.g., 3 days). Furthermore, the initial set of TOrC 
samples was collected from a laboratory-scale system that had been operating for ~60 days, 
whereas the new samples were collected from a system that had been seeded with ‘full-scale’ 
microorganisms immediately prior to the experiment. 
In contrast with the first sample set, tetracycline was actually detected in two of the SBR 
effluents at concentrations of 12 ng/L and 14 ng/L, but this was likely due to the lower detection 
limits achieved for those particular samples. For trimethoprim and the ‘moderate removal’ 
TOrCs, there was a clear improvement in water quality for MLSS concentrations greater than 
1000 mg/L, but there was no clear distinction between MLSS concentrations of 2000, 3000, or 
4000 mg/L. Atenolol, gemfibrozil, and trimethoprim have been described as having low sorption  
Table 4-9. Summary of TOrC concentrations during phase 1 (variation of MLSS concentration) 
Group Antibiotic 
kbio 
(L/gss.d) Unit 
MLSS (mg/L)1 
PE 1,000 2,000 3,000 4,000 
Theoretical SRT (days)2 
0 3 6 10 15 
Antibiotics 
Ampicillin <0.1 ng/L <100 <100 <100 <100 <100 
Sulfamethoxazole (0.06-0.3) ng/L 1800 1400 1400 1300 1300 
Tetracycline <0.1 ng/L <5 12 14 <100 <100 
Trimethoprim (0.09-1.4) ng/L 480 330 140 68 130 
Vancomycin <0.1 ng/L 880 1300 1200 1100 1200 
High 
Removal 
Acetaminophen (1.8-10.5) ng/L 72000 <100 <100 <5 <5 
Caffeine (1.7-6.8) ng/L 48000 <100 <100 <100 <100 
Ibuprofen (1.7-7.3) ng/L 15000 12 <20 <20 <20 
Moderate 
Removal 
Atenolol (0.3-4.3) ng/L 770 190 27 <20 <20 
Gemfibrozil (0.3-5.8) ng/L 1100 330 7 3 3 
Triclosan (0.2-1.8) ng/L 210 68 40 28 33 
Low Removal 
Primidone <0.1 ng/L 190 200 190 190 200 
Sucralose <0.1 ng/L 47000 52000 47000 54000 52000 
TCEP <0.1 ng/L 220 290 250 260 250 
1Reactor seeded with RAS from full-scale WWTP with ~7-day SRT 
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potentials (Salveson et al., 2012) so their greater removal at the higher MLSS concentrations 
may be attributable to faster kinetics resulting from more abundant biomass. Triclosan has a 
higher sorption potential (Salveson et al., 2012) so its removal is likely a combination of sorption 
and biotransformation. For gemfibrozil, the removal efficiency in the MLSS experiment was 
greater than what was observed during the previous SRT testing. This may be attributable to 
differences in the microbial community that developed during long-term operation of the SBRs 
versus the microbial community of the RAS seed from the full-scale system. Therefore, greater 
TOrC removal at longer SRTs appears to be due to a combination of (1) greater physical removal 
due to higher MLSS concentrations and (2) greater biotransformation due to (a) more abundant 
biomass and (b) more mature microbial communities. Additional MLSS experiments with RAS 
seeds from full-scale facilities with a wider range of SRTs would be needed to verify this theory. 
The second order rate constants listed in Table 4-9 were calculated based on the initial and final 
concentrations of the compounds and MLSS concentration. The results showed that the 
calculated rate constants differed as a function of MLSS concentrations. 
III. Phase 2 antibiotic concentration testing  
For phase 2, the antibiotic spiking concentrations corresponding with 1x, 10x, and 100x ambient 
levels were determined based on the TOrC data from phase 1 and were summarized previously 
in Table 1. For the TOrC analyses, PE and SBR effluent samples were collected on consecutive 
days at the end of phase 2. Therefore, treatment performance was characteristic of warm 
temperature conditions in which the extent of nitrification was ~98% and the extent of 
denitrification was ~15% for all SBRs (Table 4-2). The resulting TOrC concentrations are 
summarized in Table 4-10. 
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As summarized in Table 4-11, the observed concentrations for sulfamethoxazole, trimethoprim, 
and vancomycin were relatively consistent with the target concentrations. Deviations from the 
target concentrations were primarily due to temporal variability in ambient concentrations (i.e., 
1x) and presumably adsorption onto suspended solids (e.g., for vancomycin). On the other hand, 
the observed concentrations of ampicillin and tetracycline were significantly different from the 
target concentrations. In fact, ampicillin was <MRL in all samples, even when spiked at 20 μg/L. 
With respect to the PE samples, tetracycline was only present at reportable concentrations in the 
100x sample, and even though the antibiotic was spiked at 10 μg/L, the observed concentration 
was only 0.3 μg/L. Tetracycline was reliably detected in several secondary effluents (i.e., after 
biological treatment), even when the PE had not been spiked. This suggests that matrix 
interference may have been a significant factor.  
Factors such as adsorption and hydrolysis may have also affected the observed concentrations of 
ampicillin and tetracycline. Gao et al. (2012) detected tetracycline in PE (164 ng/L) but not in 
secondary effluent. Extracted solids resulted in consistent tetracycline detection (750 μg/kg dw), 
thereby suggesting that the compound preferentially adsorbed to solids and was removed in the 
clarification process. As described earlier, other studies in the literature describe a wide range of 
values for tetracycline, and there are some studies reporting tetracycline at <MRL (Watkinson et 
al., 2009). With respect to ampicillin, there is a general paucity of data describing typical 
concentrations in wastewater, but Li and Zhang. (2011) noted that both ampicillin and 
tetracycline rapidly adsorb onto solids. Therefore, one can conclude that a combination of 
analytical and natural limitations likely hindered reliable detection of ampicillin and tetracycline, 
despite the fact that these compounds were spiked at high concentrations. Regardless, based on 
the other three antibiotics, the antibiotic delivery system appeared to work as intended.  
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For phase 2, the primary objective of the TOrC sampling was to evaluate whether the elevated 
antibiotic concentrations hindered the biotransformation capabilities of the microbial community. 
The general water quality parameters, particularly with respect to sCOD removal, nitrification, 
and bulk organic matter transformation, provided a preliminary indication that the spiked 
antibiotics had no significant impact on treatment efficacy. The SBR effluent concentrations for 
the ‘high removal’ (i.e., acetaminophen, caffeine, and ibuprofen) and ‘moderate removal’ (i.e., 
atenolol, gemfibrozil, and triclosan) compounds further support this conclusion, as those 
concentrations were significantly attenuated via biotransformation even in the 100x SBR. This is 
supported by Li and Zhang. (2011) who observed significant caffeine attenuation via 
biotransformation even with a suite of antibiotics spiked at the high μg/L level. Therefore, 
elevated antibiotic concentrations (up to 1.25% of the standard MIC) do not appear to impact the 
functional capacity of the microbial community in wastewater treatment applications. 
With respect to antibiotic removal, the concentrations of ampicillin were always <MRL so it was 
not possible to assess its treatment efficacy. For the primary effluents, tetracycline was detected 
only in the 100x samples, but it was consistently detected in the secondary effluents, partially 
due to the lower MRLs. The tetracycline concentrations in the 10x secondary effluents were 
consistently in the 16-30 ng/L range (theoretical C0 = 1 μg/L) but increased to 160 ng/L in the 
100x secondary effluents (theoretical C0 = 10 μg/L). In contrast with the phase 1 testing, the 
SBRs were able to achieve net reductions in sulfamethoxazole concentrations of 29% for the 1x 
samples, 46% for the 10x samples, and 42% for the 100x samples. Despite the high relative 
removal, the effluent concentrations of sulfamethoxazole were still 50-60 μg/L for the 100x 
SBRs due to the higher spiking levels. The vancomycin data were inconsistent considering that 
removals of 30-68% were achieved on day 1, while all of the day 2 samples resulted in increases 
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in concentration. Finally, trimethoprim was the only compound that exhibited consistent 
decreases in relative removal efficiency as the antibiotic spiking level increased from 1x (85% 
removal) to 10x (70% removal) to 100x (53% removal). 
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Table 4-10. Summary of TOrC concentrations during phase 2 (variation of antibiotic concentrations) 
Antibiotic Unit Day 1 Day 2 
PE11 1X 1X2 PE21 10XA PE31 10XB PE41 100X PE11 1X PE21 10XA PE31 10XB PE41 100X 100X2 
Ampicillin ng/L <100 <100 <100 <100 <100 <10000 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 
Sulfamethoxazole ng/L 2700 2000 2000 12000 6300 11000 6100 92000 51000 2300 1500 11000 5600 11000 5900 100000 59000 60000 
Tetracycline ng/L <100 23 <100 <100 26 <10000 25 390 160 <100 16 <100 24 <100 30 140 160 160 
Trimethoprim ng/L 980 110 89 4800 1300 5000 1300 45000 20000 910 220 4800 1500 4300 850 48000 23000 23000 
Vancomycin ng/L 1200 1100 1100 2100 2000 6500 2100 33000 23000 920 1300 1700 2300 1800 2200 28000 26000 28000 
Acetaminophen ng/L 100000 <100 <100 96000 <100 100000 <100 98000 <100 90000 <100 91000 <100 90000 <100 94000 <100 <100 
Caffeine ng/L 67000 <5 <5 66000 <100 64000 <100 63000 <100 70000 <100 66000 <100 64000 <100 65000 <100 <100 
Ibuprofen ng/L 24000 14 17 22000 14 23000 23 23000 27 22000 23 22000 14 22000 13 22000 11 11 
Atenolol ng/L 1200 120 120 1200 130 1200 160 1200 130 1100 <2000 1100 <2000 1100 <2000 1100 <2000 <2000 
Gemfibrozil ng/L 1600 7.6 7.5 1600 31 1700 61 1700 41 1500 420 1600 18 1600 16 1600 33 33 
Triclosan ng/L 240 36 33 230 46 220 54 210 41 270 150 190 100 240 50 230 42 40 
Primidone ng/L 210 210 200 220 210 240 210 220 170 190 190 190 200 180 190 190 190 180 
Sucralose ng/L 38000 44000 45000 40000 43000 40000 46000 41000 37000 42000 51000 40000 45000 37000 46000 43000 47000 39000 
TCEP ng/L 330 310 300 320 300 290 290 280 280 160 250 160 240 160 230 160 230 240 
1Target antibiotic concentrations summarized in Table 1 
2Duplicate sample collected 
Table 4-11. Comparison of target and observed concentrations in phase 2  
Antibiotic Units 1X 10x 100x 
Target Actual Target Actual Target Actual 
Ampicillin μg/L 0.2 <0.1 2 <0.1 20 <0.1 
Sulfamethoxazole μg/L 1 2.5 10 11 100 96 
Tetracycline μg/L 0.1 <0.1 1 <0.1 10 0.3 
Trimethoprim μg/L 0.5 0.9 5 4.7 50 47 
Vancomycin μg/L 0.5 1.1 5 3.0 50 31 
Comparison of target and observed concentrations in phase 2 primary effluent based on averages from sampling on consecutive days 
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The trimethoprim removal efficacy for the 1x SBR (with a 7-day SRT) was also significantly 
greater than the removal efficacy for the 7-day SRT in phase 1. In phase 1, the low removal was 
initially attributed to the immature microbial community, as supported by the literature, but 
considering the 85% removal in phase 2, the phase 1 result may have actually been due to the 
lower temperature.  
4.4.4 Molecular characterization of the microbial community 
I. Phase 1 SRT testing  
Improvements in water quality at longer SRTs are sometimes attributed to a diversification of the 
microbial community (Roh and Chu, 2011). The previous sections indicated that improvements 
in water quality parameters (sCOD, absorbance/fluorescence, nitrogen, and TOrC 
concentrations) were correlated with longer SRTs, while higher influent concentrations of 
antibiotics had a minimal impact on treatment performance. This section explores how SRT and 
antibiotic loading impacted the microbial community as a means of potentially linking changes 
in water quality with community diversification.  
Goods coverage plot for Phase 1 is presented in Figure 4-8. Goods coverage is a number between 
0 and 1, with 1 indicating that all expected species have been observed. Goods numbers in Table 
4-12 indicate that no additional sequencing was required. The curves on the plot also reached 
asymptote indicating that the sample size were adequate for all the samples to be considered 
representative of the whole community. Species richness and diversity indices including ACE, 
Chao1, Goods, Shannon, and Simpson were calculated and are presented in Table 4-12. Species 
richness indices are numbers associated with only the count of species in samples. Species 
diversity not only accounts for spices count, but also considers the relative abundance of species, 
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which is a parameter that incorporates richness and evenness. Diversity indices increased at 
longer SRTs, thereby indicating that microbial community diversity increased for longer SRTs. 
Tables 4-13 and 4-14 summarize genera with relative abundances greater than 0.5% in the first 
and second sample sets, respectively, during phase 1. The results of the first and second sample 
sets are presented together in this text. Figures 4-9 and 4-10 illustrate the same data and offer a 
direct visual comparison between samples. Arcobacter, Bacteroides, Tolumonas, Aeromonas, 
Acinetobacter, and Acidovorax were the most abundant genera in PE and they comprised 
(33.2%-29.5%), (7.67%-11.5%), (3.13%-4.54%), (2.49%-3.67%), (3.24%-2.90%), and (3.84%-
1.97%) of the total microbial community, respectively. A similar study conducted by McLellan 
et al. (2010) identified Acinetobacter, Aeromonas, and Arcobacter among the most abundant 
taxa in sewage profile. The results from McLellan et al. (2010) study were from two full-scale 
WWTPs in Milwaukee metropolitan area. Gonzalez-Martinez et al. (2016) also analyzed the 
microbial community structure of wastewater influent among 10 WWTPs in Netherlands. At the 
genus level, the authors detected Aeromonas (2.5-13%), Arcobacter (3-42%), and Bacteroides 
(5.05-19.5%) in all samples. The literature suggests these heterotrophic bacteria are all capable 
of biochemical oxygen demand (BOD) degradation, although Arcobacter is aerobic (Collado et 
al., 2011), Aeromonas is a facultative anaerobe (Igbinosa et al., 2012), and Bacteroides is 
anaerobic (Ueki et al., 2008). These bacteria were generally outcompeted during biological 
treatment, thereby leading to reduced relative prevalence in the SBR effluents. Arcobacter was 
still abundant after biological treatment, although its relative prevalence decreased from ~30% to 
<10%. When the samples were collected during the current study, limited nitrification or 
denitrification was observed for the 2-day SRT (Table S3), presumably due to a combination of 
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the short SRT and low temperature, however Acidovorax was reported to have an important role 
in denitrification (Hoshino et al., 2005; Kniemeyer et al., 1999; Heylen et al, 2008). 
 
Figure 4-8. Goods coverage plot for phase 1 
Table 4-12. Diversity and richness indices  
 PE 2-Day SRT 7-Day SRT A 7-Day SRT B 20-Day SRT 
Shannon 4.607 4.442 5.168 5.749 5.813 
Simpson 0.121 0.122 0.066 0.032 0.036 
ACE 230.897 178.939 207.739 205.565 219.101 
Chao1 230.925 175.020 206.049 205.245 218.042 
Goods 0.998 0.998 0.999 0.998 0.999 
Diversity and richness indices including Shannon, Simpson, ACE, Chao1, and Goods mean values of all samples 
(Average of two trials are reported)
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Table 4-13. Relative abundance of microbial community structure (first sample set) 
Phylum Class Order Family Genus PE 2 Days 7A Days 7B Days 20 Days 
Bacteroidetes 
 
 
Bacteroidia Bacteroidales Bacteroidaceae Bacteroides 7.67% 1.10% 0.20% 0.17% 0.48% 
Flavobacteriia 
Bacteroidales Prevotellaceae Prevotella 0.92% 0.27% 0.06% 0.01% 0.09% 
Flavobacteriales 
 
Cryomorphaceae Fluviicola 0.00% 0.82% 0.52% 2.99% 0.90% 
Flavobacteriaceae 
 
Cloacibacterium 0.61% 0.48% 0.04% 0.10% 0.12% 
Flavobacterium 0.11% 0.95% 1.69% 2.56% 2.71% 
Sphingobacteriia Sphingobacteriales  
Chitinophagaceae Sediminibacterium 0.00% 0.09% 0.87% 1.18% 0.00% 
Saprospiraceae Haliscomenobacter 0.02% 0.00% 0.20% 0.02% 0.59% 
Sphingobacteriaceae Sphingobacterium 0.00% 0.00% 1.65% 0.06% 0.27% 
Firmicutes 
 
Bacilli 
 
Lactobacillales 
 
Carnobacteriaceae Agitococcus 0.00% 4.26% 14.73% 7.52% 2.31% 
Streptococcaceae Streptococcus 1.14% 0.10% 0.25% 0.10% 0.11% 
Nitrospirae Nitrospira Nitrospirales Nitrospiraceae Nitrospira 0.00% 0.01% 0.00% 0.04% 1.18% 
Proteobacteria 
Betaproteobacteria 
Burkholderiales 
 
Comamonadaceae 
 
Acidovorax 3.84% 4.77% 1.76% 0.76% 1.22% 
Hydrogenophaga 0.01% 2.92% 0.58% 0.14% 0.03% 
Simplicispira 0.20% 0.46% 1.85% 5.24% 5.84% 
Neisseriales Neisseriaceae Uruburuella 0.57% 0.31% 0.45% 0.13% 0.27% 
Rhodocyclales 
 
Rhodocyclaceae 
 
Thauera 0.10% 0.06% 3.49% 3.79% 10.14% 
Zoogloea 0.07% 2.11% 0.61% 0.39% 0.05% 
Epsilonproteobacteria Campylobacterales Campylobacteraceae Arcobacter 33.21% 8.15% 3.01% 1.82% 4.90% 
Gammaproteobacteria 
Aeromonadales 
 Aeromonadaceae 
Aeromonas 2.49% 0.99% 0.29% 0.27% 0.47% 
Tolumonas 3.13% 0.73% 0.27% 0.08% 0.37% 
Enterobacteriales Enterobacteriaceae Salmonella 0.00% 0.11% 2.55% 3.42% 1.34% 
Pseudomonadales 
 
Moraxellaceae 
 
Acinetobacter 3.24% 20.42% 1.46% 0.72% 1.33% 
Moraxella 0.75% 0.49% 0.30% 0.26% 0.31% 
Pseudomonadales 
 
Pseudomonadaceae 
 
Cellvibrio 0.00% 0.00% 0.57% 1.42% 0.30% 
Pseudomonas 0.70% 0.86% 1.96% 1.52% 1.23% 
Thiotrichales Thiotrichaceae Thiothrix 0.08% 5.88% 3.27% 7.04% 0.00% 
Spirochaetes Spirochaetia Spirochaetales Leptospiraceae 
Leptonema 0.00% 0.00% 0.80% 0.39% 0.05% 
Leptospira 0.00% 0.12% 4.21% 0.04% 0.00% 
Other Other Other Other Other 41.13% 42.86% 52.34% 57.84% 63.38% 
Microbial community structure in the primary effluent and SBR effluents as a function of SRT (first sample set). A particular genus was included in the table if 
its relative abundance was >0.5% in at least one sample 
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Table 4-14. Relative abundance of microbial community (second sample set) 
Phylum Class Order Family Genus PE SRT = 2 SRT = 7A SRT = 7B SRT = 20 
Bacteroidetes 
 
Bacteroidia Bacteroidales 
Bacteroidaceae Bacteroides 11.52% 0.49% 0.04% 0.09% 0.07% 
Porphyromonadaceae Parabacteroides 2.41% 0.07% 0.10% 0.07% 0.05% 
Prevotellaceae Prevotella 2.26% 0.13% 0.02% 0.02% 0.11% 
Cytophagia Cytophagales Cytophagaceae Leadbetterella 0.00% 0.00% 0.43% 0.04% 1.05% 
Flavobacteriia Flavobacteriales 
Cryomorphaceae Fluviicola 0.00% 0.02% 0.31% 2.32% 1.06% 
Flavobacteriaceae Flavobacterium 0.07% 1.29% 2.44% 2.47% 4.01% 
 Sphingobacteriia Sphingobacteriales Saprospiraceae Haliscomenobacter 0.00% 0.00% 0.11% 0.02% 0.75% 
Firmicutes 
Bacilli Lactobacillales 
Carnobacteriaceae Agitococcus 0.00% 0.40% 2.62% 4.30% 2.98% 
Enterococcaceae Enterococcus 0.08% 0.00% 0.04% 0.77% 0.05% 
Streptococcaceae Streptococcus 0.86% 0.18% 0.13% 0.49% 0.27% 
Clostridia Clostridiales Ruminococcaceae Ruminococcus 0.82% 0.04% 0.00% 0.07% 0.13% 
Proteobacteria 
Alphaproteobacteria 
Caulobacterales Caulobacteraceae Phenylobacterium 0.00% 0.00% 0.22% 0.78% 0.00% 
Rhodobacterales Rhodobacteraceae Rhodobacter 0.00% 0.02% 0.41% 0.75% 0.52% 
Sphingomonadales Sphingomonadaceae Novosphingobium 0.00% 0.00% 0.37% 0.64% 0.00% 
Betaproteobacteria 
Burkholderiales 
Burkholderiaceae Chitinimonas 0.00% 0.00% 0.03% 2.28% 0.53% 
Comamonadaceae 
Acidovorax 1.97% 0.02% 1.60% 1.41% 1.01% 
Alicycliphilus 0.01% 0.06% 0.72% 1.98% 0.64% 
Comamonas 0.70% 0.40% 0.04% 0.05% 0.14% 
Hydrogenophaga 0.04% 0.80% 0.48% 0.88% 0.02% 
Simplicispira 0.09% 1.26% 2.28% 4.78% 6.88% 
Neisseriales Chromobacteriaceae Aquaspirillum 0.20% 2.85% 0.00% 0.00% 0.00% 
Rhodocyclales Rhodocyclaceae 
Dechloromonas 0.20% 1.14% 0.88% 1.13% 1.35% 
Rhodocyclus 0.13% 0.03% 0.27% 0.77% 0.42% 
Thauera 0.06% 0.28% 14.89% 7.04% 8.97% 
Uliginosibacterium 0.04% 0.01% 0.31% 1.25% 2.03% 
Zoogloea 0.43% 1.22% 1.49% 2.26% 1.14% 
Epsilonproteobacteria  Campylobacterales Campylobacteraceae 
Arcobacter 29.45% 2.48% 0.86% 0.55% 1.34% 
Sulfurospirillum 1.04% 0.06% 0.02% 0.00% 0.00% 
Gammaproteobacteria 
Aeromonadales  Aeromonadaceae 
Aeromonas 3.67% 0.87% 0.09% 0.34% 0.42% 
Tolumonas 4.54% 0.21% 0.00% 0.04% 0.01% 
Enterobacteriales Enterobacteriaceae Enterobacter 0.53% 0.11% 0.03% 0.08% 0.15% 
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Klebsiella 0.73% 0.11% 0.01% 0.01% 0.03% 
Salmonella 0.00% 0.04% 1.77% 1.36% 2.04% 
Oceanospirillales Halomonadaceae Halomonas 0.00% 0.01% 0.16% 0.00% 0.71% 
Pasteurellales Pasteurellaceae Haemophilus 0.50% 0.04% 0.00% 0.00% 0.00% 
Pseudomonadales 
Moraxellaceae 
Acinetobacter 2.90% 4.50% 0.58% 1.04% 1.06% 
Moraxella 1.01% 0.39% 0.08% 0.31% 0.15% 
Pseudomonadaceae 
Cellvibrio 0.01% 0.00% 0.30% 1.07% 0.77% 
Pseudomonas 0.80% 2.27% 1.82% 1.65% 1.94% 
Thiotrichales Thiotrichaceae Thiothrix 0.10% 5.05% 6.23% 1.32% 0.04% 
Competibacteraceae Competibacteraceae Candidatus Competibacter 0.00% 0.00% 0.11% 0.18% 0.90% 
Xanthomonadales Xanthomonadaceae 
Aquimonas 0.01% 0.00% 0.36% 0.82% 0.00% 
Arenimonas 0.00% 0.00% 0.09% 1.56% 0.00% 
Thermomonas 0.02% 0.17% 1.48% 0.95% 0.86% 
Spirochaetes Spirochaetia Spirochaetales Leptospiraceae Leptonema 0.00% 0.74% 0.26% 0.57% 0.00% 
Other Other Other Other Other 32.80% 72.22% 55.51% 51.49% 55.45% 
Microbial community structure in the primary effluent and SBR effluents as a function of SRT (second sample set). A particular genus was included in the table 
if its relative abundance was >0.5% in at least one sample 
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Figure 4-9. Microbial community structure (first sample set) 
Microbial community structure in the primary effluent and SBR effluents as a function of SRT (first sample set). Each column represents a genus with relative 
abundance >0.5% in at least one sample. The individual percentages represent the relative abundance in each sample 
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Figure 4-10. Microbial community structure (second sample set) 
Microbial community structure in the primary effluent and SBR effluents as a function of SRT (second sample set). Each column represents a genus with relative 
abundance >0.5% in at least one sample. The individual percentages represent the relative abundance in each sample 
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Tolumonas and Arcobacer are speculated to have a role on biodegradation of antibacterial and 
anti-inflammatory organic matter (Wang et al., 2016). Bacteria of Acinetobacter is reported to 
play a role in biodegradation of organic and inorganic hazardous waste including xenobiotics and 
halogens pollutants (Abdel-el-haleem, 2003). Although Acinetobacter is associated with 
biodegradation of hazardous waste pollutants, this genus has emerged as a significant 
nosocomial pathogen probably because of intensive consumption of broad-spectrum antibiotics 
in hospitals (Towner, 2009). 
For the 2-day SRT, Acinetobacter, Arcobacter, Thiothrix, Acidovorax, Agitococcus, and 
Dechloromonas were the most abundant genera with (20.4%-4.50%), (8.15%-2.48%), (5.9%-
5.05%) , (4.77%-0.02%), (4.26%-0.40%), and (2.92%-1.14%) of total microbial community, 
respectively. Gonzalez-Martinez et al. (2016) studied the structure of the microbial communities 
in three bioreactors operated with SRTs of less than 1 day. The results showed that Acidovorax 
(2.5-7.5%), Aeromonas (3.3-6.0%), Arcobacter (1-25%), Dechloromonas (1-7%), and 
Rhodoferax (1.1-11.6%) were among the most abundant genera in their bioreactors. Therefore, 
Acidovorax, Arcobacter, Aeromonas, and Dechloromonas were common between the studies; 
Agitococcus, Acinetobacter, and Thiothrix were relatively abundant in the current study but not 
in Gonzalez-Martinez et al. (2016); and Rhodoferax was relatively abundant in Gonzalez-
Martinez et al. (2016) but not in the current study.  
For the two reactors with a 7-day SRT, Agitococcus (14.73%-2.62%), Thauera (3.49%-14.89%), 
Thiothrix (7.04%-1.32%), Simplicispira (1.85%-5.24%), Salmonella (3.42%-1.36%), and 
Arcobacter (3.01%-0.55%) were the most abundant genera, and for the 20-day SRT, Thauera 
(10.14%-8.97%), Simplicispira (5.84%-6.88%), Arcobacter (4.90%-1.34%), and 
Falovobacterium (2.71%-4.01%) were the most abundant genera. Salmonella is particularly 
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interesting because some species are responsible for one million foodborne illnesses in the 
United States, with 19,000 hospitalizations and 380 deaths (Centers for Disease Control and 
Prevention, 2016). Espigares et al. (2006) reported no significant difference in Salmonella 
prevalence before and after activated sludge systems, but the current study suggests a positive 
correlation between Salmonella abundance and SRTs ≥7 days. Falovobacterium and Zoogloea 
(0.05%-2.26%) has been linked to biomass floc formation (Wastewater Bacteria, 2007). Both 
genera are abundant in longer SRTs, while Falovobacterium is most abundant in 20 day SRT and 
Zoogloea is most abundant in 7 day SRT. Zoogloea also plays a role in floc formation (Shao et 
al., 2009) and biodegradation of antibacterial organic matter (Wang et al., 2016). Thiothrix, 
which was abundant in 7-day SRT, can oxidize sulfides as an energy source (Wastewater 
Bacteria, 2007).  
A PCA can be used to identify statistically significant changes in the core genera of microbial 
community (top 10 genera), or conclude that communities are statistically similar. Figure 4-11A 
summarizes the results of the PCA (combining both sample sets) for phase 1. The positioning of 
the samples (red dots) and genera (blue dots) relative to each other provide a statistical 
representation of their similarities. For example, there were apparent differences in the PE and 2-
day SRT, but they were more similar to each other than the longer SRTs of 7 and 20 days. The 
PCA also confirms that the two sample sets and the duplicate reactors with 7-day SRTs proved to 
be statistically similar. With respect to the genera, the PCA indicates that Arcobacter is closely 
linked to PE, while Thauera, Simplicispira, and Agitococcus were more representative of 7-day 
and 20-day SRT. Genera in the lower left corner of Figure 4-11A were typically found in all the 
samples. Those genera that are close to the center of diagram, are typically found in all the 
123 
samples but with varying relative abundance (e.g., Acinetobacter, Bacteroides and Aeromonas in 
the lower left corner of Figure 4-11A).  
Although many studies, including the current research, have focused on the core genera of 
microbial communities (Ahmed et al., 2007; Gonzalez-Martinez et al., 2016), some studies have 
explored rare microorganisms as well Vuono et al. (2016) explored both abundant and rare 
microorganisms in activated sludge systems. Their results showed that rare microorganisms may 
have an unrecognized role based on their higher protein synthesis. It should be noted that the role 
of rare microorganisms in the Vuono et al. (2016) study might be highlighted due to the presence 
of anaerobic, anoxic, and aerobic treatment systems. For example, phosphate accumulating 
organisms (PAOs) were determined to be among the rare taxa with significantly high 
rRNA/rDNA ratio. It is well known that the combination of anaerobic and aerobic cycles will 
result in higher accumulation of polyphosphates in PAOs within their cells during aerobic cycle, 
which is not the case for conventional activated sludge systems with aerobic cycle only. 
Therefore, the functionality of PAOs may be highlighted in this scenario, although they are not 
among the core genera of microbial community. 
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Figure 4-11. Results of principal component analyses for phase 1 and phase 2  
Results of principal component analyses for A) phase 1 (left picture) and B) phase 2 (right picture) of the core 
genera of the microbial community (top 10 genera). Each figure reflects the data from both sample events during 
each phase. Red dots represent the different samples (i.e., primary effluent vs. SRTs and primary effluent vs. relative 
antibiotic concentrations), and blue dots represent the different genera 
Lu et al. (2015) presented their microbial community data in the context of relative abundance of 
pathogens, including Arcobacter butzieri, Salmonella enterica, Aeromonas hydrophila, and 
Escherichia coli. Table 8 summarizes the relative abundances of these pathogens in the current 
study as a function of SRT. According to Table 15, Acrobacter butzieri, Aeromonas hydrophila 
were detected in PE and longer SRTs reduce the abundancy of these two species. However, 
Salmonella enterica was not detected in PE and was found to be increasingly abundant in longer 
SRTs. Escherichia coli was also not detected in PE, 2-days SRT, and 7-day SRT, however, it was 
found in 20-day SRT.  
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Table 4-15. Comparison of the relative abundance of potential pathogens  
Species 
Phase 1 Phase 2 
SRT (days) 
(%) 
Relative Antibiotic Concentration 
(%) 
PE 2 7 (A) 7 (B) 20 PE 1X 10X (A) 10X (B) 100X 
Salmonella 
enterica 0.00 0.07 2.15 2.38 1.68 0.00 0.00 0.00 0.00 0.00 
Arcobacter 
butzieri 0.13 0.02 0.00 0.00 0.01 0.25 0.002 0.00 0.00 0.00 
Aeromonas 
hydrophila 2.10 0.78  0.27 0.26 0.37 0.00 0.00 0.00 0.00 0.00 
Escherichia coli 0.00 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.00 0.00 
Comparison of the relative abundance of potential pathogens in the primary effluent and SBR effluents as a function 
of SRT. (Average of two trials are reported in each Phase) 
II. Phase 2 antibiotic concentration testing  
Figure 4-11B shows the effect of ambient antibiotic concentrations on microbial community 
structure in PE and the SBRs. As previously described, all the SBRs were operated at the same 
SRT (~7 days) at this stage. Arcobacter was found to be dominant in PE and Zoogloea, 
Nitrospira, and Thauera were mostly abundant in the the SBRs. Acidovorax, and Bacteroides 
were found in all samples, however they were more abundant in PE. The results revealed that 
targeted antibiotic concentrations did not change the microbial community structure and 
function. All samples from the SBRs were analyzed to be similar for the top most abundant 
genera. Of the list of potential pathogens presented earlier, Acrobacter butzieri was found only in 
PE, and none of the pathogens were found in the MLSS samples from the SBRs (Table 15). 
4.4.5 Microbial community analysis with respect to the treatment aspects 
Longer SRTs are associated with lower micropollutants concentrations and higher nutrient 
removal. Microbial community analysis can be used to determine the relative abundance of 
microorganisms that are able to degrade trace organic compounds. Wojcieszyńska et al, (2014) 
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listed Pseudomonas, Sphingomonas, and Stenotrophomonas as genera capable of degrading 
naproxen. These genera were also found in this study. The abundance of these genera were 
varied among the biological reactors, however for Pseudomonas was relatively higher in 20-day 
(1.93%) compared to 7-day SRT (1.83%) and PE (0.79%). Sphingomonas was only detected in 
20-day and 7-day SRT in low percentages (<0.1%). Pseudomonas was also reported as genus 
capable of using caffeine as sole carbon source (Summers et al., 2015). Wu et al, (2012) reported 
some species of Stenotrophomonas, Pseudomonas, and Burkholderia that are able to degrade 
paracetamol (Acetaminophen). The relative abundance of Burkholderia was lower than 0.5%, 
however, it was only detected in 20-day SRT (0.13%). It should be noted that not all of the 
species of a genus can degrade a specific compound, however, the data can be used as baseline to 
determine the possible relations between abundancy of microorganisms and the concentrations of 
micropollutants.  
4.5 Conclusions 
SRT is a key parameter in designing biological wastewater treatment processes. Depending on 
the treatment objectives, SRT can be varied to maximize the treatment efficiencies. In this study, 
it was shown that SRT can change the microbial community structures in the SBRs. Long SRTs 
are associated with lower TOrCs and total organic carbon (TOC) and better treated effluent 
quality. Microbial community structure in PE was shown to be different than biological 
treatment process. In PE, Acinetobacter and Arcobacter were among the most abundant genera, 
however they were outcompeted in the SBRs. Nitrospira, a nitrifying genus, was seen to be more 
dominant in longer SRTs, indicating the role of SRT on changing microbial communities. 
Furthermore, higher concentrations of antibiotics (up to 100 times of typical concentrations in 
wastewater) was shown to have minimal effect on changing microbial communities and the 
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performance of the SBRs. This really important in case of accidental release of industrial 
wastewater into domestic wastewater. Biological wastewater treatment process was able to 
handle the higher concentrations of antibiotics and the results showed that the SBRs performance 
did not changed considerably. 
Therefore, longer SRTs are generally beneficial in terms of effluent water quality, and higher 
(but still subclinical) influent antibiotic concentrations have minimal impact on treatment 
performance. However, the literature suggests that these conditions may also proliferate 
antibiotic resistance during biological wastewater treatment. More studies are needed to further 
clarify the role of biological wastewater treatment with respect to antibiotic resistance, and 
operational decision making must not only consider conventional water quality parameters but 
also contaminants of emerging concern, including pharmaceuticals and antibiotic resistance 
elements (e.g., antibiotics, antibiotic resistant bacteria, and antibiotic resistance genes). 
Molecular tools will continue to play a significant role in developing a comprehensive 
understanding of microbial community structure and function, specifically related to water 
quality.  
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5.0 EFFECT OF SOLIDS RETENTION TIME AND ELEVATED ANTIBIOTIC 
CONCENTRATIONS ON THE FATE OF ANTIBIOTIC RESISTANCE AND 
MICROPOLLUTANTS REMOVAL DURING BIOLOGICAL WASTEWATER TREATMENT  
5.1 Abstract 
Solids retention time (SRT) is a key factor in designing biological wastewater treatment 
processes. Longer SRTs can lead to reductions in trace organic compound (TOrC) 
concentrations, facilitate nutrient removal, reduce oxidant scavenging, and mitigate membrane 
fouling. However, longer SRTs may contribute to antibiotic resistance (AR) proliferation. Also, 
higher antibiotic concentrations in biological treatment systems may negatively impact the 
performance of reactors by inhibiting sensitive bacteria or contribute to AR proliferation by 
exerting a selective pressure. This research aimed to characterize the role of SRT and elevated 
antibiotic concentrations on AR proliferation in biological treatment processes. Spread plate 
technique was used to determine the number of Gram positive Staphylococcus/Streptococcus 
strains. The extent of AR was also determined based on minimum inhibitory concentrations 
(MICs) of resistant isolates. The results revealed that longer SRTs select for antibiotic resistant 
bacteria (ARBs). The results also showed that higher concentration of antibiotics also led to 
higher rate of AR.  
5.2 Introduction 
Antibiotic resistant bacteria (ARBs) and antibiotic resistance genes (ARGs) are now considered 
contaminants of emerging concern (CECs) that pose a threat to public health (Pruden et al., 
2006). Although dissemination and proliferation of ARBs and ARGs are governed by very 
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complex environmental pathways, but it seems that wastewater treatment plants (WWTPs) have 
an important role in mitigation or proliferation of ARBs and ARGs. WWTPs are engineered 
quality solutions to water pollution in environment, but they are also considered significant 
reservoirs for antibiotic resistance (AR) (Novo and Manaia, 2010). Previous studies investigated 
the role of wastewater treatment plants in the proliferation or mitigation of antibiotic resistant 
bacteria (ARBs) and antibiotic resistance genes (ARGs) (Guo et al., 2015; Su et al., 2014; Zhang 
et al., 2015). Previous studies highlighted the selection pressure exerted on bacteria in 
wastewater matrices (Schwartz et al., 2003). Specifically, the presence of antibiotics can form a 
selective pressure that increases the concentration of ARBs by inhibiting antibiotic-susceptible 
bacteria. This medium also increases the chance of mutation and horizontal gene transfer (HGT) 
(Martínez, 2008; Wang and Schaffner, 2011). 
Data reported in previous publications are sometimes inconsistent and contradictory. For 
example, Aminov et al. (2001) and Auerbach et al. (2007) showed that due to the continuous 
exposure of bacteria to sub-inhibitory concentrations of antibiotics, wastewater treatment plants 
provide an environment that is potentially suitable for proliferation of ARGs and ARBs. 
However, (Suller and Russell, 2000) showed that continuous exposure of a triclosan-sensitive 
Staphylococcus aureus strain to sub-inhibitory concentrations of triclosan did not promote any 
changes in triclosan susceptibility or to other targeted antibiotics. 
Despite the efforts to elucidate the role of wastewater treatment plans (WWTPs) in relation to 
antibiotic resistance, there is still no clear evidence that WWTPs, especially the biological 
treatment processes, are contributing to the proliferation of AR. Some studies suggest that 
WWTPs achieve a significant reduction in the number of ARBs (Guo et al., 2015; Huang et al., 
2012), while other research indicates that WWTPs serve as major contributors of ARBs and 
130 
ARGs (Kim et al., 2010). These uncertainties may arise from research evaluating different 
treatment technologies, operational conditions, influent wastewater quality or wastewater 
constituents, and different methodologies for the detection of ARBs and ARGs. Therefore, 
additional studies and analyses are needed to assess the role of wastewater treatment processes 
on proliferation and mitigation of antibiotic resistance.  
ARGs in wastewater are of interest due their ability to escape from advanced treatment systems. 
(Wang et al., 2015) monitored the fate of 10 subtypes of ARGs for sulfonamide, tetracycline, -
lactam class, and macrolide resistance and the class 1 integrase gene (intI1) across each stage of 
5 full-scale pharmaceutical WWTPs in China. The results showed that the WWTPs can reduce 
the number of ARGs by 0.5-2.5 orders of magnitude in the aqueous phase, but a significant 
amount of ARGs are discharged in dewatered sludge. The total load of ARGs in dewatered 
sludge was 7-fold to 308-fold higher than raw influent and 16-fold to 638-fold higher than final 
effluent. The results also showed the proliferation of ARGs in the biological treatment processes. 
Chen and Zhang, (2013) conducted research to evaluate the removal rate of ARGs in WWTPs in 
China. Three WWTPs with different advanced treatment systems (biological aerated filter, 
constructed wetland, and UV disinfection) were selected to quantify the concentration of ARGs. 
In this study, the concentrations of 16S rRNA genes, tetM, tetO, tetQ, sulI, sulII and intI1 were 
measured in wastewater and biosolids. The results revealed that ARGs concentration decreased 
by 1.3 - 2.1 orders of magnitude in the constructed wetland and by 1.0-1.2 orders of magnitude 
in the biological aerated filter. However, only small changes were observed for the targeted 
ARGs between influent and effluent of the UV disinfection system. The same observation was 
made by McKinney and Pruden, (2012) regarding the limited potential of UV disinfection to 
damage ARGs in wastewater effluents.  
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Amador et al. (2015) evaluated the role of hospitals and wastewater treatment plants as 
contributors of AR in Portugal. The ampicillin-resistant Enterobacteriaceae were enumerated 
and isolated and tested for antimicrobial susceptibility using the disk diffusion method. The 
study measured the resistance to the -lactam group of antibiotics, including cefoxitin and the 
combination of amoxicillin and calvulanic acid, and the non--lactam group, including 
tetracycline and the combination of trimethoprim and sulfamethoxazole. The results showed that 
wastewater treatment plant effluent contained a higher rate of multidrug resistance compared 
with the untreated influent. A similar study was performed by Nagulapally et al. (2009) to 
examine the occurrence of ciprofloxacin, trimethoprim/sulfamethoxazole, and vancomycin 
resistant bacteria in a wastewater treatment plant. The results revealed that a significant number 
of fecal coliforms, E. coli, and enterococci exhibited resistance to the target antibiotics in 
municipal treatment plants.  
Although many of the recent AR studies focus on molecular methods, some studies are assessing 
AR occurrence and fate through culture-based methods. (Zhang et al., 2015b) studied AR among 
heterotrophic bacteria using traditional spread plating and streaking techniques. The bacterial 
isolates were tested for susceptibility to 12 different antibiotics based on the standard 
concentrations identified by the CLSI. One of the major findings from the study was that 
wastewater treatment plants typically reduced the extent of multi-drug resistance in the treated 
effluent. In other words, bacteria present in the effluent were resistant to fewer antibiotics than 
bacteria present earlier in the treatment train. Through sequencing, they also discovered that 
Gram negative bacteria dominated the wastewater influent, while Gram positive bacteria 
dominated the effluent. 
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Wastewater is a source of constituents of concern, including pathogenic bacteria, nutrients, 
heavy metals, and trace organic contaminants (TOrCs), including antibiotics. Therefore, 
wastewater treatment plants, especially those that employ longer SRTs, have the potential to 
continuously expose bacteria to sub-inhibitory concentrations of a wide range of antimicrobial 
compounds (Aminov et al., 2001; Auerbach et al., 2007). On the other hand, longer SRTs may 
select for bacteria with the ability to degrade a wide variety of organic compounds, including 
some TOrCs. Once the readily biodegradable compounds are depleted in engineered biological 
treatment applications, the microbial community experiences some degree of starvation, and only 
those bacteria with the ability to degrade recalcitrant compounds can survive. Recent studies 
have demonstrated the relationship between SRT and TOrC removal. Suarez et al. (2010) 
suggested that TOrC removal was linked to nitrification, while other studies reported that it was 
specifically related to SRT (Clara et al., 2005; Melcer and Klecka, 2011). Multiple studies 
identified “critical” SRTs for significant TOrC removal. Clara et al. (2005) identified a broadly 
applicable “critical” SRT of 10 days, while Oppenheimer et al. (2007) and Salveson et al. (2012) 
identified compound-specific “minimum” or “threshold” SRTs, respectively. 
A typical WWTP usually has three major treatment steps: (1) preliminary/primary, (2) secondary 
treatment, and (3) tertiary/advanced treatment. During primary treatment, large solids and grit 
are physically removed by screening and sedimentation. In secondary treatment, a major portion 
of the biodegradable organic matter, or biochemical oxygen demand (BOD), is removed via 
cellular respiration by native biomass. In addition to BOD removal via aeration, the biological 
process can be engineered to achieve nitrification (aerobic), denitrification (anoxic), and 
phosphorus removal (sequential anerobic and aerobic). The secondary process also involves 
physical removal of the biomass by sedimentation in secondary clarifiers or by membranes in 
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membrane bioreactors. In many WWTPs, secondary effluent is then subjected to tertiary 
treatment involving filtration and disinfection. 
In particular, biological treatment processes in WWTPs may provide an ideal environment for 
the proliferation of AR. Bacteria in these systems are exposed to sub-inhibitory concentrations of 
a suite of antibiotics and other AR inducing elements and compounds (Aminov et al., 2001; 
Auerbach et al., 2007). Depending on the operational conditions, bacteria remain in the 
bioreactors for varying amounts of time depending on the treatment target (i.e., BOD removal or 
BOD/nutrient removal). Solids retention time (SRT) is one of the key operational parameters in a 
suspended growth bioreactor and refers to the average amount of time the bacteria stay in the 
system before being ‘wasted.’ With longer SRTs, bacteria may have a greater chance of 
obtaining antibiotic resistance elements through horizontal gene transfer mechanisms. Those 
elements can then be propagated via vertical gene transfer, or bacterial replication. Despite the 
potential for AR transfer, it is not yet clear whether the biological treatment process actually 
contributes to the proliferation of AR or whether it actually provides some level of mitigation 
due to AR bacteria being outcompeted. 
This research was conducted to provide a better understanding of the effect of varying SRT on 
AR proliferation and the fate of antibacterial compounds. SRT is a fundamental parameter in 
designing biological treatment systems and may greatly influence the fate of AR in wastewater 
treatment plants. Developing a correlation between SRT and AR may help environmental 
engineers and policy makers to make an inform decision regarding wastewater treatment design 
and operation. This research also explores the effect of elevated antibiotic concentrations in 
biological treatment systems. Higher concentration of antibiotics may negatively impact the 
134 
performance of biological treatment and proliferate AR. This study investigates the relationship 
between ambient antibiotic concentrations and AR proliferation.  
5.3 Materials and methods 
5.3.1 Description of laboratory-scale sequencing batch reactors 
 The laboratory-scale activated sludge process was achieved with four parallel SBRs 
(Figures 3-2 and 3-3) fed with primary effluent from a full-scale WWTP in Las Vegas, Nevada. 
The acrylic SBRs had a total volume of 8 L and a working volume of 4 L after accounting for the 
volume of settled solids. Automation of the SBRs was achieved with a series of multi-station 
outlet timers, a peristaltic pump, electric actuated ball values, and solenoid valves. A MasterFlex 
peristaltic pump (Model 77200-62, Cole Parmer, Vernon Hills, IL) was used to transfer primary 
effluent from a wet well through a polytetrafluoroethylene/stainless steel strainer (Hach, 
Loveland, CO) and a 50-µm cartridge filter (Watts WPC50-975) prior to filling the reactors. The 
cartridge filters were replaced every two days to mitigate fouling and anaerobic conditions. A 
four-station irrigation timer (Orbit, Bountiful, UT) was used to control the volume fed to each 
reactor. Electric actuated solenoid valves (Parker Hannifin Corporation, Cleveland, OH) and an 
industrial grade air compressor (Porter-Cable PCFP02003; 3.5 gallons; 135 psi) were used to 
aerate the SBRs to achieve a relatively constant dissolved oxygen concentration of 3 to 4 mg/L. 
The compressed air was passed through a pressure gauge and air flow meter before being fed 
into the SBRs via stone diffusers. Aeration was sufficient to achieve adequate mixing of the 
mixed liquor without the need for mechanical mixing. The target SRTs were achieved by 
wasting predetermined volumes of mixed liquor toward the end of each aeration phase, and this 
was accomplished with four electric actuated ball valves (W.E. Anderson, Michigan City, IN).  
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The SBRs were initially seeded with return activated sludge (RAS) from the full-scale WWTP, 
which typically operates at an SRT of ~7 days. The SBRs were operated with a cycle time of 8 
hours for 3 cycles per day over a period of 60 days. Each cycle consisted of the following five 
stages: (1) filling with primary effluent for 29 minutes as the irrigation timer cycled through each 
reactor, (2) immediate aeration for 6.5 hours, (3) solids settling for 1 hour, (4) discharge of 
settled effluent for 30 minutes, and (4) idle for 1 minute. Again, solids wasting was performed 
toward the end of each aeration phase to minimize clogging of the ball valves. SRTs of 2 days, 7 
days (in duplicate), and 20 days were targeted for this phase (Figure 3-2).   
In order to evaluate the effect of influent antibiotic concentration, the SRTs of the four reactors 
remained constant at ~7 days, but the reactor influent (i.e., primary effluent) contained target 
antibiotics at concentrations of 1x (ambient concentrations), ~10x (in duplicate), and ~100x 
(Figure 3-3). Based on the initial round of TOrC sampling (results shown later in Table 5-4) the 
antibiotic concentrations shown in Table 5-1 were selected for this phase of the research. The 
table also shows the corresponding MICs to illustrate that the concentrations still represent sub-
inhibitory levels. The highest concentrations as a percentage of the MIC are for trimethoprim and 
vancomycin, which were spiked at 1.25% of the MIC. Because the concentrations of ampicillin 
and tetracycline were <MRL in the primary effluent (Table 5-1), the 1x concentrations were 
actually spiked at twice the analytical MRL to achieve detections during the second round of 
TOrC sampling. 
Table 5-1. Summary of Spiked Antibiotic Concentrations 
Antibiotic Units 1X 10x 100x MIC 100x/MIC 
Ampicillin μg/L 0.2 (spiked) 2 20 32,000 0.06% 
Sulfamethoxazole μg/L 1 (ambient) 10 100 76,000 0.13% 
Tetracycline μg/L 0.1 (spiked) 1 10 16,000 0.06% 
Trimethoprim μg/L 0.5 (ambient) 5 50 4,000 1.25% 
Vancomycin μg/L 0.5 (ambient) 5 50 4,000 1.25% 
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5.3.2  Preparation of antibiotic stock solutions 
As mentioned earlier, five different antibiotics were selected for this project including: ampicillin 
sodium salt (Sigma Aldrich, St. Louis, MO), sulfamethoxazole (Sigma Aldrich, St. Louis, MO), 
tetracycline hydrochloride (Sigma Aldrich, St. Louis, MO), vancomycin hydrochloride (Sigma 
Aldrich, St. Louis, MO), and trimethoprim (Sigma Aldrich, St. Louis, MO). All antibiotic stock 
solutions were prepared based on the Clinical and Laboratory Standards Institute (CLSI, 2012). 
Appropriate Solvents were used for each antibiotic including: 0.01 M PBS for ampicillin, sterile 
nanopure hot water and minimal amount of 2.5 M NaOH for sulfamethoxazole, 90% volume of 
sterile nanopure water with 10% volume of 0.05 M hydrochloric acid for trimethoprim, and 
sterile nanopure water for tetracycline and vancomycin. The antibiotic stock solutions were then 
passed through acrodisc syringe filters to be sterilized. All stock solutions were stored in 
refrigerator at at 4±2°C and were used within 48 hours. 
5.3.3 Analytical methods 
I. General water quality parameters 
A series of general water quality parameters was monitored for the duration of the study to 
ensure the SBRs were properly mimicking a full-scale activated sludge system. These tests 
included pH, MLSS concentration, mixed liquor volatile suspended solids (MLVSS) 
concentration, soluble chemical oxygen demand (sCOD), nitrogen speciation (i.e., ammonia, 
nitrate, and nitrite), and dissolved oxygen (DO). Standard methods were employed when 
applicable; a summary of the analyses and associated methods is provided in Table B1 
(Appendix B).  
II. Trace organic compounds 
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The target antibiotics include ampicillin (AMP), sulfamethoxazole (SMX), trimethoprim (TMP), 
tetracycline (TC), and vancomycin (VA). The target antibiotics were selected based on their 
frequency of clinical administration and previous reports of the occurrence of the antibiotics or 
their associated antibiotic resistance genes in water and wastewater. A suite of indicator TOrCs 
was identified to complement the target antibiotics. The indicator TOrCs include compounds 
with varying susceptibility to biodegradation and sorption in addition to compounds with 
antimicrobial properties, including triclocarban and triclosan. These compounds were selected 
based on their ubiquity in wastewater, their utility in evaluating process performance, and the 
project team’s experience and familiarity with their analysis and occurrence, specifically as part 
of a previous Water Environment Research Foundation project (WERF-CEC4R08; Salveson et 
al., 2012). Although the primary objective of this study was to evaluate the effects of SRT on 
AR, the inclusion of the indicator TOrCs allowed the team to expand on its previous work 
evaluating the relationship between SRT and TOrC removal (Gerrity et al., 2013; Salveson et al., 
2012) 
Primary and secondary effluent (i.e., settled effluent) samples from the four SBRs were collected 
in 1-L, silanized, amber glass bottles preserved with sodium azide (1 g/ L) and ascorbic acid (50 
mg/L). Samples were immediately placed on ice and held at 4°C for up to 14 days until further 
processing, which consisted of filtration with 0.7-μm glass fiber filters and on-line solid phase 
extraction (SPE). The samples were then analyzed for the target compounds by liquid 
chromatography tandem mass spectrometry (LC-MS/MS) with isotope dilution according to 
previously published methods (Vanderford and Snyder, 2006). 
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5.3.4 Microbiological methods  
I. Detection of culturable antibiotic resistant bacteria and minimum inhibitory 
concentrations (MICs) 
For the spread plate analyses, a selective supplement was used to isolate for Gram positive 
bacteria, specifically Staphylococcus and Streptococcus. Gram positive bacteria were selected as 
the target microorganisms due to their importance for emerging multidrug resistance. In addition, 
bacteria with intrinsic resistance to the target antibiotics might have significantly confounded the 
results. Therefore, the culture methods focused on Gram positive bacteria.  
Mueller Hinton agar containing Staph/Strep selective supplement was used to identify the total 
culturable Gram positive bacteria in samples. MH media has a high buffering capacity, which 
reduces the possibility of chemical transformations. Also, as mentioned before, MH media 
contains minimum amount of thymidine and thymine. Therefore, any interference due to the 
presence of thymidine and thymine is minimized. Plating was performed by using spread plate 
technique. In order to ensure data quality and limit the number of plates per sample event, the 
microbiological sampling was divided into two phases. Early in the week, samples were 
collected and tested for resistance to AMP and SMX/TMP. A second set of samples were 
collected later in the week and tested for resistance to TC and VA. All reactors and sampling 
locations were tested simultaneously for the two sets of samples. Three set of samples were 
collected for these tasks over the two months. In order to isolate resistant strains, bacteria were 
exposed to the target antibiotics (supplemented in growth media) at their reported minimum 
inhibitory concentrations (MICs). MICs which were used in this project are listed in Table 5-2 
(CLSI, 2012). 
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Table 5-2. Summary of minimum inhibitory concentrations (MICs) for each antibiotic 
Antibiotic MIC (μg/mL) 
AMP 32 
SMX/TMPa 76/4 
TC 16 
VA 4 
 
A 50 mL grab sample was collected in a sterile conical tube during the each SBR draw phase. A 
total of five samples from the SBRs were transported on ice to the laboratory. All samples were 
processed within 8 hours. Samples were transferred onto 0.9% sodium chloride for the first 
dilution and then were serially diluted in 0.01M phosphate buffer saline (PBS) to get 25 to 250 
colony forming unit (CFU) per plate. 100 µL of each sample was aseptically transferred onto 
each plate containing MH agar supplemented with different concentrations of target antibiotics 
and Staph/Strep selective supplement. Each target dilution was plated in triplicate. Plates were 
incubated at 35±0.5°C for 24±2 hours. The results were reported as the mean of triplicate plates 
± one standard deviation in CFU/100 µL. Negative controls were used to verify the absence of 
foreign contamination. An analysis schematic is provided in Figure 5-1. 
Visible colonies on MH agar with the presence of antibiotics and staph/strep supplement were 
considered antibiotic resistant Staph/Strep bacteria. A total of eight random isolates were 
harvested from each set of triplicate plates. The isolates were transferred into culture tubes 
containing MH broth for overnight incubation. These antibiotic resistant pure cultures were then 
sent to the University of Arizona for the MIC assay.  
In MIC assay, a series of wells in a 96-well tray were spiked with 50 μL of a pure culture in 
addition to serial dilutions of the corresponding target antibiotic (0 to 32 times the standard 
MIC). The minimum concentration at which growth is inhibited (based on absorbance at 600 
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nm) was reported as the sample MIC. Growth is determined by a BioTek Synergy HT Multi-
Mode Microplate reader. The MIC assay is depicted in Figure 5-2. 
5.3.5 Statistical analysis 
Single factor analysis of variance (ANOVA) with post-hoc Tukey’s test was performed with 
XLSTAT (Addinsoft, NY) at a significance level of 0.05. 
5.3.6 Limitations 
As indicated earlier, the mail goal of this study was to characterize the role of solids retention 
time and antibiotic concentrations on proliferation of antibiotic resistance. Therefore, the SBRs 
were operated in two phases during Fall 2015 (September through November) and Spring 2016 
(March through May). Although the SBRs were Installed in a shed, but the temperature changed 
drastically over time (from September to November for first phase and March to May for the 
second phase. With respect to the size of the SBRs, temperature variation was higher in the SBRs 
compared to a biological system in a full scale plant. In the next few sections, the effect of 
temperature on the fate of AR in the SBRs will be discussed, however it should be remembered 
that the temperature variation in a full scale plant is much lower than a small SBR. 
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Figure 5-1. Schematic of spread plate analysis 
Schematic of spread plate analysis for Staph/Strep bacteria (M-H agar contained Staph/Strep selective supplement 
for the selection of Staph/Strep) 
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Figure 5-2. Schematic of minimum inhibitory concentration analysis 
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5.4 Results and discussion 
5.4.1 The effect of varying solids retention time on sequencing batch reactor performance 
The general water quality of the SBRs was monitored on an approximately weekly basis to 
validate the performance of the activated sludge process. The average pH of the primary effluent 
was 6.4±0.2, and the pH of the secondary effluent was relatively constant, regardless of SRT, 
with an average of 6.9±0.2. During the aeration phase, the average DO concentration was 
relatively constant in the four SBRs with an average of 4.7±0.5 mg/L and no reading lower than 
3.7 mg/L. 
The principal treatment objectives of the activated sludge process are the removal of organic 
matter and nitrogen (sometimes phosphorus as well). Reductions in BOD are typically used to 
verify the removal of organic matter, although TOC or sCOD can also be used as a surrogate in 
some applications (Christian et al., 2016). Figure 5-3 illustrates the average sCOD, total 
suspended solids (or MLSS), and volatile suspended solids (or MLVSS) in the primary and 
secondary effluents as a function of SRT. Consistent with full-scale activated sludge systems, 
there was a clear trend in sCOD removal in that longer SRTs resulted in lower and more 
consistent effluent COD concentrations. There was also a positive correlation between SRT and 
MLSS/MLVSS because of the greater ‘recycle ratio’ for longer SRTs.  
To further validate the performance of the reactors, nitrogen speciation was performed to 
determine the extent of nitrification in each reactor (Figure 5-4). As expected, the nitrogen in the 
primary effluent was almost entirely in the form of ammonia, and the extent of nitrification 
increased with longer SRTs. Activated sludge systems with SRTs <5 days are typically assumed 
to be deficient in nitrifying bacteria (Tai et al., 2006), which limits the conversion of ammonia to 
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nitrite and nitrate. Assuming sufficient oxygen input, longer SRTs lead to the development of 
more mature microbial communities that are capable of converting nearly all of the ammonia to 
nitrate, nitrite, and/or nitrogen gas, depending on the exact operational conditions. The longer 
SRTs achieved nearly complete nitrification and also appeared to achieve partial denitrification 
based on an estimation of the nitrogen mass balance. 
As this experiment progressed, the ambient temperature at the study site decreased from 
approximately 32°C down to less than 10°C, thereby causing the water temperature to decrease 
and hindering the removal of organic matter and the extent of nitrification (Head and 
Oleszkiewicz, 2004). These trends were observed for sCOD, ammonia, and nitrate, as shown in 
Figure 5-5. The sCOD in the secondary effluents increased only slightly at lower temperatures, 
but nitrification was clearly impeded, as indicated by the increasing ammonia concentrations and 
decreasing nitrate concentrations in the secondary effluents. 
 
Figure 5-3. Average concentrations of sCOD, MLSS and MLVSS 
Average concentrations of sCOD, MLSS and MLVSS in the SBRs as a function of SRT. The primary effluent (PE) 
represents the feed water quality prior to biological treatment in the SBRs. Columns represent the mean values for 5 
sample events over 60 days of operation of the SBRs, and error bars represent ±1 standard deviation 
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Figure 5-4. Average concentrations of ammonia, nitrate, and nitrite (varying SRT) 
Average concentrations of ammonia, nitrate, and nitrite in the SBRs as a function of SRT. The primary effluent (PE) 
represents the feed water quality prior to biological treatment in the SBRs. Columns represent the mean values for 3 
sample events over 60 days of operation of the SBRs, and error bars represent ±1 standard deviation. The final 2 
sample events were excluded because of temperature effects (described in main text and illustrated in Figure 3) 
 
Figure 5-5. Effect of temperature on sCOD, ammonia, and nitrate (varying SRT) 
Effect of temperature on sCOD, ammonia, and nitrate as a function of SRT over 60 days of operation of the SBRs 
5.4.2 The effect of elevated antibiotic concentrations on the sequencing batch reactors 
performance 
Over the duration of running the SBRs with elevated antibiotic concentrations, the pH of the 
primary effluent was consistently 6.8, and the pH of the four reactors was consistently 7.1-7.2. 
The average DO concentrations were 3.7-3.8 in the four reactors, with no reading lower than 3.4 
mg/L.  
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Figure 5-6 illustrates the average sCOD in the primary effluent and the four secondary effluents, 
and it also illustrates the average total and volatile suspended solids concentrations in the 
primary effluent and mixed liquors. In contrast with the last experiment, for which the varying 
SRTs had a significant impact on general water quality parameters, all the reactors were 
designed to work with SRT of ~7 days. As a result, the MLSS and MLVSS values were nearly 
identical in the four reactors, with an overall average MLSS of 2,274±43 mg/L and an overall 
average MLVSS of 1,840±53 mg/L. The stable operation of the SBRs resulted in an overall 
average sCOD reduction of 87% and an overall average sCOD of 22±0.40 mg/L in the secondary 
effluent. These consistencies between the reactors provide a preliminary indication that the 
varying antibiotic concentrations in the SBR feeds were not impacting overall treatment 
performance. Also, when the samples were collected for the general water quality analyses, the 
ambient temperature ranged from 72°F-99°F (22°C-37°C). Therefore, there were no significant 
changes in system performance as there were when the temperature dropped to less than 50°F 
(10°C) during this phase.  
Similar to sCOD, there were no significant differences between the reactors with respect to 
nitrification. Again, all reactors were operated with an SRT of ~7 days, which is sufficient to 
maintain a stable population of nitrifiers. As a result, the ammonia in the primary effluent 
(average of 32.8±1.8 mg-N/L) was consistently converted to nitrate (overall average of 27.7±0.5 
mg-N/L) and, to a much lesser extent, nitrite (overall 0.01±0.00 mg-N/L) (Figure 5-7). The 
residual ammonia concentration in the four reactors was an average of 0.7±0.2 mg-N/L. 
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Figure 5-6. Average concentrations of sCOD, MLSS and MLVSS (elevated antibiotic concentrations) 
Average concentrations of sCOD, MLSS and MLVSS in the SBRs with elevated antibiotic concentrations. The 
primary effluent (PE) represents the feed water quality prior to biological treatment in the SBRs. Columns represent 
the mean values for 5 sample events over 60 days of operation of the SBRs, and error bars represent ±1 standard 
deviation 
 
Figure 5-7. Average concentrations of ammonia, nitrate (elevated antibiotic concentrations) 
Average concentrations of ammonia, nitrate, and nitrite in the SBRs with elevated antibiotic 
concentrations. The primary effluent (PE) represents the feed water quality prior to biological treatment in 
the SBRs. Columns represent the mean values for 3 sample events over 60 days of operation of the SBRs, 
and error bars represent ±1 standard deviation 
5.4.3 The effect of varying SRT on mitigation of micropollutants 
Sampling for indicator trace organic compounds and the target antibiotics was performed at the 
end of 2 months of operation to ensure that a stable microbial population had developed in the 
reactors prior to testing. Two independent sets of samples were collected to assess variability in 
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TOrC mitigation between cycles. TOrCs were analyzed in the primary effluent and in the 
secondary effluent from each of the SBRs. 
The exact mechanism of bioattenuation of trace organic compounds in activated sludge systems 
is not completely understood, although multiple studies have demonstrated a positive correlation 
between solids retention time and TOrC elimination. For the more biodegradable compounds, it 
is unclear whether the benefit of longer SRTs is actually due to the higher solids concentration 
(i.e., a greater amount of biomass) or the greater diversity of the microbial community, more 
specifically the proliferation of microbes capable of specific biological processes (e.g., 
nitrification and/or denitrification). Again, it is important to note that the TOrC samples in the 
current study were collected toward the end of 60-day operation of the SBRs when the 
temperatures in the reactors had decreased to the approximate threshold for nitrification. 
Therefore, any reductions in TOrC concentrations in the SBRs were achieved during periods of 
limited nitrification and slightly reduced metabolic activity.  
A summary of the TOrC concentrations for this phase is provided in Table 5-3. The target 
compounds for this study were selected to encompass a wide range of treatability in terms of 
biodegradation and sorption. The attenuation of the target compounds was generally in 
agreement with these TOrC properties, particularly with respect to biodegradability. The most 
biodegradable compounds (e.g., caffeine, ibuprofen, naproxen) achieved—or at least 
approached—their respective method reporting limits (MRLs) at longer SRTs, while the least 
biodegradable compounds (e.g., TCEP and carbamazepine) experienced little change in 
concentration as a result of biological treatment. Interestingly, the most hydrophobic compounds 
(e.g., triclocarban and fluoxetine) actually increased in concentration after biological treatment, 
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presumably due to some type of chemical equilibrium phenomenon that caused these compounds 
to desorb over time. These general observations are illustrated in Figure 5-8. 
 
 
Figure 5-8. Summary of TOrC mitigation as a function of SRT 
With respect to the target antibiotics, only trimethoprim exhibited a significant level of 
attenuation, and that was only observed for an SRT of 20 days. Sulfamethoxazole remained 
relatively constant during biological treatment at concentrations ranging from 1 to 1.5 μg/L. 
150 
Table 5-3. Summary of TOrC concentrations in the PE and effluent from the SBRs as a function of SRT 
TOrC 
 Day 1 (11/20/2015) Day 2 (11/21/2015) 
SRT PE PE1 2 21 7A 7B 20 PE PE1 2 7A 7B 20 201 
Ampicillin ng/L <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 
Sulfamethoxazole ng/L 990 970 1100 1000 1400 1500 1300 1100 1300 1100 1200 1400 1200 1200 
Tetracycline ng/L <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 <50 
Trimethoprim ng/L 380 370 370 330 420 420 120 530 710 500 470 410 180 180 
Vancomycin ng/L 420 470 670 890 980 760 770 450 460 740 1000 770 820 770 
Acetaminophen ng/L 95000 94000 <10000 <10000 <10000 <10000 <10000 93000 100000 <10000 <10000 <10000 <10000 <10000 
Atenolol ng/L 880 830 790 710 480 320 71 1100 1100 960 440 300 110 110 
Caffeine ng/L 67000 68000 50000 51000 <50 <50 <50 66000 73000 43000 <50 61 <50 <50 
Carbamazepine ng/L 130 130 110 120 120 120 120 130 130 110 110 130 110 100 
DEET ng/L 260 260 250 250 270 220 160 320 370 310 300 230 180 180 
Fluoxetine ng/L 8.8 16 7.9 7.8 26 22 20 16 26 7.6 28 23 22 22 
Gemfibrozil ng/L 1800 1700 1500 1500 1700 1300 72 1400 1700 1600 1500 1100 140 140 
Ibuprofen ng/L 19000 19000 15000 16000 220 110 17 23000 24000 16000 89 250 <10 <10 
Meprobamate ng/L 750 780 940 900 850 400 890 940 1100 1300 1000 420 1000 1000 
Naproxen ng/L 18000 18000 16000 16000 2600 200 18 19000 20000 15000 1400 330 21 23 
Primidone ng/L 180 180 200 190 210 200 210 210 200 210 210 220 220 200 
Sucralose ng/L 42000 41000 54000 47000 49000 49000 47000 45000 45000 51000 48000 40000 40000 42000 
TCEP ng/L 260 250 260 260 260 260 260 300 300 310 280 280 330 330 
Triclocarban ng/L 14 15 49 55 64 72 77 14 14 59 64 60 42 42 
Triclosan ng/L 140 140 400 360 160 71 59 210 220 470 190 72 58 67 
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Similar to Watkinson et al. (2009), who studied antibiotic occurrence in Australia, tetracycline 
concentrations were <MRL in all samples in the current study. A separate study of spiked 
tetracycline noted that removal was significantly correlated with SRT, while varying HRT 
(between 7 and 24 hours) had no significant impact on tetracycline removal (Kim et al., 2005). In 
the current study, the ‘last resort’ antibiotic vancomycin was consistently detected in primary 
effluent and biologically treated samples, and similar to hydrophobic compounds like 
triclocarban, vancomycin actually increased in concentration (up to 1 μg/L) after biological 
treatment. 
5.4.4 The effect of elevated antibiotic concentrations on the SBRs performance with 
respect to trace organic compounds 
The TOrC experiments in this phase had two primary objectives: (1) verify the spiking levels of 
the target antibiotics and (2) evaluate the effects of elevated antibiotic concentrations on 
treatment performance. TOrC samples were collected on consecutive days to evaluate the 
reproducibility of the data. The resulting concentrations are summarized in Table 5-4, and a 
direct comparison with the target antibiotic concentrations is provided in Table 5-5. 
With respect to the first objective, the actual concentrations observed in the primary effluent 
pumped to each SBR were generally consistent with the target concentrations (i.e., 1x, 10x, or 
100x) for sulfamethoxazole, trimethoprim, and vancomycin. Differences between the observed 
and target concentrations of these antibiotics, particularly for vancomycin, may have been due to 
rapid adsorption onto the suspended solids in the primary effluent. On the other hand, the 
observed concentrations of ampicillin and tetracycline were significantly different from the 
target concentrations.
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Table 5-4. Summary of TOrC concentrations in the PE and effluent from the SBRs with elevated antibiotic concentrations 
TOrC  Day 1 (5/12/2016) Day 2 (5/13/2016) 
 PE1 1X 1X1 PE2 10XA PE3 10XB PE4 100X PE1 1X PE2 10XA PE3 10XB PE4 100XA 100XB
Ampicillin ng/L <100 <100 <100 <100 <100 <10000 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 <100 
Sulfamethoxazole ng/L 2700 2000 2000 12000 6300 11000 6100 92000 51000 2300 1500 11000 5600 11000 5900 100000 59000 60000 
Tetracycline ng/L <100 23 <100 <100 26 <10000 25 390 160 <100 16 <100 24 <100 30 140 160 160 
Trimethoprim ng/L 980 110 89 4800 1300 5000 1300 45000 20000 910 220 4800 1500 4300 850 48000 23000 23000 
Vancomycin ng/L 1200 1100 1100 2100 2000 6500 2100 33000 23000 920 1300 1700 2300 1800 2200 28000 26000 28000 
Acetaminophen ng/L 10000 <100 <100 96000 <100 100000 <100 98000 <100 90000 <100 91000 <100 90000 <100 94000 <100 <100 
Atenolol ng/L 1200 120 120 1200 130 1200 160 1200 130 1100 <2000 1100 <2000 1100 <2000 1100 <2000 <2000 
Caffeine ng/L 67000 <5.0 <5.0 66000 <100 64000 <100 63000 <100 70000 <100 66000 <100 64000 <100 65000 <100 <100 
Carbamazepine ng/L 180 180 180 160 170 170 170 170 130 160 150 150 160 150 160 150 160 130 
DEET ng/L 1000 630 620 1100 600 1000 660 1000 500 510 470 490 480 480 390 470 400 340 
Fluoxetine ng/L <1000 19 18 <1000 16 <1000 16 <1000 16 <1000 13 <1000 22 <1000 21 <1000 22 15 
Gemfibrozil ng/L 1600 7.6 7.5 1600 31 1700 61 1700 41 1500 420 1600 18 1600 16 1600 33 33 
Ibuprofen ng/L 24000 14 17 22000 14 23000 23 23000 27 22000 23 22000 14 22000 13 22000 11 11 
Meprobamate ng/L 780 930 920 800 980 820 950 870 760 710 870 720 910 720 860 750 870 760 
Naproxen ng/L 21000 15 13 20000 14 21000 23 21000 38 19000 36 19000 10 19000 14 19000 19 18 
Primidone ng/L 210 210 200 220 210 240 210 220 170 190 190 190 200 180 190 190 190 180 
Sucralose ng/L 38000 44000 45000 40000 43000 40000 46000 41000 37000 42000 51000 40000 45000 37000 46000 43000 47000 39000 
TCEP ng/L 330 310 300 320 300 290 290 280 280 160 250 160 240 160 230 160 230 240 
Triclocarban ng/L 15 19 12 21 12 20 16 24 28 19 40 16 16 22 18 20 26 28 
Triclosan ng/L 240 36 33 230 46 220 54 210 41 270 150 190 100 240 50 230 42 40 
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Table 5-5. Comparison of Target and Observed Antibiotic Concentrations in Primary Effluent 
Antibiotic Units 1X 10x 100x 
Target Actual Target Actual Target Actual 
Ampicillin μg/L 0.2 <0.1 2 <0.1 20 <0.1 
Sulfamethoxazole μg/L 1 2.5 10 11 100 96 
Tetracycline μg/L 0.1 <0.1 1 <0.1 10 0.3 
Trimethoprim μg/L 0.5 0.9 5 4.7 50 47 
Vancomycin μg/L 0.5 1.1 5 3.0 50 31 
 
In fact, ampicillin was <MRL in all samples, even when spiked at 20 μg/L. With respect to the 
primary effluent samples, tetracycline was only present at reportable concentrations in the 100x 
sample, and even though the antibiotic was spiked at 10 μg/L, the observed concentration was 
only 0.3 μg/L. Tetracycline was reliably detected in several secondary effluents (i.e., after 
biological treatment), even when the primary effluent had not been spiked. This suggests that 
matrix interference may have been a significant factor. 
Factors such as adsorption and hydrolysis may have also affected the observed concentrations of 
ampicillin and tetracycline. Gao et al. (2012) detected tetracycline in primary effluent (164 ng/L) 
but not in secondary effluent. Extracted solids resulted in consistent tetracycline detection (750 
μg/kg dw), thereby suggesting that the compound preferentially adsorbed to solids and was 
removed in the clarification process. Other studies in the literature describe a wide range of 
values for tetracycline, and there are several studies reporting tetracycline at <MRL (Watkinson 
et al., 2009). With respect to ampicillin, there is a general paucity of data describing typical 
concentrations in wastewater, but Li and Zhang, (2010) noted that both ampicillin and 
tetracycline rapidly adsorb onto solids. Therefore, one can conclude that a combination of 
analytical and natural limitations likely hindered reliable detection of ampicillin and tetracycline, 
despite the fact that these compounds were spiked at high concentrations. Regardless, based on 
the other three antibiotics, the antibiotic delivery system appeared to work as intended.  
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The second objective of the TOrC sampling was to evaluate whether the elevated antibiotic 
concentrations might hinder the biodegradation capabilities of the microbial community. The 
general water quality parameters, particularly with respect to sCOD removal and nitrification, 
provided a preliminary indication that the spiked antibiotics had no significant impact on 
treatment efficacy. The SBR effluent concentrations for the most biodegradable compounds 
(e.g., acetaminophen, caffeine, naproxen, and ibuprofen) further support this conclusion, as those 
concentrations were significantly attenuated via biodegradation even in the 100x SBR. This is 
supported by Li and Zhang (2010) who observed significant caffeine attenuation via 
biodegradation even with a suite of antibiotics spiked at the high μg/L level. Therefore, elevated 
antibiotic concentrations (up to 1.25% of the standard MIC) do not appear to impact the 
functional capacity of the microbial community in wastewater treatment applications.   
5.4.5 The effect of varying SRT on culturable antibiotic resistant bacteria 
The geometric mean plate counts and standard deviations for the three sample events are 
summarized in Figure 5-9 through Figure 5-11. As mentioned earlier, each sample event for the 
antibiotic resistance testing was divided into two different groups to limit the plating on each 
day. Therefore, each data set includes two different primary effluent samples. The first sample 
event was performed 3 and 5 days post-startup, which corresponds to 9 and 15 treatment cycles, 
respectively. Sample event 2 was performed 31 and 33 days post-startup (93 and 99 treatment 
cycles), and sample event 3 was performed 53 and 55 days post-startup (159 and 165 treatment 
cycles). For sample events 1 and 2, ampicillin and sulfamethoxazole/trimethoprim were tested as 
part of group 1, and tetracycline and vancomycin were tested as part of group 2. The groupings 
were then swapped for sample event 3 to eliminate any sample/analysis bias. 
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Figure 5-9. Percentage of Resistant Staph/Strep in the SBRs with varying SRT (Sample Event 1) 
 
Figure 5-10. Percentage of Resistant Staph/Strep in the SBRs with varying SRT (Sample Event 2) 
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Figure 5-11. Percentage of Resistant Staph/Strep in the SBRs with varying SRT (Sample Event 3) 
The plate counts were used to calculate the ratios of total Staph/Strep in each MLSS sample to 
total Staph/Strep in the primary effluent (Table 5-6 through Table 5-8). The values were 
generally a function of SRT in that longer SRTs with greater ‘recycle ratios’ led to higher levels 
of Staph/Strep in the MLSS. To calculate the ratio of antibiotic resistant bacteria, the plate counts 
on media supplemented with each antibiotic (i.e., MH + Staph/Strep supplement + antibiotic) 
were divided by the plate counts for that same sample on media that did not contain antibiotics 
(i.e., MH + Staph/Strep supplement).  
The data suggest that biological treatment appears to select for antibiotic resistant bacteria. This 
is based on the fact that the antibiotic resistant Staph/Strep comprise a greater percentage of the 
total Staph/Strep population in the MLSS compared to the primary effluent. Furthermore, the 
data suggest that longer SRTs also select for antibiotic resistance, as indicated by the higher 
percentages for SRTs of 7 and 20 days. For sample event 1, it is important to note that the 
microbial community in the SBR targeting the longest SRT was not exactly representative of a 
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20-day SRT at this point in the study. The SBRs were seeded with RAS from the full-scale 
facility, which operates at a moderate SRT of ~6-7 days. Considering that the first set of samples 
were collected 3- and 5-days post-startup, the SRT in the last reactor had not yet reached 20 
days, although it was longer than the other three reactors. In the first sample event, the antibiotic 
resistance effect appeared to be more pronounced for ampicillin and 
sulfamethoxazole/trimethoprim than for tetracycline and vancomycin (Figure 5-9).  
For sample event 2 (Figure 5-10), there was still a consistent positive correlation between the 
ratio of antibiotic resistant Staph/Strep and SRT, but the actual percentages dramatically 
decreased compared to sample event 1, except for vancomycin which actually increased. This 
trend continued into sample event 3 in which the percentage of antibiotic resistant Staph/Strep 
decreased to less than 10% for ampicillin, sulfamethoxazole/trimethoprim, and tetracycline 
(Figure 10). The percentages for vancomycin decreased slightly but remained relatively 
consistent with sample event 2. Despite the decrease in percentages, the level of antibiotic 
resistance was consistently higher in the MLSS and for longer SRTs. The temporal trends across 
the three sample events are illustrated in Figure 5-12.  
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Table 5-6. The effect of varying SRT on culturable Staph/Strep resistant bacteria (Sample Event 1) 
Sample MH+S/S (CFU/100 μL) 
MH+S/S+AMP 
(CFU/100 μL) 
MH+S/S+ 
SMX/TMP 
(CFU/100 μL) 
MH+S/S 
(CFU/100 μL) 
MH+S/S+TET    
(CFU/100 μL) 
MH+S/S+VA         
(CFU/100 μL) 
Primary Effluent (8.69±0.46)x103 (7.23±0.15)x101 (6.12±0.59)x101 (4.86±0.40)x103 (6.32±0.49)x101 (3.46±0.15)x101 
SRT = 2 Days (5.57±0.72)x103 (1.02±0.06)x103 (1.05±0.05)x103 (1.90±0.06)x104 (1.38±0.08)x103 (1.90±0.10)x103 
SRT = 7 Days (A) (7.10±0.86)x103 (1.37±0.08)x103 (1.86±0.05)x103 (2.61±0.40)x104 (2.16±0.12)x103 (3.52±0.31)x103 
SRT = 7 Days (B) (5.10±0.17)x103 (1.38±0.03)x103 (1.13±0.07)x103 (2.77±0.06)x104 (2.40±0.17)x103 (3.42±0.32)x103 
SRT = 20 Days (3.12±0.29)x104 (1.05±0.05)x104 (9.44±0.81)x103 (8.36±0.35)x104 (8.20±0.17)x103 (1.20±0.03)x104 
Table 5-7. The effect of varying SRT on culturable Staph/Strep resistant bacteria (Sample Event 2) 
Sample MH+S/S (CFU/100 μL) 
MH+S/S+AMP 
(CFU/100 μL) 
MH+S/S+ 
SMX/TMP 
(CFU/100 μL) 
MH+S/S 
(CFU/100 μL) 
MH+S/S+TET    
(CFU/100 μL) 
MH+S/S+VA         
(CFU/100 μL) 
Primary Effluent (1.63±0.40)x104 (2.32±0.32)x102 (2.93±0.57)x102 (2.27±0.44)x104 (2.05±0.29)x102 (4.97±0.62)x102 
SRT = 2 Days (1.89±0.17)x104 (4.29±0.76)x102 (4.85±0.51)x102 (2.50±0.71)x104 (2.70±0.50)x102 (3.77±0.60)x103 
SRT = 7 Days (A) (5.54±0.61)x104 (2.66±0.25)x103 (7.08±0.66)x103 (2.87±0.46)x104 (4.13±0.29)x102 (5.54±0.64)x103 
SRT = 7 Days (B) (5.30±0.27)x104 (1.92±0.25)x103 (5.79±0.40)x103 (3.55±0.40)x104 (3.77±0.53)x102 (6.31±0.68)x103 
SRT = 20 Days (8.48±0.69)x104 (8.93±0.15)x103 (1.24±0.06)x104 (3.92±0.32)x104 (1.82±0.25)x103 (1.00±0.08)x104 
Table 5-8. The effect of varying SRT on culturable Staph/Strep resistant bacteria (Sample Event 3) 
Sample MH+S/S (CFU/100 μL) 
MH+S/S+AMP 
(CFU/100 μL) 
MH+S/S+ 
SMX/TMP 
(CFU/100 μL) 
MH+S/S 
(CFU/100 μL) 
MH+S/S+TET    
(CFU/100 μL) 
MH+S/S+VA         
(CFU/100 μL) 
Primary Effluent (3.59±0.85)x104 (1.36±0.21)x102 (4.22±0.40)x102 (3.87±0.60)x104 (3.87±0.60)x101 (6.22±0.50)x102 
SRT = 2 Days (5.56±0.32)x104 (4.80±1.00)x102 (1.16±0.15)x103 (5.95±0.47)x104 (2.06±0.25)x102 (8.62±1.15)x103 
SRT = 7 Days (A) (6.69±0.36)x104 (9.35±0.60)x102 (4.26±2.20)x103 (8.42±0.59)x104 (3.71±0.50)x102 (1.38±0.27)x104 
SRT = 7 Days (B) (6.56±0.45)x104 (1.02±0.07)x103 (4.39±0.76)x103 (8.59±0.46)x104 (4.22±0.45)x102 (1.40±0.35)x104 
SRT = 20 Days (1.25±0.06)x105 (4.23±0.31)x103 (1.03±0.06)x104 (9.96±0.25)x104 (2.38±0.67)x103 (2.29±0.27)x104 
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Figure 5-12. Temporal trend in antibiotic resistant percentage (Varying SRT) 
One potential hypothesis for the decrease observed in Figure 5-12 is that the resistance 
mechanisms became too ‘expensive’ for the bacteria to maintain after experiencing 
environmental stress (i.e., cold temperatures). Environmental stressors such as temperature, pH, 
salinity can induce structural and physiological responses among certain species of bacteria 
(Beales, 2004). McMahon et al. (2007) studied the responses of Gram negative E. coli and 
Salmonella enterica and Gram positive Staphylococcus aureus to exposure to cold temperatures 
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(10°C for E. coli and Salmonella and 21°C for Staphylococcus). The level of AR exhibited by E. 
coli remained relatively constant after exposure to cold temperatures, but the level of AR 
exhibited by Salmonella enterica decreased significantly, particularly for trimethoprim. 
Staphylococcus exhibited a decrease in AR for one of the three antibiotics tested (i.e., oxacillin 
but not gentamicin or erythromycin), although the lowest temperatures tested was 21°C. On the 
other hand, Miller et al. (2014) reported an increase in intl1 and sul1 when biosolids were stored 
at temperatures less than 10°C. Therefore, temperature effects appear to be species- and 
antibiotic-specific and might also differ for culture versus molecular methods. More specifically, 
changes in temperature might induce changes in gene prevalence but not necessarily gene 
expression. This topic requires further investigation to fully explain the effects of temperature on 
AR prevalence.  
5.4.6 The effect of elevated antibiotic concentrations on culturable antibiotic resistant 
bacteria 
Three sample events were performed to evaluate the potential proliferation of AR during 
biological treatment with elevated antibiotic concentrations. Each sample event was divided into 
two subsamples to yield a more manageable number of plates on a given day. Resistance to 
ampicillin and sulfamethoxazole/trimethoprim was evaluated in the first subsample, and 
resistance to tetracycline and vancomycin was evaluated in the second subsample. The first 
sample event was performed 3 and 5 days after startup (i.e., after 9 and 15 SBR cycles, 
respectively), and the second sample event was performed 31 and 33 days after startup (i.e., after 
93 and 99 SBR cycles, respectively. The third sample event was scheduled to be performed after 
approximately 60 days of operation, but an unforeseen scheduling issue forced the reactors to be 
shut down after 50 days of operation. For the third sample event, the SBRs were restarted and 
161 
allowed to operate for an additional 14-16 days prior to sample collection (i.e., after 42 and 48 
SBR cycles, respectively). Over the duration of the SBRs in this phase, the ambient temperature 
increased from 59°F to 77°F (15°C to 25°C). 
The plate counts for sample events 1 to 3 are summarized in Table 5-9 to Table 5-11. These plate 
counts were used to determine the ratios of culturable Staph/Strep in the four mixed liquors 
relative to the culturable Staph/Strep in the primary effluent. This calculation was used as a 
means to characterize the change in the overall Staph/Strep population during biological 
treatment. 
The plate counts were also used to determine the percentage of culturable Staph/Strep that were 
resistant to the target antibiotics spiked at their standard MICs. These data are summarized in 
Figure 5-13 to Figure 5-15. The three sample events are directly compared in Figure 5-16 to 
illustrate the temporal trend in antibiotic resistance. These data yielded the following general 
observations: 
 Consistent with previous phase (varying SRT), biological treatment appears to increase 
the prevalence of culturable AR bacteria with respect to all of the target antibiotics.  
 The relative prevalence of AR bacteria in the mixed liquor ranged from as low as 2% for 
1x tetracycline to as high as 32% for 100x vancomycin. 
 There was a slight positive correlation between influent antibiotic concentrations and the 
prevalence of culturable AR bacteria.  
Consistent with previous task (varying SRT), there appears to be a positive correlation between 
temperature and culture-based antibiotic resistance. In varying SRT phase, AR decreased sharply 
as the temperature decreased, and in elevated antibiotic concentrations phase, AR increased with 
increasing temperature. 
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Single factor analysis of variance (ANOVA) with post-hoc Tukey’s test was also performed and 
the results are summarized in Appendix C. As it was expected, two 7-day SRT reactors were not 
significantly different (p>0.5) for most of the samples. Except for vancomycin and tetracycline, 
AR rates were significantly different among 2-day, 7-day and 20-day SRT (p<0.5). For 
ampicillin and tetracycline, only one sampling event showed no significant difference between 2-
day, 7-day, and 20-day SRT. According to the results from statistical analysis, longer SRTs may 
promote antibiotic resistance at least for some antibiotics.  
 
 
Figure 5-13. Percentage of Resistant Staph/Strep in the SBRs with elevated antibiotic concentrations 
(Sample Event 1) 
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Figure 5-14. Percentage of Resistant Staph/Strep in the SBRs with elevated antibiotic concentrations 
(Sample Event 2) 
 
 
Figure 5-15. Percentage of Resistant Staph/Strep in the SBRs with elevated antibiotic concentrations 
(Sample Event 3) 
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Figure 5-16. Temporal trend in antibiotic resistant percentage (Elevated antibiotic concentrations) 
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Table 5-9. The effect of elevated antibiotic concentrations on culturable Staph/Strep resistant bacteria (Sample Event 1) 
Sample MH+S/S (CFU/100 μL) 
MH+S/S+AMP 
(CFU/100 μL) 
MH+S/S+ 
SMX/TMP 
(CFU/100 μL) 
MH+S/S 
(CFU/100 μL) 
MH+S/S+TET    
(CFU/100 μL) 
MH+S/S+VA         
(CFU/100 μL) 
Primary Effluent (2.00±0.10)x104 (1.86±0.15)x102 (5.65±0.58)x102 (1.34±0.35)x104 (1.66±0.21)x102 (9.62±0.55)x102 
1X (1.86±0.12)x104 (5.39±0.36)x102 (7.39±0.53)x102 (2.20±0.49)x104 (4.38±0.52)x102 (2.06±0.25)x103 
10X (A) (1.83±0.15)x104 (2.89±0.27)x103 (1.52±0.47)x103 (2.23±0.15)x104 (7.65±0.58)x102 (3.00±0.10)x103 
10X (B) (1.83±0.06)x104 (1.99±0.20)x103 (1.67±0.06)x103 (2.16±0.12)x104 (7.21±0.70)x102 (3.16±0.21)x103 
100X (1.96±0.15)x104 (2.90±0.17)x103 (1.91±0.38)x103 (1.96±0.21)x104 (8.69±0.36)x102 (3.59±0.65)x103 
Table 5-10. The effect of elevated antibiotic concentrations on culturable Staph/Strep resistant bacteria (Sample Event 2) 
Sample MH+S/S (CFU/100 μL) 
MH+S/S+AMP 
(CFU/100 μL) 
MH+S/S+ 
SMX/TMP 
(CFU/100 μL) 
MH+S/S 
(CFU/100 μL) 
MH+S/S+TET    
(CFU/100 μL) 
MH+S/S+VA         
(CFU/100 μL) 
Primary Effluent (4.05±0.50)x103 (3.14±0.51)x102 (7.99±0.36)x101 (7.56±1.53)x103 (1.37±0.36)x102 (8.06±0.21)x102 
1X (6.95±1.00)x103 (7.23±1.53)x102 (2.78±0.40)x102 (1.32±0.25)x104 (8.19±3.21)x102 (1.82±0.32)x103 
10X (A) (7.65±0.58)x103 (1.13±0.12)x103 (5.69±0.44)x102 (1.35±0.25)x104 (9.52±2.08)x102 (3.23±0.21)x103 
10X (B) (8.24±1.53)x103 (1.24±0.31)x103 (6.42±0.57)x102 (1.24±0.31)x104 (1.03±0.35)x103 (2.93±0.15)x103 
100X (7.56±1.53)x103 (1.72±0.21)x103 (8.58±0.70)x102 (1.27±0.35)x104 (1.44±0.35)x103 (3.73±0.12)x103 
Table 5-11. The effect of elevated antibiotic concentrations on culturable Staph/Strep resistant bacteria (Sample Event 3) 
Sample MH+S/S (CFU/100 μL) 
MH+S/S+AMP 
(CFU/100 μL) 
MH+S/S+ 
SMX/TMP 
(CFU/100 μL) 
MH+S/S 
(CFU/100 μL) 
MH+S/S+TET    
(CFU/100 μL) 
MH+S/S+VA         
(CFU/100 μL) 
Primary Effluent (9.25±1.53)x103 (2.67±0.46)x102 (4.79±0.75)x102 (5.85±1.73)x103 (4.44±0.61)x101 (8.46±0.50)x102 
1X (7.83±3.51)x103 (5.83±0.78)x102 (7.40±0.30)x102 (8.32±0.58)x103 (6.65±0.58)x102 (1.65±0.18)x103 
10X (A) (6.21±1.53)x103 (9.62±1.16)x102 (8.59±0.46)x102 (8.51±2.08)x103 (1.09±0.42)x103 (2.36±0.23)x103 
10X (B) (6.80±2.00)x103 (1.01±0.08)x103 (8.16±0.31)x102 (8.96±1.00)x103 (1.24±0.31)x103 (2.01±0.64)x103 
100X (5.65±0.58)x103 (1.48±0.07)x103 (8.73±0.32)x102 (9.78±2.65)x103 (2.26±0.21)x103 (3.16±0.31)x103 
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Single factor analysis of variance (ANOVA) with post-hoc Tukey’s test was performed to 
determine if the differences between AR resistance rates for the four SBRs were statistically 
significant. The results are summarized in Appendix C. Significant differences were expected 
between the 2-, 7-, and 20-day SRTs, but no significant differences were expected between the 
two reactors operating with a 7-day SRT.  This was true for the two latter sample events, which 
showed no significant difference (p>0.5) for the 7-day SRTs for all antibiotics except AMP. In 
contrast, the first sample event exhibited significant differences, although these samples were 
collected only three days post-start-up when the microbial communities in the SBRs had not yet 
stabilized with respect to their corresponding SRTs. For the second and third sample events, 
when the temperature decreased considerably, the rate of AR decreased for all SRTs. Therefore, 
no significant differences were observed between the 7-day and 20-day SRTs. However, the AR 
rates between the 2-day and 20-day SRTs were still significantly different (p<0.5). Regression 
analysis was also performed to compare the rate of antibiotic resistance between predicated and 
experimental values. The regression analysis simultaneously considered all variables assumed to 
impact AR, including SRT, influent antibiotic concentrations, and temperature. Figure 5-17 
shows the correlation between predicted values and experimental observations of target 
antibiotic resistance bacteria. According to the results, all the three variables including 
temperature, SRT, and influent antibiotic concentrations were significant in predicting AMP 
resistant bacteria (P<0.5), while temperature for predicting VA resistant, SRT for predicting TC, 
and influent antibiotic concentrations for predicting SMX/TMP resistant bacteria were 
insignificant variables (p>0.5). Regression analysis also helped to determine the best coefficient 
for each variable in each antibiotic. The following equations are presented to predict AR for each 
antibiotic: 
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1) AMP resistant = 0.5 × (SRT) + 0.5 × (Temp) + 6.5 × (Antibiotic Conc.) 
2) SMX/TMP resistant = 0.5 × (SRT) + 0.5 × (Temp) 
3) TC resistant = 0.5 × (Temp) + 4.5 × (Antibiotic Conc.) 
4) VA resistant = 0.5 × (SRT) + 5.5 × (Antibiotic Conc.) 
 
Figure 5-17.  Linear correlation between predicted values and experimental observations of target 
antibiotic resistant bacteria 
5.4.7 The effect of varying SRT on minimum inhibitory concentration among antibiotic 
resistant bacteria 
Eight isolates from each of the primary effluent and mixed liquor plates (according to Figure 5-
2) were transferred to 2-mL sample tubes containing MH broth with no additional supplements 
or antibiotics, incubated overnight, and then stored at 4oC until they were shipped on ice to the 
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University of Arizona the following week. Log phase samples of each pure culture were 
prepared at the University of Arizona and used to perform the MIC assay. This was repeated 
three times to evaluate the effects of varying SRT on the extent of AR exhibited by the tested 
isolates. Table 5-12 summarizes the antibiotic concentrations used in the well trays for the MIC 
assay. 
Table 5-12. Comparison of target antibiotic concentrations used in the well trays for the MIC 
assay 
MIC AMP SMX/TMP TET VA 
0X 0 0 0 0 
0.5X 16 38/2 8 2 
1X 32 76/4 16 4 
2X 64 152/8 32 8 
4X 128 304/16 64 16 
8X 256 608/32 128 32 
16X 512 1216/64 256 64 
32X 1024 2432/128 512 128 
 
The results of the MIC assays are summarized in Table 5-13 through Table 5-17. Each table 
indicates (1) the percentage of isolates that were successfully revived at the University of 
Arizona, (2) the percentage of revived isolates that were antibiotic resistant (i.e., those that grew 
in the presence of the target antibiotic at concentrations greater than or equal to the CLSI MIC), 
(3) the observed MICs and corresponding number of isolates, (4) a weighted score for each set of 
8 isolates, and (5) an average score and standard deviation for each SRT. The intent of the 
weighted score was to provide a basis for directly comparing the results from the various SRTs. 
The weighted score was determined as follows: 
 Weighted Score =   × . 	 	  × 	 	  × 	 	  × 	 	  × 	 	  ×  	 	  ×  	 	  ×                            (Eq.  1) 
 where, nx = the number of isolates observed at each concentration. 
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By definition, any isolates inhibited at 0.5x or 1x were assumed to be susceptible to antibiotics. 
Furthermore, any isolates inhibited at 0.5x were reported to have an MIC “<1x” because they 
may have been inhibited at concentrations even lower than 0.5X. A weighting factor of 64 was 
used for isolates that grew at the highest concentration used in the MIC assay. For these isolates, 
their true MIC is >32x.  
In total, 480 isolates were harvested, processed, and shipped to the University of Arizona for the 
MIC assay. Of the 480 total harvested isolates, 415 (86%) were successfully revived for the MIC 
assay. The isolates that were pre-screened for resistance to ampicillin (70% revival rate) or 
sulfamethoxazole/trimethoprim (80% revival rate) were more difficult to revive in MH broth 
compared to those pre-screened for resistance to tetracycline (98% revival rate) or vancomycin 
(98% revival rate). 100% the revived isolates proved to be antibiotic resistant. This is expected 
considering that the isolates were previously grown on agar supplemented with the target 
antibiotic at the CLSI MIC. 
370 isolates (~90% of the total revived isolates) grew in the presence of their respective target 
antibiotics at concentrations 32 times higher than the MIC. The MICs for the remaining 45 
revived isolates were spread relatively evenly throughout the 2x-32x concentration range.  
Average weighted scores may have been artificially attenuated due to low revival percentage 
(13%; 1 isolate) coupled with low observed MIC (2x) in one instance each for the primary 
effluent and 2-day SRT. 
The isolates from the reactor with the 20-day SRT generated the highest average weighted score 
and the lowest standard deviation when the data for all antibiotics were aggregated, perhaps 
suggesting a positive correlation between SRT and extent of AR. However, the primary effluent 
and shorter SRTs were relatively similar to each other and exhibited high standard deviations, 
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which makes a true relationship uncertain. In addition, the data for individual antibiotics 
demonstrated no clear relationship between extent of AR and SRT. Considering that ~90% of the 
isolates grew at the highest tested concentration, even higher antibiotic concentrations (i.e., 
>32x) would have to be tested to get a more precise representation of extent of AR. 
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Table 5-13. Summary of Task 1 MIC Data for Primary Effluent 
SRT Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
Pr
im
ar
y 
Ef
flu
en
t 
AMP 
1 100% 100% 
32 
0 0 0 0 0 0 0 8 64.0 
58.8 8.9 
54.3 19.0 
2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 50% 100% 0 0 1 0 0 0 0 3 48.5 
SMX/TMP 
1 75% 100% 
76/4 
0 0 2 1 0 0 0 3 33.3 
33.1 31.0 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 13% 100% 0 0 1 0 0 0 0 0 2.0 
TET 
1 100% 100% 
16 
0 0 1 0 0 0 0 7 56.3 
61.4 4.5 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 88% 100% 0 0 0 0 0 0 0 7 64.0 
VA 
1 100% 100% 
4 
0 0 0 0 0 0 0 8 64.0 
64.0 0.0 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
Table 5-14. Summary of Task 1 MIC Data for 2-Day SRT (Varying SRT) 
SRT 
(d) 
Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
2 
AMP 
1 88% 100% 
32 
0 0 0 0 0 0 0 7 64.0 
43.3 35.8 
54.8 20.9 
2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 13% 100% 0 0 1 0 0 0 0 0 2.0 
SMX/TMP 
1 100% 100% 
76/4 
0 0 0 0 0 0 0 8 64.0 
64.0 0.0 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 88% 100% 0 0 0 0 0 0 0 7 64.0 
TET 
1 100% 100% 
16 
0 0 0 0 0 0 0 8 64.0 
64.0 0.0 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
VA 
1 100% 100% 
4 
0 0 0 0 0 0 0 8 64.0 
48.0 24.3 2 100% 100% 0 0 2 1 3 0 0 2 20.0 
3 100% 100% 0 0 0 0 0 0 1 7 60.0 
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Table 5-15. Summary of Task 1 MIC Data for 7-Day A SRT (Varying SRT) 
Table 5-16. Summary of Task 1 MIC Data for 7-Day B SRT (Varying SRT) 
SRT 
(d) 
Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
7B 
AMP 
1 50% 100% 
32 
0 0 0 0 0 0 0 4 64.0 
58.8 8.9 
56.8 11.5 
2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 50% 100% 0 0 1 0 0 0 0 3 48.5 
SMX/TMP 
1 88% 100% 
76/4 
0 0 0 0 0 0 0 7 64.0 
57.1 11.9 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 75% 100% 0 0 2 0 0 0 0 4 43.3 
TET 
1 100% 100% 
16 
0 0 2 1 0 0 0 5 41.0 
56.3 13.3 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
VA 
1 100% 100% 
4 
0 0 3 0 0 0 0 5 40.8 
45.3 16.8 2 100% 100% 0 0 1 0 1 3 0 3 31.3 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
 
 
 
 
SRT 
(d) 
Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
7A 
AMP 
1 100% 100% 
32 
0 0 1 0 0 0 0 7 56.3 
61.4 4.5 
56.1 13.5 
2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 25% 100% 0 0 0 0 0 0 0 2 64.0 
SMX/TMP 
1 100% 100% 
76/4 
0 0 0 0 0 0 0 8 64.0 
57.1 11.9 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 38% 100% 0 0 1 0 0 0 0 2 43.3 
TET 
1 88% 100% 
16 
0 0 1 0 0 0 0 6 55.1 
59.0 4.5 2 100% 100% 0 0 0 0 0 1 0 7 58.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
VA 
1 100% 100% 
4 
0 0 2 0 0 0 0 6 48.5 
41.7 26.4 2 100% 100% 0 0 2 4 0 1 0 1 12.5 
3 75% 100% 0 0 0 0 0 0 0 6 64.0 
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Table 5-17. Summary of Task 1 MIC Data for 20-Day SRT (Varying SRT) 
SRT 
(d) 
Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
20 
AMP 
1 38% 100% 
32 
0 0 0 0 0 0 0 3 64.0 
64.0 0.0 
61.8 4.6 
2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 38% 100% 0 0 0 0 0 0 0 3 64.0 
SMX/TMP 
1 75% 100% 
76/4 
0 0 0 0 0 0 0 6 64.0 
64.0 0.0 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 50% 100% 0 0 0 0 0 0 0 4 64.0 
TET 
1 100% 100% 
16 
0 0 0 0 0 0 1 7 60.0 
62.7 2.3 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
VA 
1 100% 100% 
4 
0 0 1 0 1 0 0 6 49.3 
56.6 7.4 2 100% 100% 0 0 0 1 0 0 0 7 56.5 
3 88% 100% 0 0 0 0 0 0 0 7 64.0 
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5.4.8 The effect of elevated antibiotic concentrations on minimum inhibitory 
concentration among antibiotic resistant bacteria 
Similar to the previous phase (MIC assay for varying SRT), the results were analyzed and the 
weighted score for each antibiotic concentration were reported. In total, 480 isolates were 
harvested, processed, and shipped to the University of Arizona for the MIC assay. Of the 480 
total harvested isolates, 456 (95%) were successfully revived for the MIC assay. The isolates that 
were pre-screened for resistance to ampicillin (93% revival rate) or 
sulfamethoxazole/trimethoprim (93% revival rate) were more difficult to revive in MH broth 
compared to those prescreened for resistance to tetracycline (97% revival rate) or vancomycin 
(98% revival rate). This is consistent with Task 1. However, the differences in Task 2 were 
minimal, and the revival rates in Task 2 were significantly higher. 3 out of 456 revived isolates 
(0.7%) were found to be susceptible to antibiotics, specifically two isolates for ampicillin and 
one isolate for vancomycin, at or below the standard MIC. In comparison, the antibiotic 
resistance rate was 100% for the revived isolates in Task 1. Although 100% resistance was 
expected in Task 2 as well, the three isolates represent a very small fraction of the population. 
438 isolates (~96% of the total revived isolates) grew in the presence of their respective target 
antibiotics at concentrations 32 times higher than the MIC. The MICs for the remaining 18 
isolates were spread relatively evenly throughout the 0.5x-32x concentration range. 
In this phase, the primary effluent exhibited the highest weighted score. This suggests the 
Staph/Strep in the primary effluent were characterized by the greatest extent of AR and that 
biological treatment did not promote resistance to higher concentrations of antibiotics. This 
contradicts the results in varying SRT experiment. Also, due to the relatively consistent growth 
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even at 32x, it was not possible to reliably differentiate the MICs in the four SBRs. Again, 
concentrations higher than 32x would have to be tested to better characterize the effects of 
different operational conditions, such as influent antibiotic concentrations.  
Consistent with previous phase (MIC assay with varying SRT), vancomycin exhibited the lowest 
average weighted score after aggregating all of the samples. Therefore, vancomycin proved to be 
the most effective antibiotic, although the level of resistance was still high. 
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Table 5-18. Summary of Task 2 MIC Data for Primary Effluent 
Sam
-ple 
Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
Pr
im
ar
y 
Ef
flu
en
t 
AMP 
1 100% 100% 
32 
0 0 0 0 0 0 0 8 0 
64.0 0.0 
63.7 1.2 
2 88% 100% 0 0 0 0 0 0 0 7 0 
3 100% 100% 0 0 0 0 0 0 0 8 0 
SMX/TMP 
1 100% 100% 
76/4 
0 0 0 0 0 0 1 7 0 
62.7 2.3 2 100% 100% 0 0 0 0 0 0 0 8 0 
3 88% 100% 0 0 0 0 0 0 0 7 0 
TET 
1 100% 100% 
16 
0 0 0 0 0 0 0 8 0 
64.0 0.0 2 75% 100% 0 0 0 0 0 0 0 6 0 
3 100% 100% 0 0 0 0 0 0 0 8 0 
VA 
1 100% 100% 
4 
0 0 0 0 0 0 0 8 0 
64.0 0.0 2 100% 100% 0 0 0 0 0 0 0 8 0 
3 88% 100% 0 0 0 0 0 0 0 7 0 
 
Table 5-19. Summary of Task 2 MIC Data for 1X Antibiotic Concentrations 
Sam
-ple 
Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
1X
 
AMP 
1 88% 100% 
32 
0 0 0 0 0 0 0 7 64.0 
61.0 5.2 
61.3 5.0 
2 88% 86% 1 0 0 0 0 0 0 6 54.9 
3 75% 100% 0 0 0 0 0 0 0 6 64.0 
SMX/TMP 
1 100% 100% 
76/4 
0 0 0 0 0 0 0 8 64.0 
64.0 0.0 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
TET 
1 100% 100% 
16 
0 0 0 0 0 0 0 8 64.0 
64.0 0.0 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
VA 
1 100% 88% 
4 
0 1 0 0 0 0 1 6 52.1 
56.0 6.9 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 2 0 6 52.0 
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Table 5-20. Summary of Task 2 MIC Data for 10X (A) Antibiotic Concentrations 
Sam
-ple 
Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
10
X
 (A
) 
AMP 
1 100% 100% 
32 
0 0 0 0 0 0 0 8 64.0 
64.0 0.0 
61.3 6.3 
2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
SMX/TMP 
1 100% 100% 
76/4 
0 0 0 0 0 0 0 8 64.0 
64.0 0.0 2 88% 100% 0 0 0 0 0 0 0 7 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
TET 
1 88% 100% 
16 
0 0 1 1 0 0 0 5 46.6 
58.2 10.1 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
VA 
1 100% 100% 
4 
0 0 0 2 0 0 0 6 49.0 
59.0 8.7 2 88% 100% 0 0 0 0 0 0 0 7 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
 
Table 5-21. Summary of Task 2 MIC Data for 10X (B) Antibiotic Concentrations 
Sam
-ple 
Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
10
X
 (B
) 
AMP 
1 100% 100% 
32 
0 0 0 0 0 0 0 8 64.0 
56.5 13.0 
61.7 6.5 
2 100% 88% 1 0 0 1 1 0 0 5 41.6 
3 88% 100% 0 0 0 0 0 0 0 7 64.0 
SMX/TMP 
1 75% 100% 
76/4 
0 0 0 0 0 0 0 6 64.0 
64.0 0.0 2 75% 100% 0 0 0 0 0 0 0 6 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
TET 
1 100% 100% 
16 
0 0 0 0 0 0 0 8 64.0 
64.0 0.0 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
VA 
1 100% 100% 
4 
0 0 0 0 0 0 0 8 64.0 
62.5 2.6 2 88% 100% 0 0 0 0 0 0 1 6 59.4 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
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Table 5-22. Summary of Task 2 MIC Data for 100X Antibiotic Concentrations 
Sam
-ple 
Antibiotic Sample 
Event 
% 
Revi-
ved 
% 
AR 
CLSI 
MIC 
Observed MIC and Number of Isolates Weight-
ed Score 
Avg. 
Score 
St. 
Dev. 
Avg. 
Score 
St. 
Dev. 
(μg/mL) <1X 1X 2X 4X 8X 16X 32X >32X 
10
0X
 
AMP 
1 75% 100% 
32 
0 0 0 0 0 0 0 6 64.0 
64.0 0.0 
61.5 4.9 
2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 88% 100% 0 0 0 0 0 0 0 7 64.0 
SMX/TMP 
1 75% 100% 
76/4 
0 0 0 0 0 0 0 6 64.0 
61.4 4.5 2 100% 100% 0 0 1 0 0 0 0 7 56.3 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
TET 
1 100% 100% 
16 
0 0 0 0 0 0 0 8 64.0 
64.0 0.0 2 100% 100% 0 0 0 0 0 0 0 8 64.0 
3 88% 100% 0 0 0 0 0 0 0 7 64.0 
VA 
1 100% 100% 
4 
0 0 1 1 0 0 0 6 48.8 
56.6 7.6 2 100% 100% 0 0 0 0 1 0 0 7 57.0 
3 100% 100% 0 0 0 0 0 0 0 8 64.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
179 
5.5 Conclusions 
Solids retention time (SRT) is one of the most important factors in designing and operating 
activated sludge systems for biological wastewater treatment. Longer SRTs have been shown to 
alter the structure and function of microbial communities, thereby leading to improved treatment 
efficacy with respect to bulk and trace organics, nutrient removal, and membrane fouling. 
However, research has also shown that longer SRTs lead to increased prevalence of antibiotic 
resistant bacteria, perhaps due to increased exposure to antibiotics present in influent wastewater. 
In this study, the goal was to develop a baseline understanding of antibiotics and antibiotic 
resistant bacteria during wastewater treatment. According to the results, longer SRTs are 
associated with lower TOrCs concentrations and higher antibiotic resistance rate. First of all, it 
should be noted that any changes in the rate of AR in biological treatment systems does not 
necessarily indicates higher rate of AR in the product water. In fact, most of the MLSS are 
separated from wastewater through clarifiers. Then, recycled water is subjected to advanced 
treatment processes (e.g., disinfection, filtration) in many WWTPs. Furthermore, focusing on 
antibiotic resistance does not emphasize its greater importance over TOrCs. In fact, the results 
showed that biological treatment systems even in low SRTs select for AR. Therefore, more 
research projects need to be done to explore the risks associated with AR and TOrCs. In ideal 
scenario, research projects may focus on alternative approaches that minimize the proliferation 
of AR and maximize the removal of TOrCs removal. The generated results from this study can 
be used for further investigation of the safety of treated municipal wastewater.  
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6.0 CONCLUSIONS 
According to the existing literature, biological treatment systems in WWTPs are considered 
significant reservoirs of AR. The results from this study provide further support for that 
statement and even suggest that biological treatment systems select for ARBs. This was 
concluded because of the higher rate of ARBs in biological reactors compared to the rates in 
primary effluent. SRT also plays an important role in the fate of ARBs in biological treatment 
systems. Longer SRTs are favorable since they can lead to reductions in trace organic compound 
(TOrC) and nutrient concentrations. However, according to the results from this study, 
employing longer SRTs may contribute to the proliferation of antibiotic resistance. Further 
studies are needed in this area to identify the optimum SRT, which simultaneously addresses 
both concerns (i.e., maximize TOrC removal while minimizing AR proliferation). It should be 
noted again that the outcomes of this study aimed to develop a baseline understanding of 
antibiotics and antibiotic resistant bacteria during wastewater treatment. Although this work 
explained their fate during biological treatment, it does not address the human health impacts of 
the use of recycled water or the presence of antibiotic resistant bacteria in the product water. 
However, the generated results can be used for further investigation of the safety of treated 
municipal wastewater.  
Despite efforts to understand the fate of antibiotic resistance in WWTPs, specifically in 
biological treatment systems, there are still many uncertainties regarding this issue. 
Contradictory outcomes may arise when studies focus on different influent wastewater qualities, 
different treatment technologies and/or operational conditions, and even different methodologies 
for assessment of microbial community structure. The results from Chapter 3 actually proved 
that the understanding of antibiotic resistance patterns is more complicated than expected. 
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Considering that longer SRTs are associated with higher rates of cell death and decay and higher 
concentrations of cellular debris, the resulting dissolved intracellular components, such as 
thymine or thymidine, may be used by bacteria to negate the bacteriostatic effects of some 
antibiotics, including TMP and SMX. Therefore, free thymine/thymidine in environmental 
samples may still result in overestimation of AR prevalence unless bacteria are separated from 
their matrix before assay (e.g., with membrane filtration). More studies are recommended in this 
area to identify possible compounds that negate the effects of antibiotics, which may lead to 
overestimation of AR prevalence. 
With respect to the microbial community in biological treatment systems, there is strong 
evidence that SRT impacts microbial biodiversity. However, it is still unclear whether the higher 
rates of antibiotic resistance observed at longer SRTs are caused by changes in microbial 
community structure and/or changes in the composition of the wastewater matrix. With 
increasing rates of antibiotic production and consumption or due to accidental releases, it is quite 
possible that antibiotic concentrations in raw wastewaters will increase over time. At first, it was 
hypothesized that higher concentrations of antibiotics would increase the risk of biological 
treatment failure and adversely impact microbial community structure. However, the results 
actually showed that higher antibiotic concentrations had minimal effects on the performance of 
the biological reactors and microbial community structure, but higher rates of antibiotic resistant 
bacteria. 
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7.0 APPENDIX A 
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Table A1. Summary of TOrC concentrations in the primary effluent and secondary effluent from 
the SBRs as a function of SRT.  
Day Sample / SRT TMP 
(ng/L) 
%a 
Removal 
SMX 
(ng/L) 
%a 
Removal 
Atenolol 
(ng/L) 
%a 
Removal 
1 
PE 380 -- 990 -- 880 -- 
PE (duplicate) 370 -- 970 -- 830 -- 
2 days 370 1 1,100 -12 790 8 
2 days (duplicate) 330 12 1,000 -2 710 17 
7 days (reactor A) 420 -12 1,400 -43 480 44 
7 days (reactor B) 420 -12 1,500 -53 320 63 
20 days 120 68 1,300 -33 71 92 
2 
PE 530 -- 1,100 -- 1,100 -- 
PE (duplicate) 710 -- 1,300 -- 1,100 -- 
2 days 500 19 1,100 8 960 13 
7 days (reactor A) 470 24 1,200 0 440 60 
7 days (reactor B) 410 34 1,400 -17 300 73 
20 days 180 71 1,200 0 110 90 
20 days (duplicate) 180 71 1,200 0 110 90 
a % removal calculated based on average PE concentration for each day 
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Table A2. ANOVA and Tukey’s test for manual augmentation of thymidine with reagent-grade 
chemical. 
 
 
Table A3. ANOVA and Tukey’s test for manual augmentation of thymidine via cell lysing. 
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Table A4. ANOVA and Tukey’s test to evaluate the effects of varying MLSS filtrate volumes 
(from 7-day SRT) on apparent TMP resistance among bacteria from the MLSS operated with a 
2-day SRT. 
 
 
Table A5. ANOVA and Tukey’s test to evaluate the effects of varying MLSS filtrate volumes 
(from 7-day SRT) on apparent TMP resistance among bacteria from the MLSS operated with a 
7-day SRT. 
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Table A6. ANOVA and Tukey’s test to evaluate the effects of varying MLSS filtrate volumes 
(from 7-day SRT) on apparent TMP resistance among bacteria from the MLSS operated with a 
20-day SRT. 
 
Table A7. ANOVA and Tukey’s test to evaluate the effects of varying SRT on apparent TMP 
resistance. 
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Table A8. ANOVA and Tukey’s test to evaluate the effects of varying SRT on multi-drug 
resistance across three separate sample events. Separate ANOVAs were performed for the 
individual sample events due to the effect of temperature on relative resistance.  
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8.0 APPENDIX B 
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Table B1. Summary of methods for water quality parameters 
Measurement Sampling and 
Measurement Method 
Analysis Method Sample 
Container/ 
Quantity of 
Sample 
Preservation/ 
Storage 
Hold Time 
pH Orion Model 720A pH meter 
Standard Method 
4500-H B 
20 mL glass 
vials/10 mL None 
Immediate 
analysis 
MLSS  
0.45-µm glass fiber filters, 
25-mL baking crucibles, 
105ºC oven, analytical 
balance 
Standard Methods 
2540 D 
50 mL centrifuge 
tube/10 mL 
Refrigeration/ 
Store @ 42C 7 d 
MLVSS 
0.45-µm glass fiber filters, 
25-mL baking crucibles, 
550ºC oven, analytical 
balance 
Standard Methods 
2540 D,E 
50 mL centrifuge 
tube/10 mL 
Refrigeration/ 
Store @ 42C 7 d 
NH3 
Hach DR/5000 
spectrophotometer, 
Salicylate Method 
Hach Method 
10031 
150 mL amber glass 
bottle/100 μL 
HCl addition to 
pH<2 / Store @ 
42C 
28 d 
NO3 
Hach DR/5000 
spectrophotometer, 
Cadmium Reduction 
Method 
Hach Method 8039 150 mL amber glass bottle/10 mL 
Filter / Store @ 
42C 48 h 
NO2 
Hach DR/5000 
spectrophotometer, 
Diazotization Method 
Hach Method 8507 150 mL amber glass bottle/10 mL 
Filter / Store @ 
42C 48 h 
DO O2 electrode probe Standard Method 4500-O G 
40 mL glass 
vials/20 mL None 
Immediate 
analysis 
Soluble COD 
(sCOD) 
Hach DR/5000 
spectrophotometer, 
Reactor Digestion Method 
U.S. EPA method 
410.4, Hach 
Method 8000 
20 mL glass vials/2 
mL 
H2SO4 addition to 
pH<2 / Store @ 
42C 
28 d 
Spread Plates Spread plate on select nutrient media agars 
Described in main 
text 
50 mL conical 
tube/100 μL per 
plate 
None 8 h 
TOrCs 
LC-MS/MS, API 4000 
triple-quadrupole mass 
spectrometer 
Trenholm et al. 
(2006); Vanderford 
and Snyder (2006) 
500 mL pre-cleaned 
amber bottle 
1 g/L NaN3 and 50 
mg/L Ascorbic 
Acid / Store @ 
42C 
28 days 
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9.0 APPENDIX C 
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Table C1. ANOVA and Tukey’s test to evaluate the effects of varying SRT on SMX/TMP resistance. 
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Table C2. ANOVA and Tukey’s test to evaluate the effects of varying SRT on AMP resistance. 
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Table C3. ANOVA and Tukey’s test to evaluate the effects of varying SRT on TC resistance. 
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Table C4. ANOVA and Tukey’s test to evaluate the effects of varying SRT on VA resistance. 
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Table C5. ANOVA and Tukey’s test to evaluate the effects of varying influent antibiotic concentrations 
on VA resistance. 
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Table C6. ANOVA and Tukey’s test to evaluate the effects of varying influent antibiotic concentrations 
on SMX/TMP resistance. 
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Table C7. ANOVA and Tukey’s test to evaluate the effects of varying influent antibiotic concentrations 
on TC resistance. 
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Table C8. ANOVA and Tukey’s test to evaluate the effects of varying influent antibiotic concentrations 
on AMP resistance. 
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